Sentence,class,file
"2012 October 17, 2014; Available from: http://www.cdc.gov/hantavirus/ outbreaks/yosemite-national-park-2012.html.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.npr.org/blogs/health/2014/10/27/359323578/new-yorks-disease-detectives-hit-the-street-in-search-of-ebola.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.edition.cnn.com/2014/10/08/health/thomas- eric-duncan-ebola/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from:  http://www.csmonitor.com/USA/2014/1001/First-US-Ebola-case-Why-the-delayed-diagnosis-video.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.edition.cnn.com/2014/10/16/health/us-ebola/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.dfw.cbslocal.com/2014/10/15/comparison-of-contact-between-two-sick-nurses-ebola-patient/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.independent.co.uk/life-style/health-and-families/how-the-ebola-virus-got-its-name-and-how-we-caught-it-from-animals-9770193.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
2014; Available from: http://www.who.int/csr/disease/ebola/ overview-august-2014/en/ [Last accessed on 2014 Nov 15].,OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
2014; Available from: http://www.who.int/csr/resources/publications/ebola/travel-guidance/ en/ [Last accessed on 2014 Nov 15].,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
2014; Available from: http://phc.amedd.army.mil/topics/discond/diseases/pages/EbolaVirusDisease.aspx [Last accessed on 2014 Nov 15].,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available  from: http://www.mddionline.com/article/containing-ebola-7-next-gen- rapid-diagnostic-tests-11-07-14.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.newsday.com/business/chembio-diagnostics-developing-rapid-test-for-ebola-1.9550864.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.nbcnews.com/storyline/ebola-virus-outbreak/dallas-nurse-amber-vinson-ebola-free-will-leave-hospital-n235316.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.washingtonpost.com/local/dallas-nurse-treated-for-ebola-at-nih-now-virus- free/2014/10/24/91355cd2-5b8c-11e4-bd61-346aee66ba29_story.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"2014 October 28, 2014; Available from: http://www.usatoday.com/story/news/nation/2014/10/13/ebola-nurse-who/17182599/.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.newrepublic.com/article/119376/ebola-drug-zmapp-darpa- program-could-get-it-africa.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from:  http://www.nytimes.com/2014/08/08/health/second-experimental-drug- allowed-for-treating-ebola.html?_r=0.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://ir.chimerix.com/releasedetail.cfm?releaseid=868807.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.forbes.com/sites/davidkroll/2014/10/07/chimerixs-brincidofovir-given-to-dallas-nebraska-ebola-patients/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.washingtonpost.com/news/to-your- health/wp/2014/09/16/an-ebola-vaccine-was-given-to-10-volunteers-and-there-are-no-red-flags-yet/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.dddmag.com/articles/2014/09/two-anti-ebola-vaccines-historic-race.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.investors.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.blogs.reuters.com/great-debate/2014/07/30/efforts-against-ebola-outbreak-hampered-by-victims-lack-of-trust-in- healthcare-workers/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.cnn.com/2014/10/15/health/texas-ebola- nurses-union-claims/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"2014 November 12, 2014; Available from:  http://www.nytimes.com/2014/11/12/nyregion/craig-spencer-new-york-ebola-patient-bellevue.html?_r=0.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"2014  November 9, 2014; Available from: http://www.who.int/csr/resources/publications/ebola/blood-collect-en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.cnn.com/2014/10/16/us/ germ-zapping-robot-ebola/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from:  http://www.telegram.com/article/20141109/NEWS/311099832/1246.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.foxnews.com/health/2014/11/04/ebolas-orphans-survivors-care-for-children-left-behind-by-disease/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.un.org/apps/news/story.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.mediaite.com/online/schools-in%C2%A0texas-ohio-close- over-ebola-panic/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"2014 November 12, 2014; Available from: http://www.cdc.gov/media/releases/2014/p1022-post-arrival-monitoring.html.",OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.nytimes.com/2014/10/30/us/kaci-hickox-nurse-under-ebola-quarantine-threatens-lawsuit.html?_r=0.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://philadelphia.cbslocal.com/2014/10/27/ebola-nurse-forced-into-quarantine-in-n-j-contemplates-civil-rights-lawsuit/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.washingtonpost.com/news/to-your-health/wp/2014/09/30/ nigerias-ebola-outbreak-may-be-coming-to-an-end/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.humanosphere.org/global-health/2014/11/calls-increased-efforts-amid-promising-worrying-progress-ebola/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.dailymail.co.uk/,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.e-ir.info/2014/10/20/ebola-and-the-politics-of-a-global- health-crisis/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"2014 November 10, 2014; Available from: http://www.foxnews.com/health/2014/09/23/who-forecasts-more-than-20000-ebola-cases-by-november-2/.",Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.weeklystandard.com/blogs/general-if-ebola-reaches-central-america-there-will-be-mass-migration-us_810793.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available  from: http://www.abc.net.au/news/2014-10-17/health-minister-defends-australias-ebola-response/5821036.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.miamiherald.com/news/nation-world/world/americas/article3073953.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://edition.cnn.com/2014/09/24/business/ebola-cost-warning/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.bbc.com/news/business-28865434.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.voanews.com/content/ebola-outbreak-who-response-one-billion-dollars/2451347.html.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php.,OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://www.cbsnews.com/news/ebola-outbreak-latest-texas-patient-to-be-transferred-to-atlanta-hospital/.,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
Available from: http://abcnews.go.com/Health/nurse-ebola-arrives-emory/care involved?[180-182].,Non-OADS,/arxiv_data1/oa_pdf/90/d1/JGID-6-164.PMC4265832.pdf
"Retrieved from http://studentorgs.utexas.edu/salsa/proceedings/2006/Bieswanger.pdf Bishop, D. (2003).",Non-OADS,/arxiv_data1/oa_pdf/4a/d8/bjdp0032-0415.PMC4265847.pdf
"Retrieved from http://stakeholders.ofcom.org.uk/ market-data-research/media-literacy/medlitpub/medlitpubrss/ukchildrensml11/ Plester, B., Wood, C., & Bell, V. (2008).",OADS,/arxiv_data1/oa_pdf/4a/d8/bjdp0032-0415.PMC4265847.pdf
http://www.articlesbase.com/ cell-phones-articles/cell-phone-texting-can-endanger-spelling-276413.html Received 22 April 2013; revised version received 24 April 2014Relationships between grammar and texting 429,Non-OADS,/arxiv_data1/oa_pdf/4a/d8/bjdp0032-0415.PMC4265847.pdf
"(Accessed July 10, 2010 at http://www.whocc.no/).",Non-OADS,/arxiv_data1/oa_pdf/a9/47/pds0022-1326.PMC4265848.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/23/TODENTJ-8-213.PMC4265849.pdf
The subsets of genesthat we selected were based on pathways of Kyoto Encyclopedia ofGenes and Genomes (KEGG; http://www.genome.jp/kegg/).,OADS,/arxiv_data1/oa_pdf/f1/98/cga0054-0094.PMC4265850.pdf
ontology (GO) analysis was performed with Cytoscape (http:// cytoscape.org/index.php) and Biological Network Gene Ontologytool (BiNGO; http://www.psb.ugent.be/cbd/papers/BiNGO/Home.html).,OADS,/arxiv_data1/oa_pdf/f1/98/cga0054-0094.PMC4265850.pdf
"Analysis with molecu-lar network software (Cytoscape plug-in Agilent literature search;http://www.agilent.com/labs/research/litsearch.html) for these eightgenes made the molecular network that included the four genes(Ywhab, Nek2, Tacc1 and Frk ), thereafter the other four genes were excluded from the candidates.",OADS,/arxiv_data1/oa_pdf/f1/98/cga0054-0094.PMC4265850.pdf
available at : http://statistics.berkeley.edu/tech-reports/633.,OADS,/arxiv_data1/oa_pdf/f1/98/cga0054-0094.PMC4265850.pdf
"Norén N. Statistical methods for knowledge discovery in adverse drug reaction surveillance, Matematiska Institutionen 2007, http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6764 (last accessed on 28 September 2012).",OADS,/arxiv_data1/oa_pdf/e8/e4/pds0023-0787.PMC4265853.pdf
"Stem Cell Reports Report Induced Neural Stem Cells Achieve Long-T erm Survival and Functional Integration in the Adult Mouse Brain Kathrin Hemmer,1,2Mingyue Zhang,3Thea van Wu ¨llen,1,2Marna Sakalem,2,3Natalia Tapia,4 Aidos Baumuratov,1Christian Kaltschmidt,5Barbara Kaltschmidt,5Hans R. Scho ¨ler,4Weiqi Zhang,3 and Jens C. Schwamborn1,2,* 1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Esch-sur-Alzette, Luxembourg 2Stem Cell Biology and Regeneration Group, Institute of Cell Biology, ZMBE, Westfa ¨lische Wilhelms-University Mu ¨nster, 48149 Mu ¨nster, Germany 3Laboratory for Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Laboratory for Molecular Psychiatry, Westfa ¨lische Wilhelms-University of Mu ¨nster, 48149 Mu ¨nster, Germany 4Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, 48149 Mu ¨nster, Germany 5Molecular Neurobiology, Faculty of Biology, University of Bielefeld, 33501 Bielefeld, Germany *Correspondence: jens.schwamborn@uni.lu http://dx.doi.org/10.1016/j.stemcr.2014.06.017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b2/55/main.PMC4265999.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and one ﬁgure and can be found with this article online athttp://dx.doi.org/10.1016/j.stemcr.2014.06.017 .,Non-OADS,/arxiv_data1/oa_pdf/b2/55/main.PMC4265999.pdf
The graphical abstract was produced using Servier Medical Art(http://www.servier.com ).,Non-OADS,/arxiv_data1/oa_pdf/b2/55/main.PMC4265999.pdf
"Stem Cell Reports Article T ranscriptional Repression by the BRG1-SWI/SNF Complex Affects the Pluripotency of Human Embryonic Stem Cells Xiaoli Zhang,1,7Bing Li,1,7Wenguo Li,1,7Lijuan Ma,1Dongyan Zheng,1Leping Li,2Weijing Yang,5Min Chu,1 Wei Chen,1Richard B. Mailman,4Jun Zhu,5Guoping Fan,6Trevor K. Archer,3and Yuan Wang1,* 1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China 2Biostatistics Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Service s, Research Triangle Park, NC 27709, USA 3Chromatin and Gene Expression Group, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Inst itutes of Health, Department of Health and Human Services, Research Triangle Park, NC 27709, USA 4Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033-0850, USA 5Systems Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesd a, MD 20892, USA 6Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-7088, USA 7Co-ﬁrst author *Correspondence: ywang@bio.ecnu.edu.cn http://dx.doi.org/10.1016/j.stemcr.2014.07.004 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e9/2a/main.PMC4266000.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and six tables and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2014.07.004 .",OADS,/arxiv_data1/oa_pdf/e9/2a/main.PMC4266000.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.07.001 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/62/main.PMC4266001.pdf
http://dx.doi.org/10.1016/j.stemcr.2014.07.008 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8b/main.PMC4266002.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/a8/8b/main.PMC4266002.pdf
"Stem Cell Reports Article CRISPR-Mediated Genomic Deletion of Sox2 in the Axolotl Shows a Requirement in Spinal Cord Neural Stem Cell Ampliﬁcation during TailRegeneration Ji-Feng Fei,1Maritta Schuez,1Akira Tazaki,1Yuka Taniguchi,1Kathleen Roensch,1and Elly M. Tanaka1,* 1DFG Center for Regenerative Therapies, Dresden (CRTD), Technische Universita ¨t Dresden, Dresden 01307, Germany *Correspondence: elly.tanaka@crt-dresden.de http://dx.doi.org/10.1016/j.stemcr.2014.06.018 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/41/1f/main.PMC4266004.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/41/1f/main.PMC4266004.pdf
"Stem Cell Reports Report SLIT/ROBO2 Signaling Promotes Mammary Stem Cell Senescence by Inhibiting Wnt Signaling Gwyndolen Harburg,1Jennifer Compton,1Wei Liu,2Naomi Iwai,1Shahrzad Zada,1Rebecca Marlow,3 Phyllis Strickland,1Yi Arial Zeng,2and Lindsay Hinck1,* 1Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, CA 95064, USA 2Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China 3Breakthrough Breast Cancer Unit, King’s College London School of Medicine, London SE1 9RT, UK *Correspondence: lhinck@ucsc.edu http://dx.doi.org/10.1016/j.stemcr.2014.07.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/2a/a7/main.PMC4266005.pdf
"Stem Cell Reports Article T ransiently Active Wnt/ b-Catenin Signaling Is Not Required but Must Be Silenced for Stem Cell Function during Muscle Regeneration Malea M. Murphy,1,2,3Alexandra C. Keefe,1,2Jennifer A. Lawson,1Steven D. Flygare,1Mark Yandell,1 and Gabrielle Kardon1,* 1Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA 2Co-ﬁrst author 3Present address: Children’s Research Institute at UT Southwestern, Dallas, TX 75390, USA *Correspondence: gkardon@genetics.utah.edu http://dx.doi.org/10.1016/j.stemcr.2014.06.019 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/78/eb/main.PMC4266007.pdf
andavailable at https://github.com/stevendﬂygare/muscleQNT ).,Non-OADS,/arxiv_data1/oa_pdf/78/eb/main.PMC4266007.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2014.06.019 .",OADS,/arxiv_data1/oa_pdf/78/eb/main.PMC4266007.pdf
"Stem Cell Reports Perspective Professional Regulation: A Potentially Valuable T ool in Responding to ‘‘Stem Cell T ourism’’ Amy Zarzeczny,1,*Timothy Caulﬁeld,2Ubaka Ogbogu,3Peter Bell,4Valorie A. Crooks,5Kalina Kamenova,6 Zubin Master,7Christen Rachul,6Jeremy Snyder,8Maeghan Toews,6and Sonja Zoeller1 1Johnson-Shoyama Graduate School of Public Policy, University of Regina, Regina, SK S4S 0A2, Canada 2Faculty of Law and School of Public Health, Health Law Institute, University of Alberta, Edmonton, AB T6G 2H5, Canada 3Faculties of Law and Pharmacy and Pharmaceutical Sciences, Health Law Institute, University of Alberta, Edmonton, AB T6G 2H5, Canada 4Department of Family Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7 5Department of Geography, Simon Fraser University, Burnaby, BC V5A 1S6, Canada 6Health Law Institute, University of Alberta, Edmonton, AB T6G 2H5, Canada 7Alden March Bioethics Institute, Albany Medical College, Albany, NY 12208-3478, USA 8Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada *Correspondence: amy.zarzeczny@uregina.ca http://dx.doi.org/10.1016/j.stemcr.2014.06.016 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
http://www.gmc-uk.org/ International_Comparison_of_Ten_Medical_Regulatory_Systems___ﬁnal_report.pdf_25404378.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
http://www.fda.gov/ICECI/ CriminalInvestigations/ucm268867.htm .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
http://www.isscr.org/ home/publications/patient-handbook .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
http://www.isscr.org/docs/default-source/ isscr-statements/isscr-acbistatement-091113-ﬂ.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
http://www.hli.ualberta.ca/ Research/Public_Outreach_Award.aspx .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
1980-81. http://www.qp.gov.sk.ca/documents/ English/Statutes/Statutes/M10-1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"The Telegraph, April 8, 2012. http://www.telegraph.co.uk/ health/healthnews/9192157/Stem-cell-clinic-that-preyed-on-the- vulnerable.html .",Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"http://dx.doi.org/10.1016/j.scr.2014.04.014 .Ogbogu, U., Rachul, C., and Caulﬁeld, T. (2013).",OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"January 9, 2014. https://techmedweb.omb.state.",Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"The New York Times, April 13, 2012. http://www.nytimes.com/2012/ 04/14/us/new-rules-on-adult-stem-cells-approved-in-texas.html .",Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"November 9, 2010. http://www.healthprofessionals.gov.sg/content/dam/hprof/smc/docs/press_releases/15.Press%20Release_Dr%20Wong%20Yoke%20Meng4_9Nov10.pdf .",Non-OADS,/arxiv_data1/oa_pdf/ea/16/main.PMC4266009.pdf
"Lundbeck A/S, Ottiliavej 9, Valby 2500, Denmark *Correspondence: mar@bioneer.dk http://dx.doi.org/10.1016/j.stemcr.2014.07.006 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f2/d7/main.PMC4266010.pdf
ACCESSION NUMBERS The GEO ( http://www.ncbi.nlm.nih.gov/geo/ ) accession number for the microarray data reported in this paper is GSE48665.,Non-OADS,/arxiv_data1/oa_pdf/f2/d7/main.PMC4266010.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and three tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2014.07.",OADS,/arxiv_data1/oa_pdf/f2/d7/main.PMC4266010.pdf
"Stem Cell Reports Article Methylation and T ranscripts Expression at the Imprinted GNAS Locus in Human Embryonic and Induced Pluripotent Stem Cells and Their Derivatives Virginie Grybek,1Laetitia Aubry,2,3Ste´phanie Maupetit-Me ´houas,1,8Catherine Le Stunff,1Ce´cile Denis,4 Mathilde Girard,4Agne`s Linglart,1,5,6and Caroline Silve1,6,7,* 1INSERM U986, Ho ˆpital Bice ˆtre, Le Kremlin Bice ˆtre 94276, France 2UEVE UMR 861, I-Stem, AFM, Evry 91030, France 3INSERM UMR 861, I-Stem, AFM, Evry 91030, France 4CECS, I-Stem, AFM, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, Evry 91030, France 5Service d’Endocrinologie Pe ´diatrique, Ho ˆpital Bice ˆtre-AP-HP, Le Kremlin Bice ˆtre 94276, France 6Centre de Re ´fe´rence des Maladies Rares du Me ´tabolisme Phospho-Calcique Ho ˆpital Bice ˆtre, Le Kremlin Bice ˆtre 94276, France 7Laboratoire de Biochimie Hormonale et Ge ´ne´tique, Ho ˆpital Bichat Claude Bernard-AP-HP, Paris 75018, France 8Present address: Laboratoire GReD, P. Arnaud Team, CNRS 6293, Clermont Universite ´, INSERM U1103, Faculte ´de Me ´decine, Clermont-Ferrand Cedex 63001, France*Correspondence: caroline.silve@inserm.fr http://dx.doi.org/10.1016/j.stemcr.2014.07.002 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3d/ce/main.PMC4266011.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and two tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2014.07.002 .,Non-OADS,/arxiv_data1/oa_pdf/3d/ce/main.PMC4266011.pdf
"Stem Cell Reports Article T racing the Origin of the HSC Hierarchy Reveals an SCF-Dependent, IL-3-Independent CD43/C0Embryonic Precursor Stanislav Rybtsov,1Antoniana Batsivari,1Kateryna Bilotkach,1Daria Paruzina,1Jordi Senserrich,1 Oleg Nerushev,2and Alexander Medvinsky1,* 1MRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK 2School of Chemistry, EaStCHEM, The University of Edinburgh, Edinburgh EH9 3JJ, Scotland, UK *Correspondence: a.medvinsky@ed.ac.uk http://dx.doi.org/10.1016/j.stemcr.2014.07.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/main.PMC4266012.pdf
Images of cells were downloaded from Servier Medical Art ( http://www.servier.com/ ) with the owner’s permission.,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/main.PMC4266012.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2014.,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/main.PMC4266012.pdf
"http://informahealthcare.com/jas ISSN: 0277-0903 (print), 1532-4303 (electronic) J Asthma, 2014; 51(10): 1035–1042 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/02770903.2014.939282 OCCUPATIONAL ASTHMA Distribution of asthma by occupation: Washington State Behavioral Risk Factor Surveillance System Data, 2006–2009 Naomi J. Anderson, MPH, Zihong Joyce Fan, PhD, Carolyn Reeb-Whitaker, MS, CIH , David K. Bonauto, MD, MPH , and Edmund Rauser, BS, PE Safety and Health Assessment and Research for Prevention (SHARP) Program, Washington State Department of Labor and Industries, Olympia, Washington, USA Abstract Objective : To estimate the prevalence of asthma in workers by occupation in Washington State.",Non-OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.cdc.gov/brfss/acbs/index.htm.,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.cdc.gov/brfss/acbs/index.htm.,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Software and User Manual are available at:http://www.cdc.gov/niosh/soic/default.html.,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
SIC Manual available at: https://www.osha.- gov/tutorials/sic_help.html.,Non-OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.onetonline.org/find/descriptor/result/4.C.2.b.1.d.,Non-OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.bls.gov/soc/ [last accessed 16 Jan 2014].,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.cdc.gov/brfss/annual_data/2007/2007SummaryDataQualityReport.docx [last accessed 3 Jul 2014].,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.cdc.gov/brfss/annual_data/2008/2008_Summary_Data_Quality_Report.,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from: http://www.cdc.gov/brfss/annual_data/2009/2009_Summary_Data_ Quality_Report.docx [last accessed 3 Jul 2014].,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
Available from http://www.cdc.gov/niosh/topics/coding/ [last accessed 3 Jul 2014].,OADS,/arxiv_data1/oa_pdf/ea/a2/JAS-51-1035.PMC4266043.pdf
"http://informahealthcare.com/iht ISSN: 0895-8378 (print), 1091-7691 (electronic) Inhal Toxicol, 2014; 26(14): 861–865 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/08958378.2014.965559 RESEARCH ARTICLE Cigarette smoking is associated with dose-dependent adverse effects on paraoxonase activity and fibrinogen in young women Gajalakshmi Ramanathan1, Jesus A. Araujo1, Jeffrey Gornbein2, Fen Yin1, and Holly R. Middlekauff1 1Department of Medicine, Division of Cardiology, David Geffen School of Medicine, UCLA, A2-237 CHS, 650 Charles Young Drive South, Los Angeles, CA, USA, and2Department of Biomathematics, David Geffen School of Medicine, SBCC-Life Sciences 5202, 650 Charles Young Drive South, Los Angeles, CA, USA Abstract Context : Smoking is associated with increased fibrinogen and decreased paraoxonase (PON) activity, markers of inflammation and oxidative stress, in patients with coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/02/4d/IHT-26-861.PMC4266070.pdf
"http://informahealthcare.com/bij ISSN: 0269-9052 (print), 1362-301X (electronic) Brain Inj, 2014; 28(13–14): 1646–1656 !2014 Informa UK Ltd. DOI: 10.3109/02699052.2014.946449 ORIGINAL ARTICLE Revisiting the neurofunctional approach: Conceptualizing the core components for the rehabilitation of everyday living skills Jo Clark-Wilson1, Gordon Muir Giles2,3, & Doreen M. Baxter4 1Managing Partner, Occupational Therapist and Case Manager, Head First, Hawkhurst, Kent, UK,2Director of Neurobehavioral services, Crestwood Treatment Center, Fremont, CA, USA,3Professor, Department of Occupational Therapy, Samuel Merritt University, Oakland, CA, USA, and 4Consultant Clinical Neuropsychologist, Head First, Hawkhurst, Kent, UK Abstract Background : Introduced in the 1980s, the neurofunctional approach (NFA) is one of the few interventions designed primarily for clients with severe deficits following traumatic brain injury(TBI).",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/BIJ-28-1646.PMC4266071.pdf
"Available from: URL:   http://www.vetinst.no/Publikasjoner/ NORM-NORM-VET/NORM-NORM-VET -2012        Shallcross   LJ ,  Petersen   I ,  Rosenthal   J ,  Johnson   AM , [15]   Freemantle   M ,  Hayward   AC  .",Non-OADS,/arxiv_data1/oa_pdf/99/9c/INF-46-832.PMC4266085.pdf
"Available from:  http://www.ecdc.europa.eu/en/publications/publications/101129_ter_hiv_testing_evidence.pdf        Adler   A ,  Mounier-Jack   S ,  Coker   RJ  .",Non-OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
"Available from: http://www.folkhalsomyndigheten.se/documents/projektweb-bar/rav/rekommendationer/rav-behandling-antiviral-hivin-fektion-2013-uppdaterad-version.pdf        Bärnighausen   T ,  McWalter   TA ,  Rosner   Z ,  Newell   ML ,  [6]  Welte   A  .",OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
[10]   Available from: http://www.unaids.org/en/media/unaids/ contentassets/dataimport/pub/basedocument/2010/epi_alert_1stqtr2010_en.pdf       Monitoring recently acquired HIV infections in the Euro- [11]  pean context .,Non-OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
Available from: http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb_C/1317140300680       National Strategy to Combat HIV/AIDS and Certain Other [13]  Communicable Diseases.,Non-OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
"Available  from: http://www.regeringen.se/sb/d/108/a/55679        Karlsson   A ,  Bj ö rkman   P ,  Bratt   G ,  Ekvall   H ,  Gissl é n   M , [14]   S ö nnerborg   A ,  et   al  .",OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
Available from:  http://www.folkhalsomyndigheten.,Non-OADS,/arxiv_data1/oa_pdf/ca/e5/INF-46-862.PMC4266095.pdf
"http://informahealthcare.com/jic ISSN: 1356-1820 (print), 1469-9567 (electronic) J Interprof Care, 2015; 29(1): 3–7 !2015 Informa UK Ltd. DOI: 10.3109/13561820.2014.937483 ORIGINAL ARTICLE Interprofessional Education and Practice Guide No.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
"These resources can be accessed at: http://www.a4hi.org/education/eduResources.cfm American Interprofessional Health Collaborative has links to numer- ous IPE resources on their website, many of which could be useful in faculty development activities: http://www.aihc-us.org/ Canadian Interprofesional Health Collaborative (CIHC) is a not- for-profit organization working to advance interprofessional education inCanada.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
"Their website, which includes an IPE toolkit with numerousresources, can be accessed at: http://www.cihc.ca/ Centre for the Advancement of Interprofessional Education (CAIPE) is a UK-based centre that promotes and develops interprofessionaleducation and collaborative practice in universities and the workplace.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
"Avariety of interprofession education resources can be accessed the CAIPEwebsite: http://caIPE.org.uk/Interprofessional Education Collaborative – A collaborative of six national education associations of schools of health professions, formed in 2009.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
"They offer the IPEC Institute for faculty development, and have a variety of IPE resources on their website: https://IPEcollaborative.org/About_IPEC.html MedEdPortal is a well-established compendium of medical curricula, has developed a new repository for interprofessional curricula entitled:iCollaborative.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
This can be accessed at: https://www.mededportal.org/icollaborative/browse/ National Center for Interprofessional Education and Practice has posted numerous resources related to IPE on their website.,Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
"The center’ssite may be accessed at: http://www.ahceducation.umn.edu/national-center-for-interprofessional-practice-and-education/ References Abu-Rish, E., Kim, S., Choe, L., Varpoi, L., Malik, E., White, A.A., Craddick, K., et al.",Non-OADS,/arxiv_data1/oa_pdf/64/64/JIC-29-3.PMC4266098.pdf
The list of the data sets and all the supporting material for this manuscript are also available at website http://mouseencode.org.,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
Science http://dx.doi.org/10.1126/science.1246426 (in the press).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
Nature http://dx.doi.org/10.1038/nature13985 (this issue).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
Nature http://dx.doi.org/10.1038/nature13972 (this issue).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
bioRxiv http://dx.doi.org/10.1101/005736 (31 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
bioRxiv http://dx.doi.org/10.1101/010884 (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
bioRxiv http://dx.doi.org/10.1101/010926 (30 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
http://dx.doi.org/10.1101/ gr.168872.113 (15 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/ab/41586_2014_Article_BFnature13992.PMC4266106.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/1f/5f/ncomms2292.PMC4266136.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Song, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/5f/ncomms2292.PMC4266136.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2292 ARTICLE NATURE COMMUNICATIONS | 3:1283 | DOI: 10.1038/ncomms2292 | www.nature.com/naturecommunications 9 &2012 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/1f/5f/ncomms2292.PMC4266136.pdf
"(State-level estimates for many of these indicators are presented insupplementary Tables 1, 2, 3, and 4, available online at http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12080/abstract).",OADS,/arxiv_data1/oa_pdf/43/bd/milq0092-0667.PMC4266172.pdf
Planned Par- enthood Federation of America: annual report 2009-2010.http://issuu.com/actionfund/docs/ppfa_financials_2010_122711 _web_vf?e =1994783/2039600.,Non-OADS,/arxiv_data1/oa_pdf/43/bd/milq0092-0667.PMC4266172.pdf
US Publicly Funded Family Planning Program 709 and Prevention; 2010. http://apps.nccd.cdc.gov/DCPC_INCA/ DCPC_INCA.aspx.,Non-OADS,/arxiv_data1/oa_pdf/43/bd/milq0092-0667.PMC4266172.pdf
"Number of abortions, by state of residence, 2008. http://www.guttmacher.org/datacenter/.",OADS,/arxiv_data1/oa_pdf/43/bd/milq0092-0667.PMC4266172.pdf
Supplementary Material Additional supporting information may be found in the online version of this article at http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12080/abstract.,Non-OADS,/arxiv_data1/oa_pdf/43/bd/milq0092-0667.PMC4266172.pdf
Thestudy methods were documented in a protocol registeredand accessible at http://www.crd.york.ac.uk/prospero/(registration CRD42013004056).,OADS,/arxiv_data1/oa_pdf/77/8d/e2014.00242.PMC4266231.pdf
Available at: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/77/8d/e2014.00242.PMC4266231.pdf
"http://clinicaltrials.gov/show/NCT01625247 AccessedJuly 24, 2013.Meta-Analysis of Drainage Versus No Drainage After Laparoscopic Cholecystectomy, Picchio M et al.",OADS,/arxiv_data1/oa_pdf/77/8d/e2014.00242.PMC4266231.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 1337–1346International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1337OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7517 5Paradoxical association between body mass index  and in-hospital mortality in elderly patients with  chronic obstructive pulmonary disease in Japan Yasuhiro Yamauchi1,2 Wakae hasegawa1 hideo Yasunaga3 Mitsuhiro sunohara1 Taisuke Jo1,2 Kazutaka Takami1 hiroki Matsui3 Kiyohide Fushimi4 Takahide nagase1 1Department of respiratory  Medicine, graduate school  of Medicine, The University of T okyo,   T okyo, Japan; 2Division for health  service Promotion, The University  of T okyo, T okyo, Japan; 3Department  of Clinical epidemiology and health  economics, school of Public health,   The University of T okyo, T okyo,   Japan; 4Department of health Policy  and Informatics, T okyo Medical  and Dental University, graduate  school of Medicine, T okyo, JapanBackground and objective:  The prevalence and mortality of chronic obstructive pulmonary  disease (COPD) in elderly patients are increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
"The obesity paradox, which is based on a protective effect of  adipose tissue against mortality, has been observed in various chronic diseases, includ - ing cardiovascular disease,10 chronic heart failure,11 stroke,12 chronic kidney disease,13  type 2 diabetes mellitus,14 and pulmonary hypertension.15 Further, the obesity paradox Correspondence: Yasuhiro Yamauchi Department of respiratory Medicine,  graduate school of Medicine, The  University of Tokyo, 7-3-1 hongo,  Bunkyo-ku, Tokyo, Japan Tel +81 3 3815 5411 Fax +81 3 3815 5954 email yamauchiy-int@h.u-tokyo.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Y amauchi et al Running head recto: Obesity paradox in elderly COPD DOI: http://dx.doi.org/10.2147/COPD.S75175",Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
Available from: http://www.who.int/respiratory/copd/burden/en/index.,OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
Available from:  http://apps.who.int/bmi/index.jsp.,OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
Available from: http://www.ginasthma.org/ documents/14.,Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/69/copd-9-1337.PMC4266240.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/88/ceg-7-473.PMC4266241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 473–487Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  473REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S2753 0Systematic review of randomized controlled   trials of probiotics, prebiotics, and synbiotics   in inflammatory bowel disease Yezaz A Ghouri David M Richards Erik F Rahimi Joseph T Krill Katherine A Jelinek Andrew w DuPont The University of Texas Medical  School at Houston, Houston, T exas,   USA Correspondence: Andrew w DuPont   The University of T exas Medical School  at Houston, 6431 Fannin Street 4.234,  Houston, T exas 77030, USA   T el +1 713 500 6687   Fax +1 713 500 6699   Email Andrew.Dupont@uth.tmc.ed uBackground:  Probiotics are microorganisms that are ingested either in combination or as a  single organism in an effort to normalize intestinal microbiota and potentially improve intestinal  barrier function.",Non-OADS,/arxiv_data1/oa_pdf/f2/88/ceg-7-473.PMC4266241.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/f2/88/ceg-7-473.PMC4266241.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/88/ceg-7-473.PMC4266241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/eb/9e/ijn-9-5789.PMC4266242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5789–5809International Journal of Nanomedicine Dovepress submit your manuscript | www.dovepress.co m Dovepress 5789RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7112 8Journal name: International Journal of Nanomedicine Article Designation: ReviewY ear: 2014Volume: 9Running head verso: Ramasamy et alRunning head recto: Bioactive molecule screening by ECISDOI: http://dx.doi.org/10.2147/IJN.S71128 Drug and bioactive molecule screening based   on a bioelectrical impedance cell culture platform Abstract: This review will present a brief discussion on the recent advancements of bioelectrical  impedance cell-based biosensors, especially the electric cell-substrate impedance sensing (ECIS)  system for screening of various bioactive molecules.",Non-OADS,/arxiv_data1/oa_pdf/eb/9e/ijn-9-5789.PMC4266242.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/eb/9e/ijn-9-5789.PMC4266242.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/9e/ijn-9-5789.PMC4266242.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2014:7 329–334Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  329OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/CCID.S7330 2severity and impact of acne vulgaris on the quality  of life of adolescents in nigeria evelyn e Ogedegbe1 eshan B henshaw2 1Cedarcrest hospital, abuja,   Federal Capital T erritory, nigeria;   2Department of Medicine, Faculty   of Medicine and Dentistry, University  of Calabar, Cross river state, nigeria Correspondence: eshan B henshaw   Department of Medicine, Faculty of  Medicine and Dentistry, University   of Calabar, PMB 1115, Calabar,   Cross river state, nigeria   Tel +234 818 418 1238   email eshanbisong@yahoo.co.u kBackground:  Acne vulgaris is a common skin condition, which affects most adolescents at  some point in their lives.",Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
"Available from: http://www.who.int/mental_health/ media/68.pd f. Accessed March 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
Available from: http://www.lagosstate.gov.ng/ pagelinks.php?p= 6.,Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
Available from: http://www.population.,OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/b1/ccid-7-329.PMC4266243.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 461–469Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  461Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7228 2sepsis in Canadian children: a national   analysis using administrative data graham C Thompson1 niranjan Kissoon2 1alberta Children’s hospital,   University of Calgary, Calgary, aB,   Canada; 2British Columbia Children’s  hospital, University of British  Columbia, Vancouver, BC, Canada Correspondence:  graham C Thompson   alberta Children’s hospital,   University of Calgary, 2888 shaganappi  Trail nW, Calgary, T3B 6a8 aB, Canada   Tel +1 403 955 7295   Fax +1 403 955 7552   Email graham.thompson@ albertahealthservices.c aBackground:  Severe infection resulting in sepsis is recognized as a leading cause of morbidity  and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"The esti - mated population in Canada (in millions) during the years  2004–2008 were 31.941, 32.245, 32.576, 32.927, and 33.318,  respectively ( http://www5.statcan.gc.ca/cansim /).",OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"However, this analysis (without Quebec) repre - sented approximately 76.7% of the Canadian population in  2008 ( http://www5.statcan.gc.ca/cansim /), and to our knowl - edge, there is no difference between those children included   and those who were not included in the CIHI database.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"Available  at: http://www.cihi.ca/CIHI-ext-portal/pdf/internet/DAD_E ARNI NG_ TRUST_2003_E N. Accessed September 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"Available  at: http://www.cihi.ca/CIHI-ext-portal/pdf/internet/E ARNIN G_TRUST_ YEARS_LATER_E N. Accessed September 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
Available at: http://www.cihi.ca/CIHI-ext-portal/internet/EN/ Theme/standards +and+data+submission/cihi01068 7.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"Available at: https://secure.cihi.ca/ free_p roducts/ canadian_coding_standards_2008_e.pd f. Accessed  September 4, 2014.",OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/clep-6-461.PMC4266244.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 337–342Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  337RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5537 6Current perspectives on the spread   of dengue in India ekta Gupta Neha Ballani Department of Clinical virology,   Institute of Liver and Biliary Sciences,   New Delhi, India Correspondence: ekta Gupta   Department of Clinical virology,   Institute of Liver and Biliary Sciences,   New Delhi, India   email ektagaurisha@gmail.co mAbstract:  Dengue fever (DF) and dengue hemorrhagic fever (DHF) are important arthropod- borne viral diseases.",Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Available from: http://www.wpro.who.int/mvp/ epidemiology /dengue/Dengue_Bulletin_V ol36.pd f. Accessed August  29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
http://idsp.nic.in/idsp/IDSP/ MedOff.pd f. Accessed on 29.08.14.,OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
Available  from: http://www.who.int/csr/resources/publications/dengue/012-23.,Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Available from: http://www.who.int/tdr/publica - tions/documents/dengue-diagnosis.pd f. Accessed August 29, 2014.",OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
Available from:  http://journal.tropika.net/scielo.php?script =sci_arttext&pid =s2078- 86062010000100003&lng =en.,Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Available from: http://apps.who.int/iris/ bitstream/10665/75303/1/9789241504034_eng.pd f. Accessed August  29, 2014.",OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
"Department of health and research, New Delhi 12th plan document  Available from: http://icmr.nic.in/Publications/plan/ICMR%20 XIIth%20Plan%20(2012–2017).pd f. Accessed November 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/25/75/idr-7-337.PMC4266245.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/dddt-8-2431.PMC4266246.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2431–2438Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2431Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7496 2Design real-time reversal of tumor multidrug  resistance cleverly with shortened carbon  nanotubes Pingping Wu1 shang li2 haijun Zhang2 1Jiangsu cancer hospital, nanjing,   People’s republic of china;   2Department of Oncology,   Zhongda hospital, Medical school,   southeast University, nanjing,   People’s  republic of chinaAbstract:  Multidrug resistance (MDR) in tumors renders many currently available  chemotherapeutic drugs ineffective.",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/dddt-8-2431.PMC4266246.pdf
"These limitations have spurred efforts to search  for new, efficient strategies which not only minimize the toxicity of reversal agents, but  also improve the efficacy of the anticancer drugs to overcome MDR in tumors.correspondence: haijun Zhang Department of Oncology, Zhongda  hospital, Medical school, southeast  University, 87 Dingjiaqiao, nanjing  210009, People’s republic of china Tel +86 25 8327 5418 Fax +86 25 8327 5418 email zhanghaijunseu@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Wu et al Running head recto: Real-time reversal of tumor MDR with shortened CNTs DOI: http://dx.doi.org/10.2147/DDDT.S74962",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/dddt-8-2431.PMC4266246.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f2/4b/dddt-8-2431.PMC4266246.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/4b/dddt-8-2431.PMC4266246.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/copd-9-1357.PMC4266247.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1357–1363International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1357PersPeCtIvesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S6126 5the relationship between the COPD Assessment  T est score and airflow limitation in Japan in  patients aged over 40 years with a smoking history Daisuke Y oshimoto1 Yasutaka Nakano2 Katsuya Onishi3 Gerry Hagan4 Paul Jones5 1Glaxo smithKline, tokyo, 2Division of  respiratory Medicine, Department of  Medicine, shiga University of Medical  science, Otsu, 3Onishi Heart Clinic,   tsu, Japan; 4Independent consultant,   Marbella, spain; 5Division of Clinical  science, st George’s Hospital,   University of London, London, UK Correspondence: Paul Jones   Division of Clinical science, st George’s  Hospital, University of London,   London, UK   tel +44 20 8672 9944   email pjones@sgul.ac.u kBackground:  A large number of chronic obstructive pulmonary disease (COPD) patients  in Japan remain undiagnosed, primarily due to the underuse of spirometry.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/copd-9-1357.PMC4266247.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/copd-9-1357.PMC4266247.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/d4/copd-9-1357.PMC4266247.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/8f/dhps-6-179.PMC4266248.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 179–184Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  179Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S7522 3Frequency of medication errors in an emergency  department of a large teaching hospital   in southern iran afsaneh Vazin1 Zahra Zamani1 nahid Hatam2 1Department of clinical Pharmacy,   Faculty of Pharmacy, 2School of  Management and Medical information  Sciences, Shiraz University of Medical  Sciences, Shiraz, iran correspondence: afsaneh Vazin   Department of clinical Pharmacy,   Faculty of Pharmacy, Shiraz University   of Medical Sciences, Shiraz, iran   Tel +98 711 2424128   Fax +98 711 2424126   email vazeena@sums.ac.i rAbstract:  This study was conducted with the purpose of determining the frequency of medica - tion errors (MEs) occurring in tertiary care emergency department (ED) of a large academic  hospital in Iran.",Non-OADS,/arxiv_data1/oa_pdf/5e/8f/dhps-6-179.PMC4266248.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/5e/8f/dhps-6-179.PMC4266248.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/8f/dhps-6-179.PMC4266248.pdf
Available from: http://www.nccmerp.,Non-OADS,/arxiv_data1/oa_pdf/5e/8f/dhps-6-179.PMC4266248.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2014:7 461–471Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  461OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S6767 2Pharmacokinetics and safety of dexlansoprazole  Mr in pediatric patients with symptomatic  gastroesophageal reflux disease Michael Kukulka1 sai nudurupati2 Maria Claudia Perez3 1Department of Clinical Pharmacology,  2Department of analytical sciences,  3Department of Clinical science,  Takeda Development Center  americas, inc., Deerfield, il, Usa Correspondence: Michael Kukulka   Takeda Development Center americas,   Inc., 1 Takeda Parkway, Deerfield,   il 60015, Usa   Tel +1 224 554 2205   Fax +1 224 554 7933   Email michael.kukulka@takeda.co mObjective:  To evaluate the safety and pharmacokinetic profile of dexlansoprazole modified- release (MR) capsules in pediatric patients with symptomatic gastroesophageal reflux disease  (GERD).",Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
"The pharma - cokinetics, efficacy, and tolerability of lansoprazole have  been established in pediatric patients, aged 1 to 17 years, for  short-term treatment of symptomatic GERD and EE.11,12,16 The objective of this study (ClinicalTrials.gov reg - istration information: http://clinicaltrials.gov/ct2/show/ NCT0104509 6) was to evaluate the pharmacokinetics and  safety of dexlansoprazole MR in pediatric patients 1 to  11 years of age with symptomatic GERD.",Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
Available from: http://www.wma.net/en/30publications/10policies/ b3/index.html.pdf?print-media-type&footer-right=[page]/[toPage ].,Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
"Availabe from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/ E6_R1_Guideline.pd f. Accessed September 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/07/ceg-7-461.PMC4266249.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ibpc-7-071.PMC4266250.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pIntegrated Blood Pressure Control 2014:7 71–82Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  71RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S5143 4Potential of garlic ( Allium sativum ) in lowering   high blood pressure: mechanisms of action   and clinical relevance Karin Ried Peter Fakler National Institute of Integrative  Medicine, Melbourne, vIC, Australia Correspondence: Karin Ried   National Institute of Integrative   Medicine, 21 Burwood Road,   Hawthorn, vIC 3122, Australia   Tel +61 3 9912 9545   Fax +61 3 9804 0513   email karinried@niim.com.a uAbstract:  Garlic supplements have shown promise in the treatment of uncontrolled hypertension,  lowering blood pressure (BP) by about 10 mmHg systolic and 8 mmHg diastolic, similar to stan - dard BP medication.",Non-OADS,/arxiv_data1/oa_pdf/20/a9/ibpc-7-071.PMC4266250.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/20/a9/ibpc-7-071.PMC4266250.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ibpc-7-071.PMC4266250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 331–335Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  331ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S7434 7Does antimicrobial use density at the ward  level influence monthly central line-associated  bloodstream infection rates?,Non-OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
Available from: http://www.whocc.no/ atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
"Available from: http://www.apic.org/ Resource_/EliminationGuideForm/259c0594-17b0-459d-b395- fb143321414a/File/APIC-CRBSI-Elimination-Guide.pd f. Accessed  September 3, 2014.",OADS,/arxiv_data1/oa_pdf/b9/8c/idr-7-331.PMC4266251.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/c0/ceg-7-489.PMC4266252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2014:7 489–495Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  489REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S4266 5Targeted therapy of short-bowel syndrome   with teduglutide: the new kid on the block Kishore vipperla1 Stephen J O’Keefe2 1Division of General internal  Medicine, University of Pittsburgh  Medical Center,  2Division of  Gastroenterology, Hepatology, and  Nutrition, University of Pittsburgh  School of Medicine, Pittsburgh,    PA, USA Correspondence: Stephen J O’Keefe   Division of Gastroenterology,  Hepatology, and Nutrition, University   of Pittsburgh School of Medicine,  Mezzanine Level – C wing,  200 Lothrop  Street – PUH, Pittsburgh, PA  15213, USA   Tel +1 412 648 7217  Fax +1 412 648 9378  Email sjokeefe@pitt.ed uAbstract:  Extensive intestinal resection impairs the absorptive capacity and results in  short-bowel syndrome-associated intestinal failure (SBS-IF), when fluid, electrolyte, acid-base,  micro-, and macronutrient homeostasis cannot be maintained on a conventional oral diet.",Non-OADS,/arxiv_data1/oa_pdf/c7/c0/ceg-7-489.PMC4266252.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/c7/c0/ceg-7-489.PMC4266252.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/c0/ceg-7-489.PMC4266252.pdf
"Available  from: http://www.npsp.com/file_depot/0-10000000/0-10000/262/ folder/2023/Investor +Slide+Deck.pd f. Accessed November  19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/c0/ceg-7-489.PMC4266252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/2e/cmar-6-467.PMC4266253.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 467–473Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  467Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/CMAR.S7193 3Malignant phyllodes tumor of the breast  presenting with hypoglycemia: a case report   and literature review toni pacioles1 Rahul seth2,3 Cesar orellana3 Ivy John4 Veera panuganty3 Ruban Dhaliwal3,5 1Department of Hematology and  oncology, edwards Comprehensive  Cancer Center, Marshall University,   Huntington, WV, Usa;  2Division  of Hematology and oncology,   3Department of Medicine,   4Department of p athology,  5Division  of endocrinology, sUNY Upstate  Medical University, syracuse, NY, Usa Correspondence: toni pacioles   Department of Hematology and  oncology, edwards Comprehensive  Cancer Center, Marshall University,    1400 Hal Greer Boulevard, Huntington,  WV 25701, Usa   tel +1 304 399 6551  Fax +1 304 399 6667  email toni.pacioles@chhi.or gAbstract:  Phyllodes tumors are rare fibroepithelial neoplasms that account for less than  1%  of all breast tumors and are typically found in middle-aged women.",Non-OADS,/arxiv_data1/oa_pdf/df/2e/cmar-6-467.PMC4266253.pdf
"Available from: http://www.uptodate.com/home/index.htm l. Accessed  September  24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/2e/cmar-6-467.PMC4266253.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/df/2e/cmar-6-467.PMC4266253.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/2e/cmar-6-467.PMC4266253.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/9f/cmar-6-475.PMC4266254.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 475–479Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  475ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S7111 1Biliary stenting in advanced malignancy: an analysis  of predictive factors for survival Mehran afshar1 Koudeza Khanom2 Yuk Ting Ma1,3 Pankaj Punia1 1Cancer Centre, Queen elizabeth  hospital Birmingham, University  hospitals Birmingham nhs Trust,   Birmingham, UK; 2st James institute  of Oncology, leeds T eaching hospitals  nhs Trust, leeds, UK; 3school of  Cancer sciences, University of  Birmingham, Birmingham, UK Correspondence: Pankaj Punia   Cancer Centre, Queen elizabeth hospital  Birmingham, University hospitals  Birmingham nhs Trust, edgbaston,  Birmingham B15 2Th, UK   Tel +44 121 371 3571 ext 13571   Fax +44 121 371 3590   email p ankaj.",Non-OADS,/arxiv_data1/oa_pdf/d0/9f/cmar-6-475.PMC4266254.pdf
"Cancer Management and Research 2014:6submit your manuscript | www.dovepress.co m Dove press Dove press Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/9f/cmar-6-475.PMC4266254.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.Dove pres s Dove pres s 479survival after biliary stenting in advanced cancer with progression of cancer being the main contributing factor.,Non-OADS,/arxiv_data1/oa_pdf/d0/9f/cmar-6-475.PMC4266254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 1011–1018International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  1011OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6923 0Pre-pregnancy high-risk factors at first antenatal  visit: how predictive are these of pregnancy  outcomes?,Non-OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
Available from: http://pubs.sciepub.com/ajphr/1/5/ 3.,Non-OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
"Available  from: http://www.euro.who.int/Document/E82996.pd f. Accessed  February  7, 2014.",OADS,/arxiv_data1/oa_pdf/10/bf/ijwh-6-1011.PMC4266255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/93/ceg-7-453.PMC4266256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2014:7 453–460Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  453CasE sEriEsopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S6653 4radiofrequency ablation using Barrx for the  endoscopic treatment of radiation proctopathy: a  series of three cases anish Patel rahul Pathak Vrushak Deshpande sunil H Patel Prasanna C  Wickremesinghe Deepak Vadada Department of Gastrointestinal  Medicine, richmond University  Medical Center, staten island, NY,   Usa Correspondence: anish Patel   richmond Program, richmond University  Medical Center, Department of  Gastrointestinal Medicine, New York  Medical College, 355 Bard avenue, staten  island, NY 10310, Usa   Tel +1 718 818 2419   Email anishp255@gmail.comAbstract:  Radiation proctopathy is a complication of pelvic radiotherapy, which occurs in  patients treated for carcinoma of the prostate, rectum, urinary bladder, cervix, uterus, and   testes.",Non-OADS,/arxiv_data1/oa_pdf/7b/93/ceg-7-453.PMC4266256.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/7b/93/ceg-7-453.PMC4266256.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/93/ceg-7-453.PMC4266256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/89/copd-9-1347.PMC4266257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1347–1356International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1347OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7261 6lobar analysis of collapsibility indices to assess  functional lung volumes in COPD patients Mariko Kitano1 shingo Iwano1 naozumi hashimoto2 Keiji Matsuo3 Y oshinori hasegawa2 shinji naganawa1 1Department of radiology,   2Department of respiratory Medicine,   graduate school of Medicine,    nagoya University, nagoya, aichi,   Japan; 3Department of radiology,   Ichinomiya Municipal hospital,   Ichinomiya, aichi, Japan Correspondence: shingo Iwano   Department of radiology, nagoya   University graduate school of Medicine,   65 Tsurumai-cho, shouwa-ku,   nagoya 466-8550, Japan   Tel +81 52 744 2327   Fax +81 52 744 2335   email iwano45@med.nagoya-u.ac.j pBackground:  We investigated correlations between lung volume collapsibility indices and  pulmonary function test (PFT) results and assessed lobar differences in chronic obstructive  pulmonary disease (COPD) patients, using paired inspiratory and expiratory three dimensional  (3D) computed tomography (CT) images.",Non-OADS,/arxiv_data1/oa_pdf/5c/89/copd-9-1347.PMC4266257.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2013_Feb.20.pd f. Accessed November 10,  2013.",OADS,/arxiv_data1/oa_pdf/5c/89/copd-9-1347.PMC4266257.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5c/89/copd-9-1347.PMC4266257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/89/copd-9-1347.PMC4266257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 1023–1031International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  1023RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4947 1New molecular targets against cervical cancer Alfonso Duenas-Gonzalez1,2 Alberto Serrano-Olvera3 Lucely Cetina4 Jaime Coronel4 1Unit of Biomedical Research in  Cancer, Instituto de Investigaciones  Biomedicas UNAM/Instituto Nacional  de Cancerologia, Mexico City,   2ISSeMyM Cancer Center, T oluca,   3Medical Oncology Service, ABC  Medical Center, Mexico City, 4Division  of Clinical Research, Instituto  Nacional de Cancerologia, Mexico  City, Mexico     On behalf of the T umor Study Group Correspondence: Alfonso Duenas- Gonzalez   Unidad de Investigacion Biomedica en  Cancer, San Fernando 22, Tlalpan 14080,  Mexico City, Mexico   email alfonso_duenasg@yahoo.co mAbstract:  Cervical cancer is the third most commonly diagnosed cancer worldwide and the  fourth leading cause of cancer death in women.",Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
Available from: http://clinicaltrials.gov/show/NCT0141460 8.,Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
Available from: http://clinicaltrials.gov/show/NCT0156624 0.,Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
"Available from:  http://cancer.sanger.ac.uk/cell_lines/browse/tissue?ss=NS&sn=cervi x.  Accessed October 29, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/05/ijwh-6-1023.PMC4266260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/bc/ijwh-6-1019.PMC4266261.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 1019–1022International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  1019OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7538 9The effect of pycnogenol on patients with  dysmenorrhea using low-dose oral contraceptives Hugo Maia Jr clarice Haddad Julio casoy centro de Pesquisa e assistência  em reprodução Humana (ceP arH),   salvador, Bahia, BrazilObjective:  Menstrual symptoms such as dysmenorrhea usually occur during the hormone-free  interval in oral contraceptive users.",Non-OADS,/arxiv_data1/oa_pdf/69/bc/ijwh-6-1019.PMC4266261.pdf
"When this  occurs, the inflammatory cascade is stimulated in the endometrium, leading to an inten - sification of Cox-2 expression through activation of the NF- κB pathway in a similar  way to that occurring during progestin withdrawal bleeding.3,4 The concomitant use of correspondence: Hugo Maia Jr ceParH, 35 rua caetano Moura,  salvador, Bahia, Brazil Tel +55 71 3247 8216 Fax +55 71 3234 3442 email ceparh@uol.com.b r Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2014 Volume: 6 Running head verso: Maia Jr et al Running head recto: Pycnogenol decreases dysmenorrhea pain during hormone-free interval DOI: http://dx.doi.org/10.2147/IJWH.S75389",Non-OADS,/arxiv_data1/oa_pdf/69/bc/ijwh-6-1019.PMC4266261.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/69/bc/ijwh-6-1019.PMC4266261.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/bc/ijwh-6-1019.PMC4266261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 1033–1043International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  1033OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJWH.S6838 2a qualitative study of the experience of obstetric  fistula survivors in Addis Ababa, Ethiopia Yenenesh Tadesse  gebresilase Programme Quality Department, Vita,   Addis Ababa, Ethiopia correspondence: Yenenesh Tadesse  gebresilase   Programme Quality Department, Vita,  Yeka Sub-city, PO Box 33279,   Addis Ababa, Ethiopia   Tel +251 11 1667 5269   Fax +251 11 1667 5294   email yeneneshtadesse@gmail.co mAbstract:  Research on obstetric fistula has paid limited attention to the lived experiences of  survivors.",Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
Available  from: http://webcache.googleusercontent.com/search?q =cache:B XFtYYRXfvEJ:siteresources.worldbank.org/INTPH/Resources/ BTOTransportsrolinempoweringcommunitiesfoealthinEthiopia.,Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
"Available from:  http://www.engenderhealth.org/files/pubs/maternal-health/risk-and- resilience-obstetric-fistula-in-tanzania.pd f. Accessed August 31, 2014.",Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
Available  from: http://www.sjsu.edu/people/james.lee/courses/soci152/s1/ ajreading10labeling .pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/2c/ijwh-6-1033.PMC4266262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 483–489Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  483REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6848 0Competency-based medical education   in two Sub-Saharan African medical schools Elsie Kiguli-Malwadde1,2 E Oluwabunmi Olapade- Olaopa1,3 Sarah Kiguli2 Candice Chen4 Nelson K Sewankambo2 Adesola O Ogunniyi3 Solome Mukwaya1 Francis Omaswa1 1African Centre for Global Health  and Social Transformation, Kampala,   Uganda; 2Makerere University, College  of Health Sciences, Kampala, Uganda;   3College of Medicine, University of  Ibadan, Ibadan, Oyo State, Nigeria;   4School of Public Health and Health  Services, The George Washington  University, Washington, DC, USA Correspondence: Elsie Kiguli-Malwadde   PO Box 9519, Kampala, Uganda   Email kigulimalwadde@gmail.co mBackground:  Relatively little has been written on Medical Education in Sub-Saharan Africa,  although there are over 170 medical schools in the region.",Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
Available from:  http://www.ubos.org/onlinefiles/uploads/ubos/pdf%20documents/ abstracts/2012%20Statistical%20Abstract.pd f.  14. WHO African Region Nigeria.,Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/05/5d/amep-5-483.PMC4266263.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/f7/dddt-8-2439.PMC4266264.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2439–2448Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2439Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7135 6Matrix-induced autologous chondrocyte  implantation for the treatment of chondral  defects of the knees in chinese patients Zhongwen Zhang1 Xin Zhong2 huiru Ji1 Zibin Tang1 Jianpeng Bai1 Minmin Yao1 Jianlei hou1 Minghao Zheng3 David J Wood3 Jiazhi sun4 shu-Feng Zhou4,5 aibing liu6 1Department of Orthopedics, general  hospital of chinese People’s armed Police  Forces (caPF), Beijing; 2Department of  Mri center, general hospital of caPF ,   Beijing, People’s republic of china;   3center for Orthopedic research, school  of surgery and Pathology, University of  Western australia, Perth, Western australia,   australia; 4Department of Pharmaceutical  sciences, college of Pharmacy, University  of south Florida, Tampa, Fl, Usa; 5guizhou  Provincial Key laboratory for regenerative  Medicine, stem cell and Tissue engineering  research center and sino–Us Joint  laboratory for Medical sciences, guiyang  Medical University, guiyang, guizhou;   6Medical research center, general hospital  of chinese People’s armed Police Forces  (caPF), Beijing, People’s republic of chinaAbstract:  Articular cartilage injury is the most common type of damage seen in clinical  orthopedic practice.",Non-OADS,/arxiv_data1/oa_pdf/16/f7/dddt-8-2439.PMC4266264.pdf
"Good clinical results have been documented with this technique.17–24  However, the large surgical incision, peripheral graft hypertrophy (25% of patients) correspondence: aibing liu Medical research center, general  hospital of chinese People’s armed  Police Forces (caPF), 69 Yongding road,  Beijing, People’s republic of china Tel +86 10 5797 5922 Fax +86 10 6863 9576 email doctor_liuaibing@aliyun.co m  shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Blvd,  MDc 30, Tampa, Fl, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Zhang et al Running head recto: MACI for chondral defect knee treatment in Chinese patients DOI: http://dx.doi.org/10.2147/DDDT.S71356",Non-OADS,/arxiv_data1/oa_pdf/16/f7/dddt-8-2439.PMC4266264.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/f7/dddt-8-2439.PMC4266264.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/f7/dddt-8-2439.PMC4266264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/e1/ijn-9-5771.PMC4266265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5771–5778International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5771OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7131 0Quantum dots immunofluorescence histochemical  detection of EGFR gene mutations in  the non-small  cell lung cancers using mutation-specific antibodies Correspondence: Fu-Chun Chen Department of Thoracosurgery,  Traditional Chinese Medical Hospital  of Wenling, 21 Mingyuan North Road,  Taiping Street, Wenling, Zhejiang 317500,  People’s Republic of China email fuchunchen@126.co m  Hong-Lei Chen Department of Pathology, School of Basic  Medical Science, Wuhan University,  185 Donghu Road, Wuchang  District, Wuhan, Hubei 430071,  People’s Republic of China email hl-chen@whu.edu.c n Yan-Gang Qu1 Qian Zhang2 Qi Pan3 Xian-Da Zhao4 Yan-Hua Huang2 Fu-Chun Chen3 Hong-Lei Chen4 1Department of Pathology,   The Central Hospital of Enshi  Autonomous Prefecture, Enshi,   2Department of Molecular Pathology,   Wuhan Nano Tumor Diagnosis  Engineering Research Center, Wuhan,   Hubei, People’s Republic of China;   3Department of Thoracosurgery,   Traditional Chinese Medical  Hospital of Wenling, Wenling,   Zhejiang, People’s  Republic of China;   4Department of Pathology,   School of Basic Medical Science,   Wuhan University, Wuhan, Hubei,   People’s  Republic of ChinaBackground:  Epidermal growth factor receptor (EGFR) mutation status plays an important  role in therapeutic decision making for non-small cell lung cancer (NSCLC) patients.",Non-OADS,/arxiv_data1/oa_pdf/3b/e1/ijn-9-5771.PMC4266265.pdf
"The median survival rate for these patients  is only 8–11 months.3 In 2004, a landmark discovery had been made in that somatic mutations in the  epidermal growth factor receptor (EGFR) were associated with sensitivity to EGFR Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Qu et al Running head recto: EGFR mutation detected by QDs DOI: http://dx.doi.org/10.2147/IJN.S71310",Non-OADS,/arxiv_data1/oa_pdf/3b/e1/ijn-9-5771.PMC4266265.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3b/e1/ijn-9-5771.PMC4266265.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/e1/ijn-9-5771.PMC4266265.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/54/ceor-6-531.PMC4266266.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2014:6 531–535ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  531ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7347 3Effect of occasional epoetin use in combination  with a s table darbepoetin dosage on anemia  management in hemodialysis patients Kazumasa shimamatsu shimamatsu naika iin (Clinic),   shiseikai Medical Corporation,   Chikushino City, Japan Correspondence: Kazumasa shimamatsu   shimamatsu naika iin (Clinic), shiseikai  Medical Corporation, Futsukaichi-chuo   5-5-16, Chikushino City  818-0072, Japan   Tel +81 92 922 2052  Fax +81 92 920 1768  Email enblancetnoir@aol.co mAim:  Taking advantage of the characteristics of both darbepoetin (DA) and epoetin (EPO) might  be a reasonable option for stabilizing hemoglobin (Hb) control in hemodialysis (HD) patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/54/ceor-6-531.PMC4266266.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/a2/54/ceor-6-531.PMC4266266.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/54/ceor-6-531.PMC4266266.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5779–5787International Journal of Nanomedicine Dovepress submit your manuscript | www.dovepress.co m Dovepress 5779OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7153 3Influence of nanoparticles on color stability,  microhardness, and flexural strength of acrylic  resins specific for ocular prosthesis Agda Marobo Andreotti Marcelo Coelho Goiato Amália Moreno Adhara Smith Nobregaaldiéris alves Pesqueira Daniela Micheline dos  santos Araçatuba Dental School, São Paulo  State University, Araçatuba, São Paulo,  BrazilAbstract:  The aim of this study was to assess the effect of adding nanoparticles to N1 acrylic  resin intended for artificial sclera, in terms of the color stability, microhardness, and flexural  strength of the resin.",Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
"10–16 Research has Correspondence: Daniela Micheline  dos santos  Department of Dental Materials and Prosthodontics, Araçatuba Dental School, São Paulo State University José Bonifácio, 1193, Vila Mendonça, Araçatuba, São Paulo, Brazil 16015-050Fax +55 18 3636 3287email danielamicheline@foa.unesp.brJournal name: International Journal of Nanomedicine Article Designation: Original ResearchY ear: 2014Volume: 9Running head verso: Andreotti et alRunning head recto: Effect of NPs on flexural strength of ocular acrylic resinsDOI: http://dx.doi.org/10.2147/IJN.S71533",Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
Available from: https://law.resource.org/pub/us/cfr/ibr/003/cie.15.2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
Available from: http://www.astm.org/Standards/B277.htm.,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
Available from: http://www.astm.org/Standards/G154.htm.,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
Available from:  http://www.iso.org/iso/iso_catalogue/catalogue_ics/catalogue_detail_ics.htm?csnumber=20266.,Non-OADS,/arxiv_data1/oa_pdf/57/86/ijn-9-5779.PMC4266267.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/50/copd-9-1331.PMC4266268.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1331–1335International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1331Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S7476 6Systematic review comparing LABA, olodaterol,  and indacaterol: limitations James F Donohue Pulmonary Diseases and Critical Care  Medicine, UNC School of Medicine,   Chapel Hill, NC, USA Correspondence: James F Donohue   Pulmonary Diseases and Critical Care  Medicine, UNC School of Medicine,   CB# 7020, 130 Mason Farm road,    4th Floor Bioinformatics Building,   Chapel Hill, NC  27599, USA   email james_donohue@med.unc.ed uDear editor Roskell et al present a systematic review comparing the long-acting beta2 agonists  (LABA), olodaterol, and indacaterol in the July edition of the International Journal  of Chronic Obstructive Pulmonary Disease .1 The end-points compared for the two  LABAs were: change from baseline in trough forced expiratory volume in  1 second  (FEV1) at week  12; quality of life analyzed by change from baseline in St George’ s  Respiratory Quotient (SGRQ; total score and proportion of responders) at week  12;  transition dyspnea index (TDI), analyzed by change from baseline at week  12; use of  rescue medica tion, analyzed by change from baseline in average number of puffs per  day; and proportion of patients experiencing at least one exacerbation, analyzed in  trials with a treatment duration of  24 weeks or longer reporting data for this outcome.",Non-OADS,/arxiv_data1/oa_pdf/68/50/copd-9-1331.PMC4266268.pdf
Available from http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/68/50/copd-9-1331.PMC4266268.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/68/50/copd-9-1331.PMC4266268.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/50/copd-9-1331.PMC4266268.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/28/idr-7-323.PMC4266269.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 323–329Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  323ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IDR.S7150 5The effect of a unique propolis compound  (PropoelixTM) on clinical outcomes in patients  with dengue hemorrhagic fever lardo soroy1 sulistyo Bagus2 Iswandi Purnama Y ongkie1 Wibisono Djoko2 1Division of Tropical Medicine and  Infectious Disease, Department  of Internal Medicine, 2Research  committee, gatot soebroto central  army hospital, Jakarta, Indonesia correspondence:  lardo soroy   Division of Tropical Medicine and  Infectious Disease, Department of  Internal Medicine, gatot soebroto  central army hospital, Jl Kramat Jaya  Baru no F1/280 Jakarta Pusat 10560   email soroylardo_jkt@yahoo.co.i dBackground:  Dengue fever is a mosquito-borne virus belonging to the family Flaviviridae .",Non-OADS,/arxiv_data1/oa_pdf/16/28/idr-7-323.PMC4266269.pdf
Avail - able from: http://www.searo.who.int/entity/vector_borne_tropical_diseases/ documents/SEAROTPS60/en /.,Non-OADS,/arxiv_data1/oa_pdf/16/28/idr-7-323.PMC4266269.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection­and­drug­resistance­journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/16/28/idr-7-323.PMC4266269.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/28/idr-7-323.PMC4266269.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/f0/dddt-8-2475.PMC4266270.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2475–2491Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2475Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5549 9Optimizing iron delivery in the management  of anemia: patient considerations and the role  of ferric carboxymaltose Jorge eduardo T oblli Margarita Angerosa Nephrology Section, Department  of internal Medicine, Hospital Alemán,   School of Medicine, University  of Buenos Aires, ArgentinaAbstract:  With the challenge of optimizing iron delivery, new intravenous (iv) iron–carbohydrate  complexes have been developed in the last few years.",Non-OADS,/arxiv_data1/oa_pdf/21/f0/dddt-8-2475.PMC4266270.pdf
"Additionally, a high prevalence of anemia is associ - ated with the elderly2 and with acute as well as chronic conditions.3 Although several factors such as vitamin deficiencies (A, B12, folic acid), infec - tious diseases (parasites), chronic inflammation, and genetic disorders may cause  anemia, iron deficiency is undoubtedly the most common cause of anemia worldwide.4  Notably, iron deficiency affects not only red blood cell production but also cellular  functions related to muscle metabolism, mitochondrial function, neurotransmitters,  DNA synthesis, and the immune system.5 Iron deficiency syndromes include “absolute Correspondence: Jorge eduardo Toblli Laboratory of experimental Medicine,  Hospital Alemán, School of Medicine,  University of Buenos Aires, Av  Pueyrredon, 1640, 1118 Buenos  Aires, Argentina Tel +54 11 4 827 7000 ext 2785  Fax +54 11 4805 6087 email jorgetoblli@fibertel.com.a r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Toblli and Angerosa Running head recto: Ferric carboxymaltose in the management of iron deficiency DOI: http://dx.doi.org/10.2147/DDDT.S55499",Non-OADS,/arxiv_data1/oa_pdf/21/f0/dddt-8-2475.PMC4266270.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/21/f0/dddt-8-2475.PMC4266270.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/f0/dddt-8-2475.PMC4266270.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/13/bctt-6-191.PMC4266271.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2014:6 191–203Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  191Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S7466 3Oseltamivir phosphate monotherapy ablates  tumor neovascularization, growth, and metastasis  in mouse model of human triple-negative breast  adenocarcinoma Fiona haxho1 stephanie allison2 Farah alghamdi1,3 lacey Brodhagen1 Victoria el Kuta1 samar abdulkhalek1,4 ronald J neufeld2 Myron r szewczuk1 1Department of Biomedical and  Molecular sciences, 2Department  of Chemical engineering, Queen’s  University, Kingston, On , Canada;   3The King Fahd armed Forces  hospital, serology, Jeddah, saudi  arabia; 4Department of Molecular  genetics, lerner research institute,   Cleveland Clinic, Cleveland, Oh, Usa Correspondence: Myron r szewczuk   Department of Biomedical and Molecular  sciences, Queen’s University, Kingston,  On K7l 3n6, Canada   Tel +1 613 533 2457   Fax +1 613 533 6796   email szewczuk@queensu.c aBackground:  Triple-negative breast cancers (TNBCs) lack the estrogen, progesterone, and  epidermal growth factor (EGF) receptor-2 (HER2/neu) receptors.",Non-OADS,/arxiv_data1/oa_pdf/b4/13/bctt-6-191.PMC4266271.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/b4/13/bctt-6-191.PMC4266271.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/15/dddt-8-2321.PMC4266272.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2321–2332Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2321Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6549 5Pilot Phase ii study of mazindol in children  with attention deficit/hyperactivity disorder Objective:  Mazindol has been proposed as a potential treatment of children with attention  deficit/hyperactivity disorder (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/67/15/dddt-8-2321.PMC4266272.pdf
"The stimulants have  side effects, mostly sleep and appetite disturbances, and potential detrimental effects  on growth.10 Deleterious cardiovascular effects, including arrhythmias, hypertension,  and cardiomyopathy, were initially reported, primarily in patients with associated Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Konofal et al Running head recto: Mazindol in ADHD children DOI: http://dx.doi.org/10.2147/DDDT.S65495 eric Konofal1,2 Wei Zhao3–5 cédric laouénan5–7 Michel lecendreux1,2 Florentia Kaguelidou3–5 lila Benadjaoud4 France Mentré5–7 evelyne Jacqz-aigrain3–5 1Pediatric sleep Disorders center,   2child and adolescent Psychiatric  Department, 3Department of Pediatric  Pharmacology and Pharmacogenetics,   hôpital robert Debré, assistance  Publique – hôpitaux de Paris (aP hP),   4clinical investigation center,   institut national de la santé et de  la recherche Médicale (inserM),   5Université Paris Diderot, sorbonne  Paris cité, Paris, 6inserM, infection,   antimicrobiens, Modélisation,   evolution (iaM e), UM r1137, Paris,   7Department of Biostatistiques,   hôpital Bichat, aPhP , Paris, France correspondence: evelyne Jacqz-aigrain Department of Pediatric Pharmacology  and Pharmacogenetics, hôpital robert  Debré, clinical investigation center  cic1426, inserM, 48 Boulevard  sérurier, cedex 19, Paris 75935, France Tel +33 1 4003 2150 Fax +33 1 4003 5779 email evelyne.jacqzaigrain@gmail.co m",Non-OADS,/arxiv_data1/oa_pdf/67/15/dddt-8-2321.PMC4266272.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/67/15/dddt-8-2321.PMC4266272.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/15/dddt-8-2321.PMC4266272.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2423–2430Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2423ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7181 5Clinicopathological significance and potential  drug target of RUNX3  in breast cancer Ying-Ying Yu1 Chao Chen2 Fan-fei Kong2 Wei Zhang1 1Obstetrics and Gynecology Hospital,   Fudan University, Shanghai, People’s  Republic of China; 2Department of  Gynecology, Shanghai First Maternity  and Infant Hospital Affiliated to TongJi  University, Shanghai, People’s Republic  of ChinaBackground:  Previous reports indicate that RUNX3 is a tumor suppressor in several types  of human tumors, including breast cancer (BC).",Non-OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
"Correspondence: Wei Zhang Obstetrics and Gynecology Hospital,   Fudan University, 413 Zhaozhou Road,  Shanghai 200011, People’s Republic of  China Email weizhang611@163.co m Journal name: Drug Design, Development and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2014 Volume: 8 Running head verso: Yu et al Running head recto: RUNX3 in breast cancer DOI: http://dx.doi.org/10.2147/DDDT.S71815",Non-OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
"Briefly, RUNX3  gene was  entered into the database  (http://kmplot.com/analysis/index.",OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/69/dddt-8-2423.PMC4266273.pdf
"Key words:  memory/induced pluripotent stem cells/  herpes simplex virus type 1/fMRI/herpes  Introduction Herpes simplex virus, type 1 (HSV-1) causes human  specific infections in the majority of US adults ( http:// www.cdc.gov/nchs/nhanes.htm ) and increasing numbers  of neonates ( http://www.cdc.gov/nchs/nhanes.htm ).1,2  Mucosal lesions such as cold sores occur after primary  infection, and recurrent infections can induce blinding  stromal keratitis.",Non-OADS,/arxiv_data1/oa_pdf/91/78/sbu032.PMC4266288.pdf
fMRI data were analyzed using  SPM8 ( http://www.fil.ion.ucl.ac.uk/spm/software/spm8/ ).,OADS,/arxiv_data1/oa_pdf/91/78/sbu032.PMC4266288.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/2b/sbu108.PMC4266296.pdf
gov (#NCT00531518: http://www.clinicaltrials.gov/ ct2/results?term=NCT00531518 ).,Non-OADS,/arxiv_data1/oa_pdf/11/2b/sbu108.PMC4266296.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/53/jmdh-7-561.PMC4266327.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 561–572Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  561Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7047 0Web-based collaboration in individual care planning  challenges the user and the provider roles –   toward a power transition in caring relationships Jorunn Bjerkan1,2 solfrid Vatne3 anne Hollingen4 1norwegian research centre for  electronic Health records (eHr),  Medical Faculty, norwegian University  of science and T echnology, Trondheim,  2Faculty of Health science, nord- Trøndelag University college, levanger,  3Faculty of Health science, Molde  University college, 4Møre og romsdal  Hospital Trust, Molde, norway correspondence: Jorunn Bjerkan   norwegian University of science   and Technology/nord-Trøndelag   University college, Høgskolen i   nord-Trøndelag, PO Box 2501,   nO-7729 steinkjer, norway   Tel +47 48 60 66 79   email j orunn.bjerkan@hint.n oBackground and objective:  The Individual Care Plan (ICP) was introduced in Norway to  meet new statutory requirements for user participation in health care planning, incorporating  multidisciplinary and cross-sector collaboration.",Non-OADS,/arxiv_data1/oa_pdf/e8/53/jmdh-7-561.PMC4266327.pdf
2013; Available from: http://www.ssb.no/emner /.,Non-OADS,/arxiv_data1/oa_pdf/e8/53/jmdh-7-561.PMC4266327.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/e8/53/jmdh-7-561.PMC4266327.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/53/jmdh-7-561.PMC4266327.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2014:5 163–171Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  163ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S7262 1Misperceptions of weight status   among adolescents: sociodemographic   and behavioral correlates Amy E Bodde1 Timothy J Beebe1 Laura P Chen2 Sarah Jenkins3 Kelly Perez-Vergara4 Lila J Finney Rutten5 Jeanette Y Ziegenfuss6 1Division of Health Care Policy and  Research, Mayo Clinic, Rochester,   MN, USA;  2Seattle Children’s Hospital,   Seattle, WA, USA; 3Division of  Biomedical Statistics and Informatics,   Mayo Clinic, Rochester, MN, USA;   4Children’s Hospital, Boston, MA,  USA;   5Division of Epidemiology, Mayo Clinic,   Rochester, MN USA;  6HealthPartners  Institute for Education and Research,   Minneapolis, MN, USA Correspondence: Jeanette Y Ziegenfuss   HealthPartners Institute for Education  and Research, 8170  33rd Avenue South,   Bloomington, MN  55440, USA   Email j eanette.y.ziegenfuss@ healthpartners.co mObjective:  Accurate perceptions of weight status are important motivational triggers for  weight loss among overweight or obese individuals, yet weight misperception is prevalent.",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
Available from: http://www.cdc.gov/nccdphp/   dnpa/growthcharts/resources/sas.ht m#PDF.,OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e2/a8/prom-5-163.PMC4266328.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 993–1001Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  993ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7468 5Prospective study of incidence and predictors  of peripheral intravenous catheter-induced  complications Mostafa a abolfotouh1,2 Mahmoud salam1 ala’a Bani-Mustafa1 David White3 hanan h Balkhy2,4 1King abdullah international Medical  Research Center (K aiMRC), 2King  saud bin-abdulaziz University for  health sciences (K saU-hs), 3nursing  Department, 4infection Prevention  and Control Department, King  abdulaziz Medical City, Riyadh,   saudi arabiaBackground:  Although intravenous therapy is one of the most commonly performed procedures  in hospitalized patients, it remains susceptible to infectious and noninfectious complications.",Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
"On the other hand, major complications tend to be more severe, Correspondence: Mostafa a abolfotouh King abdullah international Medical  Research Center (KaiMRC) (Mail Code  1515), King saud bin-abdulaziz University  for health sciences (KsaU-hs), King  abdulaziz Medical City, national guard  health affairs, PO Box 22490, Riyadh  11426, saudi arabia   email mabolfotouh@gmail.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Abolfotouh et al Running head recto: Peripheral IV catheter-induced complications DOI: http://dx.doi.org/10.2147/TCRM.S74685",Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
"Available from: http://www.nursingworld.org/MainMenuCategories/ ThePracticeofProfessionalNursing/PatientSafetyQuality/Research- Measurement/The-National-Database/Nursing-Sensitive-Indicators_1/ ANA-Indicator-Histor y. Accessed June 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ec/ab/tcrm-10-993.PMC4266329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/02/tacg-7-253.PMC4266330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2014:7 253–258The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  253OriG inAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S7305 8Molecular analysis of beta-globin gene mutations  among Thai beta-thalassemia children: results   from a single center study Boonchai Boonyawat1 Chalinee Monsereenusorn2 Chanchai Traivaree2 1Division of Genetics, Department of  Pediatrics, Phramongkutklao hospital  and College of Medicine, Bangkok,   Thailand; 2Division of hematology/ Oncology, Department of Pediatrics,   Phramongkutklao hospital and  College of Medicine, Bangkok,   Thailand Correspondence: Chanchai Traivaree   Division of hematology/Oncology,  Department of Pediatrics,  Phramongkutklao hospital and College   of Medicine, 315 ratchawithi road,  ratchathewi, Bangkok 10400, Thailand   Tel +66 2 644 4130   Fax +66 2 644 4130   email ctrivaree@yahoo.co mBackground:  Beta-thalassemia is one of the most common genetic disorders in Thailand.",Non-OADS,/arxiv_data1/oa_pdf/4d/02/tacg-7-253.PMC4266330.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/4d/02/tacg-7-253.PMC4266330.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/02/tacg-7-253.PMC4266330.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/83/vhrm-10-683.PMC4266339.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 683–689Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  683ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7276 4Prevalence of risk factors at presentation and  early mortality in patients aged 80 years or older  with sT -segment elevation myocardial infarction Peter andreas claussen1,2 Michael abdelnoor3 Kristin M Kvakkestad1,2 Jan eritsland1 sigrun Halvorsen1 1Department of cardiology, Oslo  University Hospital, Ullevaal,   norway; 2Faculty of Medicine,   University of Oslo, Oslo, norway;   3centre of clinical Research: Unit of  epidemiology and Biostatistics, Oslo  University Hospital, Ullevaal, n orway correspondence: Peter andreas claussen   Department of cardiology,   Oslo University Hospital   Ulleval, PO Box 4950 nydalen,   n-0424 Oslo, norway   email paclaussen@gmail .comBackground:  Elderly patients with ST -segment elevation myocardial infarction (STEMI) are  at high risk for complications and early mortality; still, they are underrepresented in clinical  trials and observational studies.",Non-OADS,/arxiv_data1/oa_pdf/e3/83/vhrm-10-683.PMC4266339.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/e3/83/vhrm-10-683.PMC4266339.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/83/vhrm-10-683.PMC4266339.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/e9/sar-5-121.PMC4266340.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2014:5 121–127Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  121ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S7128 5Effects of different doses of testosterone   on gonadotropins, 25-hydroxyvitamin D3,   and blood lipids in healthy men Nina Gårevik Anders Rane Linda Björkhem-Bergman Lena Ekström Division of Clinical Pharmacology,   Department of Laboratory Medicine,   Karolinska Institutet, Karolinska  University Hospital, Stockholm,   Sweden Correspondence: Nina Gårevik   Division of Clinical Pharmacology C1:68,  Karolinska University Hospital, Huddinge,  SE-141 86 Stockholm, Sweden   Tel +46 8 5858 01 28   Email nina.garevik@ki.s eAims:  To study the effect and time profile of different doses of testosterone enanthate on the  blood lipid profile and gonadotropins.",Non-OADS,/arxiv_data1/oa_pdf/20/e9/sar-5-121.PMC4266340.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/20/e9/sar-5-121.PMC4266340.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/e9/sar-5-121.PMC4266340.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/32/jmdh-7-573.PMC4266360.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 573–586Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  573Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S6426 9subdural porous and notched mini-grid   electrodes for wireless intracranial   electroencephalographic recordings Muhammad Tariqus salam1 sébastien gélinas1 sébastien Desgent2 sandra Duss2 Félix Bernier T urmel1,3 lionel carmant2 Mohamad sawan1 Dang Khoa nguyen3 1Polystim neurotechnologies  laboratory, Polytechnique Montréal,   Qc, canada;  2research center,   sainte-Justine University Hospital  center (cHU sainte-Justine),   Université de Montréal, Qc , canada;   3neurology service, Department  of Medicine, notre-Dame Hospital,   centre Hospitalier de l’Université de  Montréal (cHUM), Qc , canada correspondence: Muhammad Tariqus  salam   Polystim neurotechnologies laboratory,   Polytechnique Montréal, 2900 Boulevard  edouard-Montpetit, Qc,   H3T 1J4, canada   email tariqus.salam@polymtl.c aBackground:  Intracranial electroencephalography (EEG) studies are widely used in the  presurgical evaluation of drug-refractory patients with partial epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/37/32/jmdh-7-573.PMC4266360.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/37/32/jmdh-7-573.PMC4266360.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/32/jmdh-7-573.PMC4266360.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/d2/jpr-7-727.PMC4266383.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 727–735Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  727ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6311 8a randomized clinical study of the heated  lidocaine/tetracaine patch versus subacromial  corticosteroid injection for the treatment of pain  associated with shoulder impingement syndrome Richard Radnovich1 Jeremiah Trudeau2 arnold R gammaitoni3 1injury care Medical center, Boise,   iD, Usa; 2analgesic solutions, natick,   Ma, Usa; 3nuvo Research inc., West  chester, P a, Usa correspondence: Richard Radnovich   injury care Medical center, 4850 north  Rosepoint Way, suite 100,   Boise, idaho 83713, Usa   Tel +1 208 939 2100   Fax +1 208 939 4411   email dr.radnovich@injurycaremedical.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/jpr-7-727.PMC4266383.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/de/d2/jpr-7-727.PMC4266383.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/d2/jpr-7-727.PMC4266383.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2353–2360Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2353OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7397 5single event-related changes in cerebral  oxygenated hemoglobin using word game  in schizophrenia ryo Fujiki1,2 Kiichiro Morita1,2 Mamoru sato1,2 Yuji Yamashita1,2 Yusuke Kato1,2 Y ohei ishii2 Y oshihisa shoji1,2 Naohisa Uchimura1 1Department of Neuropsychiatry,   Kurume University, 2cognitive and  Molecular research institute of Brain  Diseases, Kurume University school  of Medicine, Kurume-city, JapanAbstract:  Neuroimaging studies have been conducted using word generation tasks and have  shown greater hypofrontality in patients with schizophrenia compared with healthy subjects.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
"To our  knowledge, previous findings have not been reported regarding the cortical activation  between patients with schizophrenia and healthy subjects during a shiritori task using  NIRS; however, there have been functional magnetic resonance imaging (MRI) and  magnetoencephalography studies using this task in only healthy subjects.4,5correspondence: ryo Fujiki Department of Neuropsychiatry  and cognitive and Molecular research  institute of Brain Diseases, Kurume  University school of Medicine 67,  asahi-Machi, Kurume-city, Japan Tel +81 942 31 7564 Fax +81 942 35 6041 email fujiki_ryou@med.kurume-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Fujiki et al Running head recto: Single event-related NIRS and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S73975",Non-OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
Available from: http://www.who.int/ classifications/icd/en/GRNBOOK.pdf.,OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ed/ndt-10-2353.PMC4266384.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/e2/ppa-8-1683.PMC4266385.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1683–1690Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1683OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6692 7Efficacy of a brief multifactorial adherence- based intervention in reducing blood pressure:  a randomized clinical trial Alfonso leiva1 Antonio Aguiló2 Marta Fajó-Pascual3 lucia Moreno4 Ma carmen Martín5 elena Marina   garcia6 rosa elena Duro7 Francisca serra8 Pilar Dagosto9 Ana Aurelia Iglesias-Iglesias10 Rosa Maria Company11 Aina Yañez12 Joan Llobera13 On behalf of The Adherence Group 1Primary Care Research Unit of  Mallorca, Baleares Health Services- IbSalut, Mallorca, 2research group  on Evidence, Lifestyles and Health,   Universitat Illes Balears, Palma,   3Faculty of Health and Sport Sciences,   University of Zaragoza, Huesca, 4son  cladera health centre, Baleares health  Services-IbSalut, Mallorca, 5Actur sur  Health Centre, Aragon Health Services- Salud, Aragón, Zaragoza, 6coll D’en  Rabassa Health Centre, Baleares Health  Services-IbSalut, Mallorca, 7San Agustín  Health Centre, Baleares Health Services- IbSalut, Mallorca, 8santa María health  Centre, Baleares Health Services-IbSalut,   Mallorca, 9sineu health centre, Baleares  Health Services-IbSalut, Mallorca, 10santa  Ponça health centre, Baleares health  Services-IbSalut, Mallorca, 11Department  of Pharmacy, Manacor Hospital-Llevant  Sector, Baleares Health Services-IbSalut,   Mallorca 12Montuiri health centre,   Baleares Health Services-IbSalut,   Mallorca, 13Fundació d’Investigació  sanitaria illes Balears (F isiB), son  espases hospital, Baleares health  Services-IbSalut, Mallorca, SpainBackground:  Lowering blood pressure (BP) by antihypertensive (AHT) drugs reduces the  risks of cardiovascular events, stroke, and total mortality.",Non-OADS,/arxiv_data1/oa_pdf/af/e2/ppa-8-1683.PMC4266385.pdf
"Keywords:  hypertension, medication adherence, blood pressure, intervention studies Introduction The overall prevalence of hypertension among adults is about 35%, since the preva - lence of hypertension increases with age, from 40% of middle-aged individuals and  up to 68% of elderly individuals.1–3 It is a growing public health problem in Western  countries with aging populations.4 Most population-based studies confirm that  hypertension increases the risk for cardiovascular events.5 Antihypertensive (AHT)  agents can effectively lower blood pressure (BP) and significantly reduce the rates of  stroke, coronary heart disease, cardiovascular death, and total mortality by 30%–40%,  20%–21%, 26%–28%, and 13%–16%, respectively.6 Hypertension, however, remains difficult to control, with BP control achieved  by only 40% of hypertensive patients in primary care.7 The failure of physicians to correspondence: Alfonso leiva Primary Care Research Unit of Mallorca,  Baleares Health Services-IbSalut, C/Reina  esclaramunda n9, cp:0700, Mallorca, spain email aleiva@ibsalut.caib.e s Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Leiva et al Running head recto: Efficacy of a brief multifactorial adherence-based intervention DOI: http://dx.doi.org/10.2147/PPA.S66927",Non-OADS,/arxiv_data1/oa_pdf/af/e2/ppa-8-1683.PMC4266385.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/af/e2/ppa-8-1683.PMC4266385.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/1b/jpr-7-717.PMC4266386.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 717–726Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  717ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7304 4sensitivity of quantitative sensory models   to morphine analgesia in humans anne estrup Olesen1,2 christina Brock1,2 eva sverrisdóttir2 isabelle Myriam larsen1 asbjørn Mohr Drewes1,3 1Mech- sense, Department of  gastroenterology and hepatology,   aalborg University hospital,   aalborg, Denmark; 2Department  of Drug Design and Pharmacology,   Faculty of health and Medical  sciences, University of copenhagen,   copenhagen, Denmark; 3Department  of clinical Medicine, aalborg  University, aalborg, Denmark correspondence: anne estrup Olesen   Mech-sense, Department of  gastroenterology and hepatology,  aalborg University hospital,   Mølleparkvej 4, aalborg, Denmark   Tel +45 97 66 35 23   email aneso@rn.d kIntroduction:  Opioid analgesia can be explored with quantitative sensory testing, but most  investigations have used models of phasic pain, and such brief stimuli may be limited in the  ability to faithfully simulate natural and clinical painful experiences.",Non-OADS,/arxiv_data1/oa_pdf/bd/1b/jpr-7-717.PMC4266386.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/bd/1b/jpr-7-717.PMC4266386.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/1b/jpr-7-717.PMC4266386.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/1c/0b/ppa-8-1699.PMC4266387.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1699–1704Patient Preference and Adherence Dovepress submit your manuscript | www.dovepress.co m Dovepress 1699OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7166 6experience of insomnia, symptom attribution  and treatment preferences in individuals with  moderate to severe cOPD: a qualitative study Karen s Kauffman1 Megan Doede1 Montserrat Diaz-Abad2 steven M scharf2,3 Wanda Bell-Farrell2 Valerie e rogers1 Jeanne geiger-Brown1 1Department of Family and  community health, University of   Maryland school of n ursing,   Baltimore, MD, UsA; 2Division of   Pulmonary and critical care,   University of Maryland school of   Medicine, Baltimore, MD, UsA;   3The University of Maryland sleep  Disorders center, Baltimore, MD, UsAAbstract: Persons with chronic obstructive pulmonary disease (COPD) are known to have poor  sleep quality.",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/ppa-8-1699.PMC4266387.pdf
"Several hypnotic medications (zolpidem, eszopiclone, zaleplon, and ramelteon) correspondence: Jeanne geiger-Brown University of Maryland school of nursing, 655 W lombard st, W213, Baltimore, MD 21201, UsATel +1 410 746 5368email jgeiger@son.umaryland.ed uJournal name: Patient Preference and Adherence Article Designation: Original ResearchY ear: 2014Volume: 8Running head verso: Kauffman et alRunning head recto: Insomnia and COPDDOI: http://dx.doi.org/10.2147/PPA.S71666",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/ppa-8-1699.PMC4266387.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-preference-and-adherence-journalPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient  preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/1c/0b/ppa-8-1699.PMC4266387.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/2e/opth-8-2491.PMC4266414.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2491–2499Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2491Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7399 8Dacryocystorhinostomy ostium: parameters  to evaluate and DCr ostium scoring Mohammad Javed ali1 alkis James Psaltis2 Peter John Wormald2 1Dacryology service, l V Prasad  eye institute, hyderabad, T elangana,   india; 2Department of surgery– Otorhinolaryngology, head and neck  surgery, The University of adelaide,   adelaide, sa, australiaAim:  This study aims to provide a systematic protocol for the evaluation of a dacryocystorhinostomy  (DCR) ostium and to propose a scoring system to standardize the assessment.",Non-OADS,/arxiv_data1/oa_pdf/19/2e/opth-8-2491.PMC4266414.pdf
"They are typically asso - ciated with high success rates in the order of 80%–95% depending on the underlying  etiology.1–8 However, surgical failure occurs and can range from 4% to 13%.1,9–11 Many  causes of failure can be attributed to abnormal healing of the ostium, with scarring and  cicatricial closure of the osteotomy site being among the most commonly reported.9–12  The other causes of ostium-related failures include inadequate sac exposure, small  opening of the sac, cicatrization of the sac prior to surgery, inappropriate location of  the ostium, unopened agger nasi cells, removal of sac wall with poor approximation of  lacrimal sac and nasal mucosa membranes over the internal common opening (ICO),  granulomas, and sump syndrome.10,12,13 The majority of studies published to date  assessing post-DCR outcomes have focused on overall ostial measurements or patency Correspondence: Mohammad Javed ali Dacryology service, l V Prasad  eye institute, hyderabad 500034,  Telangana, india email drjaved007@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ali et al Running head recto: Evaluation and scoring of the DCR ostium DOI: http://dx.doi.org/10.2147/OPTH.S73998",Non-OADS,/arxiv_data1/oa_pdf/19/2e/opth-8-2491.PMC4266414.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/19/2e/opth-8-2491.PMC4266414.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/2e/opth-8-2491.PMC4266414.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/87/opth-8-2485.PMC4266415.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2485–2489Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2485Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7298 3First experience with the new high-frequency  femtosecond laser system (lDV Z8)  for cataract surgery Bojan Pajic1–3 iraklis Vastardis1,2 Zisis gatzioufas1 Brigitte Pajic-eggspuehler1 1swiss eye research Foundation, eye  Clinic Orasis, reinach, switzerland;   2eye hospital ViD ar-Orasis swiss,   Department of Physics, Faculty of  sciences, University of novi sad,   novi sad, serbia; 3Medical Faculty,   Military Medical academy, University  of Defense, Belgrade, serbiaBackground:  The purpose of this work is to report our experience using the new Z8 laser  system for femtosecond laser-assisted cataract surgery (FLACS) and to provide a sample of  the performance and safety results using this new technology.",Non-OADS,/arxiv_data1/oa_pdf/7a/87/opth-8-2485.PMC4266415.pdf
"Available data have shown that capsulotomies created using the femtosec - ond laser are more accurate in size than those created by manual continuous Correspondence: Bojan Pajic swiss eye research Foundation,  eye Clinic Orasis, Titlisstrasse  44, reinach 5734, switzerland Tel +416 2765 6080 email bpajic@datacomm.c h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Pajic et al Running head recto: High-frequency femtosecond laser system (LDV Z8) for cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S72983",Non-OADS,/arxiv_data1/oa_pdf/7a/87/opth-8-2485.PMC4266415.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7a/87/opth-8-2485.PMC4266415.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/87/opth-8-2485.PMC4266415.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/86/oajsm-5-273.PMC4266416.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 273–278Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  273OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6833 3PPARα gene variants as predicted   performance-enhancing polymorphisms   in professional italian soccer players Patrizia Proia1 Antonino Bianco1 gabriella Schiera2 Patrizia Saladino2 Valentina contrò1 giovanni caramazza3 Marcello Traina1 Keith A grimaldi4 Antonio Palma1 Antonio Paoli5 1Sport and exercise Sciences research  Unit,  2Department of Biological,   chemical and Pharmaceutical  Sciences and T echnologies,   University of Palermo, Palermo,   italy; 3regional Sports School of  cOni Sicilia, Sicily, italy; 4Biomedical  engineering laboratory, institute  of communication and computer  Systems, national Technical  University of Athens, Athens, greece;   5Department of Biomedical Sciences,   University of Padova, Padua, italy correspondence: Antonio Paoli   Department of Biomedical Sciences,  nutrition and exercise Physiology  laboratory, University of Padova, via  Marzolo,  3.",Non-OADS,/arxiv_data1/oa_pdf/e8/86/oajsm-5-273.PMC4266416.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/e8/86/oajsm-5-273.PMC4266416.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/86/oajsm-5-273.PMC4266416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2331–2337Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2331PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7495 2Parkinson’s disease-associated melanin steal Marty Hinz1 Alvin stein2 T ed cole3 1clinical research, Neuro research  clinics, inc., cape coral, FL, UsA;   2stein Orthopedic Associates,   Plantation, FL, UsA; 3cole center  for Healing, cincinnati, OH, UsAAbstract:  Urinary dopamine fluctuations in the competitive inhibition state were first  documented in 2009.",Non-OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
"The inverse is also true: changes  to only  dopamine concentrations will affect serotonin concentrations in a predictable correspondence: Marty Hinz clinical research, Neuroresearch clinics,  inc., 1008 Dolphin Dr, cape coral,  FL 33904, UsA Tel +1 218 626 2220  Fax +1 218 626 1638  email marty@hinzmd.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Perspectives Y ear: 2014 Volume: 10 Running head verso: Hinz et al Running head recto: Parkinson’s disease-associated melanin steal DOI: http://dx.doi.org/10.2147/NDT.S74952",Non-OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
Available from:  https://www.merck.com/product/usa/pi_circulars/s/sinemet/sinemet_ pi.pdf .,OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
Available  from: http://www.uniprot.org/uniprot/?query =pyridoxal+AND+organis m%3A%22Homo +sapiens+%5B9606%5D%22&sort =score.,OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
Available from: http://pubchem.ncbi.nlm.nih.gov/summary/summary.,OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
Available from: http://www.genome.,OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/50/ndt-10-2331.PMC4266417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/3e/opth-8-2501.PMC4266418.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2501–2506Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2501Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7559 2endoilluminator phototoxic maculopathy  associated with combined iCG-assisted epiretinal  membrane and internal limiting membrane peeling Y oshihiro Y onekawa ashkan M abbey ankoor r shah Benjamin J Thomas antonio Capone Jr associated retinal Consultants,   Department of Ophthalmology,   William Beaumont Hospital, royal  Oak, M i, UsaAbstract:  Phototoxic maculopathy caused by endoillumination during macular surgery is  uncommon.",Non-OADS,/arxiv_data1/oa_pdf/7b/3e/opth-8-2501.PMC4266418.pdf
"Correspondence: ashkan M abbey associated retinal Consultants,  Department of Ophthalmology,  William Beaumont Hospital, 3535 West  Thirteen Mile road, suite 344, royal  Oak, Mi 48073, Usa Tel +1 248 288 2280 Fax +1 248 288 5644 email ashkanabbey@post.harvard.ed u Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Y onekawa et al Running head recto: Endoilluminator phototoxic maculopathy  DOI: http://dx.doi.org/10.2147/OPTH.S75592",Non-OADS,/arxiv_data1/oa_pdf/7b/3e/opth-8-2501.PMC4266418.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7b/3e/opth-8-2501.PMC4266418.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/3e/opth-8-2501.PMC4266418.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/66/opth-8-2507.PMC4266419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2507–2522Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2507Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S7213 2Photoreceptor inner segment ellipsoid band   integrity on spectral domain optical coherence  tomography Sandeep Saxena1 Khushboo Srivastav1 Chui M Cheung2 Joanne Yw Ng3 Timothy YY Lai3 1Retina Service, Department of  Ophthalmology, King George’s  Medical University Lucknow,   india; 2Singapore National eye  Centre, Singapore; 3Department  of Ophthalmology and visual Sciences,   The Chinese University of Hong Kong,   Kowloon, Hong KongAbstract:  Spectral domain optical coherence tomography cross-sectional imaging of the macula  has conventionally been resolved into four bands.",Non-OADS,/arxiv_data1/oa_pdf/f3/66/opth-8-2507.PMC4266419.pdf
"The innermost and faintest band (first band) is believed to Correspondence: Timothy YY Lai Department of Ophthalmology and visual  Sciences, The Chinese University of  Hong Kong, 3/F Hong Kong eye Hospital,  Kowloon, Hong Kong Tel +852 2648 2010 email tyylai@cuhk.edu.h k Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Saxena et al Running head recto: Inner segment ellipsoid band in SD-OCT DOI: http://dx.doi.org/10.2147/OPTH.S72132",Non-OADS,/arxiv_data1/oa_pdf/f3/66/opth-8-2507.PMC4266419.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/66/opth-8-2507.PMC4266419.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/66/opth-8-2507.PMC4266419.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 267–271Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  267OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7250 9Post-marathon wearing of Masai Barefoot  T echnology shoes facilitates recovery from   race-induced fatigue: an evaluation utilizing   a visual analog scale Kento nakagawa Takashi Obu Kazuyuki Kanosue Faculty of Sport Sciences, Waseda  University, T okorozawa, Saitama, Japan correspondence: Kento nakagawa   Faculty of Sport Sciences, Waseda  University,  2-579-15 Mikajima,  Tokorozawa, Saitama, Japan   Tel +81 4 2947 6826  Fax +81 4 2947 6826  email nakagawa@aoni.waseda.j pPurpose:  To investigate the potential benefit of post-race wearing of uns table  shoes (Masai  Barefoot Technology [MBT]) on recovery from marathon race–induced fatigue.",Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
Available from: http://www.ssf.,Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
"Available from: http://prtimes.jp/a/?c=4729&r=3&f=d4729-20130220- 3156.pd f. Accessed September  3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/b5/oajsm-5-267.PMC4266420.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/df/ott-7-2215.PMC4266421.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 2215–2225OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2215Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6953 0Multidrug resistance protein  1 localization in lipid   raft domains and prostasomes in prostate  cancer cell lines alba gomà1,* roser Mir1–3,* Fina Martínez-soler1,4 avelina T ortosa4 august Vidal5,6 enric condom5,6 ricardo Pérez–T omás6 Pepita giménez-Bonafé1 1Departament de ciències  Fisiològiques ii, Faculty of Medicine,   campus of health sciences of  Bellvitge, Universitat de Barcelona,   iDiBell, Barcelona, spain;  2División  de investigación Básica, instituto  nacional de cancerología, México  DF , Mexico;  3instituto de Física,   Universidad nacional autónoma de  México (UnaM), México DF , Mexico;   4Department of Basic nursing, school  of nursing of the health campus of  Bellvitge, Universitat de Barcelona,   5Department of Pathology, hospital  Universitari de Bellvitge, 6Department  of Pathology and experimental  Therapeutics, Universitat de  Barcelona, iDiBell, Barcelona, spain *These authors contributed equally to  this work correspondence: Pepita giménez-Bonafé   Faculty of Medicine, University   of Barcelona, c/Feixa llarga s/n,   08907 l’hospitalet de llobregat,   Barcelona, spain   Tel +34 934 039 727  Fax +34 934 024 268  email pgimenez@ub.ed uBackground:  One of the problems in prostate cancer (CaP) treatment is the appearance of the  multidrug resistance phenotype, in which ATP-binding cassette transporters such as multidrug  resistance protein  1 (MRP1) play a role.",Non-OADS,/arxiv_data1/oa_pdf/43/df/ott-7-2215.PMC4266421.pdf
Avail - able from: http://www.criscancer.org/en/why-cris.php?zona=1&seccion =2&apartado= 5.,Non-OADS,/arxiv_data1/oa_pdf/43/df/ott-7-2215.PMC4266421.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/43/df/ott-7-2215.PMC4266421.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/df/ott-7-2215.PMC4266421.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2339–2351Neuropsychiatric Disease and Treatment Dovepress submit your manuscript | www.dovepress.co m Dovepress 2339OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7346 4iminodibenzyl class antipsychotics for  schizophrenia: a systematic review and    meta-analysis of carpipramine, clocapramine, and mosapramine Taro Kishi shinji Matsunaga Yuki Matsuda Nakao iwata Department of Psychiatry, Fujita  health University school of Medicine,   T oyoake, JapanBackground: We conducted a meta-analysis of the iminodibenzyl antipsychotics carpipramine,  clocapramine, and mosapramine, which are classified as second-generation antipsychotics  (SGAs) for schizophrenia treatment.",Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
"A systematic review correspondence: Taro Kishi Department of Psychiatry, Fujita health University school of Medicine, Toyoake, aichi 470-1192, JapanTel +81 5 6293 9250Fax +81 5 6293 1831email tarok@fujita-hu.ac.jpJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original ResearchY ear: 2014Volume: 10Running head verso: Kishi et alRunning head recto: Iminodibenzyl antipsychotics for schizophreniaDOI: http://dx.doi.org/10.2147/NDT.S73464",Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
"In addition, we used the drug package insert in each antipsychotic (carpipramine, http://di.mt-pharma.co.jp/file/if/f_def.pdf ;  clocapramine, http://di.mt-pharma.co.jp/file/if/f_clo.pd f;  and mosapramine, http://di.mt-pharma.co.jp/file/dc/cre.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
"Three authors (Taro Kishi, Shinji Matsunaga, and Yuki Matsuda) independently extracted, checked, and entered this data into Cochrane Collaboration Review Manager Version 5.2 for Windows (http://tech.cochrane.org/Revman, Cochrane Collaboration, Oxford, UK).",OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
Available from: http://www.info.pmda.go.jp/shinyaku/P200600001/18007800_21800AMZ10011_G100_1.pdf#search=’03195003’.,OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journalNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
Visit http://www.dovepress.com/testimonials.php to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/42/ndt-10-2339.PMC4266422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/c6/opth-8-2479.PMC4266423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2479–2484Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2479Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7170 8nasolacrimal duct obstruction following  radioactive iodine 131 therapy in differentiated  thyroid cancers: review of 19 cases Khalid hussain al-Qahtani1 Mushabbab al asiri2 Mutahir a T unio2 naji J aljohani3 Yasser Bayoumi4 iqbal Munir5 ayman alayoubi6 1Department of Otolaryngology –  head and neck surgery, College  of Medicine, advanced head and  neck Oncology, King saud University,   2radiation Oncology, Comprehensive  Cancer Center, King Fahad Medical  City, 3endocrinology and Thyroid  Oncology, King Fahad Medical City,   riyadh, saudi arabia; 4radiation  Oncology, nCi, Cairo University,   Cairo, egypt; 5nuclear Medicine  sulaiman al-habib hospital, 6Clinical  Ophthalmology, King Fahad Medical  City, riyadh, saudi arabiaBackground:  Radioactive iodine 131 (131I) therapy has long been used in the treatment of  differentiated thyroid cancers (DTC).",Non-OADS,/arxiv_data1/oa_pdf/28/c6/opth-8-2479.PMC4266423.pdf
"Other signs and symptoms are the medial  canthus mass, recurrent conjunctivitis, or infection (dacryocystitis).4 In the Kingdom of Saudi Arabia, DTC has become the second most common malig - nancy, behind only breast cancer, accounting for more than 10% of all cancers among Correspondence: Mutahir a Tunio radiation Oncology, Comprehensive  Cancer Center, King Fahad Medical City,  riyadh, saudi arabia Tel +966 1288 9999 Fax +966 1288 5754 email mkhairuddin@kfmc.med.s a Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Al-Qahtani et al Running head recto: Nasolacrimal duct obstruction following radioactive iodine therapy DOI: http://dx.doi.org/10.2147/OPTH.S71708",Non-OADS,/arxiv_data1/oa_pdf/28/c6/opth-8-2479.PMC4266423.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/28/c6/opth-8-2479.PMC4266423.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/c6/opth-8-2479.PMC4266423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/c1/opth-8-2471.PMC4266424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2471–2478Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2471Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7130 5Prognostic phenotypic and genotypic factors  associated with photodynamic therapy response  in patients with age-related macular degeneration Takashi Tsuchihashi1 Keisuke Mori1 Kuniko horie-inoue2 Yasushi Okazaki3 Takuya awata4,5 satoshi inoue2 shin Y oneya1 1Department of Ophthalmology,   2Division of gene regulation  and signal Transduction, research  Center for genomic Medicine,   Johns hopkins University school  of Medicine, Baltimore, MD,   Usa; 3Division of Translational  research, research Center for  genomic Medicine, 4Division  of endocrinology and Diabetes,   Department of Medicine, 5Division  of ri laboratory, Biomedical research  Center, saitama Medical University,   iruma, saitama, Japan Background:  This study aimed to demonstrate the phenotypic and genotypic factors associated  with photodynamic therapy (PDT) for age-related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/74/c1/opth-8-2471.PMC4266424.pdf
"Keywords:  age-related macular degeneration, photodynamic therapy, phenotypic and genotypic  factors, high temperature requirement A-1, greatest linear dimension, pigment epithelial  detachment Introduction Age-related macular degeneration (AMD; [ARMD1 MIM603075]) is the leading  cause of central vision loss in the elderly and is estimated to affect over 50 million  people worldwide.1 It is a multifactorial disease with several identified genetic and  environmental risk factors, including age, smoking, body mass index, hypertension,  and others.2–5 Family-based genome-wide and candidate region linkage studies have  successfully identified several major chromosomal regions, including 1q31 and  10q26.6–11 Photodynamic therapy (PDT) with verteporfin has been previously shown to  be beneficial and safe as one of the standard therapies for subfoveal choroidal  neovascularization (CNV).12–17 It has been reported that the effectiveness of PDT  is influenced by various baseline composition factors,18,19 such as subtypes (typical  AMD/polypoidal choroidal vasculopathy [PCV]),12–14,20–22 CNV type classified using Correspondence: Takashi Tsuchihashi Department of Ophthalmology, saitama  Medical University, 38 Morohongo,  Moroyama, iruma, saitama,   350-0495, Japan Tel +814 9276 1250 Fax +814 9295 8002 email tsuchi@saitama-med.ac.j pJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Tsuchihashi et al Running head recto: Prognostic factors in PDT for AMD DOI: http://dx.doi.org/10.2147/OPTH.S71305",Non-OADS,/arxiv_data1/oa_pdf/74/c1/opth-8-2471.PMC4266424.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/74/c1/opth-8-2471.PMC4266424.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/c1/opth-8-2471.PMC4266424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/8e/opth-8-2523.PMC4266425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2523–2528Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2523Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7234 9retrospective study of recession of four  horizontal rectus muscle in periodic alternating  nystagmus Osamu Mimura1 Hiroto ishikawa1,2 Naoki Kimura1 akiko Kimura1 Cesar V Borlongan2 1Department of Ophthalmology,   Hyogo College of Medicine,   Nishinomiya, Hyogo, Japan;   2Department of Neurosurgery and  Brain repair, University of south  Florida, Tampa, FL, UsaPurpose:  Periodic alternating nystagmus (PAN) is a spontaneous horizontal nystagmus observed  in disorders of the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/ea/8e/opth-8-2523.PMC4266425.pdf
"Furthermore, previous studies reported that these pharmaceutical interven - tions have limited effects in congenital PAN.7,8 Therefore, we examined the efficacy Correspondence: Osamu Mimura Department of Ophthalmology, Hyogo  College of Medicine, 1-1 Mukogawa-cho,  Nishinomiya, Hyogo 663-8501, Japan Tel +81 798 45 6462 Fax +81 798 45 6464 email omimura.ophthalmology.hcm@ gmail.co m Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2014 Volume: 8  Running head verso: Mimura et al Running head recto: Surgical procedure in periodic alternating nystagmus DOI: http://dx.doi.org/10.2147/OPTH.S72349",Non-OADS,/arxiv_data1/oa_pdf/ea/8e/opth-8-2523.PMC4266425.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ea/8e/opth-8-2523.PMC4266425.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/8e/opth-8-2523.PMC4266425.pdf
Available at http://cancer.gov/ cancertopics/pdq/levels-evidence-adult-treatment/HealthProfessional(last accessed 1 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/eb/27/hpb0017-0029.PMC4266438.pdf
"has received research support from Abb ott, Biotie Therapeutics, EMD- Serono, Huntington Study Group, Ipsen, Merz Pharmaceuticals, Allergan, National Parkinson Foundation, NIH/NINDS, Teva, but has no owner interest in any pharmaceuticalFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Blepharospasm BoNT outcomes Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Blepharospasm BoNT outcomes Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Blepharospasm BoNT outcomes Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/90/94/tre-04-286-6402-1.PMC4266684.pdf
"2012, http://www.pallialine.be/ accounts/129/docs/richtlijn_palliatieve_sedatie.pdf  18.",Non-OADS,/arxiv_data1/oa_pdf/bf/97/10.1177_0269216314543319.PMC4266692.pdf
"For further information, see http://www.nhscareers.nhs.uk/explore-by-career/nursing/pay-for-nurses/For information about advanced nurse practitioners, see http://www.rcn.org.uk/__data/assets/pdf_file/0003/146478/003207.pdf",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"British Medical Association, http://bma.org.uk/practical-support-at-work/gp-practices/prescribing/focus-on-antici-patory-prescribing-for-end-of-life-care  6.",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"2011, http://www.palliativedrugs.com/SamplePDF/PCF4/Chapter17.pdf; Palliativedrugs.com  7.",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"London: The Stationary Office, 2008, http://www.nao.org.uk/report/end- of-life-care/  9.",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"Inverness: Palliative Care Network and NHS Highland,  http://www.palliativedrugs.com/download/091119_AnticipatoryPrescribingJune_2008.pdf  23.",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"Norwich: Corwn Copyright, http://webarchive.nationalarchives.gov.uk/20050129173447/the-shipman-inquiry.org.uk/finalreport.asp  28.",Non-OADS,/arxiv_data1/oa_pdf/57/64/10.1177_0269216314543042.PMC4266693.pdf
"In contrast to probiotic bacteria, pathogenic bacteria   such as Escherichia coli and Clostridium perfringens are  known to cause intestinal diseases in domestic animals  Received: July 14, 2014 Accepted: September 25, 2014*Corresponding authors: e-mail: hiro@cc.tuat.ac.jp (H. Matsuda), akane@cc.tuat.ac.jp (A. Tanaka) ©2014 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.",Non-OADS,/arxiv_data1/oa_pdf/5b/f4/jes-25-065.PMC4266753.pdf
e-mail: taka@center.equinst.go.jp ©2014 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/7c/b4/jes-25-073.PMC4266754.pdf
URL  http://www.R-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/7c/b4/jes-25-073.PMC4266754.pdf
©2014 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by- nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/da/e0/jes-25-079.PMC4266755.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/37/main.PMC4266769.pdf
"8 In the ambulatory setting, a multimodal approach to pain control combining intraoperative opioids, paracetamol, nonsteroi-dal anti-in ﬂammatory drugs (NSAIDs), weak opioids, and local andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.10.001 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/95/37/main.PMC4266769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/37/main.PMC4266769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/6e/main.PMC4266770.pdf
"4The 1984 modi ﬁed New York criteria describe the classi ﬁcation criteria for AS.5Patients may be diag- nosed with AS if characteristic radiologic changes of the sacroiliac joint are present, together with de ﬁned clinical symptoms and physical ﬁndings.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.08.002 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/85/6e/main.PMC4266770.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/6e/main.PMC4266770.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
http://dx.doi.org/10.1016/j.shaw.2014.09.001Safety and Health at Work 5 (2014) 181 e185,Non-OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
Available from: http://www.richmondinstitute.com/wp- content/uploads/2012/03/Ergonomics-for-Dental-Students-2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
Available from: http://www.dciindia.org/search.aspx .,OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
Available from: http://www.dciindia.org/ BULLETIN_ST/pdf_ ﬁles/BDS%20SYLLABUS.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
Available from: http://dx.doi.org/10.1155/ 2013/716897 .S.,Non-OADS,/arxiv_data1/oa_pdf/7c/89/main.PMC4266771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/71/main.PMC4266772.pdf
http://dx.doi.org/10.1016/j.shaw.2014.08.003Safety and Health at Work 5 (2014) 186 e190,Non-OADS,/arxiv_data1/oa_pdf/27/71/main.PMC4266772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/0d/main.PMC4266773.pdf
http://dx.doi.org/10.1016/j.shaw.2014.06.001Safety and Health at Work 5 (2014) 169 e174,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/main.PMC4266773.pdf
Available from:http://www.cdc.gov/niosh/docs/2004-165/ .,OADS,/arxiv_data1/oa_pdf/a8/0d/main.PMC4266773.pdf
Available from: http://www.wcrf.org/ cancer_statistics/ .,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/main.PMC4266773.pdf
Available from: http://www.worldatlas.com/ cntycont.htm .,Non-OADS,/arxiv_data1/oa_pdf/a8/0d/main.PMC4266773.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/07/main.PMC4266774.pdf
http://dx.doi.org/10.1016/j.ijpddr.2014.10.005 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/36/07/main.PMC4266774.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/36/07/main.PMC4266774.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
......................................................................................................... 2 3 1 http://dx.doi.org/10.1016/j.ijpddr.2014.10.004 2211-3207/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author at: Wolfson Institute for Biomedical Research, Division of Medicine, University College London, Cruciform Building, Gower S treet, London WC1E 6BT, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
"The application and source code are available for free use, modiﬁcation and redistribution under the terms of the GNU Public Licence, version 2 or later; see http://www.gnu.org/ licences/gpl-2.0.html for details.",Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
The application and its source code can be downloaded from http://code.google.com/p/ wormassay/ (see Table 1 ).,OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
"WormBook, doi/10.1895/wormbook.1.7.1, < http://www.wormbook.org >.",Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
http://dx.doi.org/10.1371/ journal.pone.001042 .,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
http://dx.doi.org/10.1371/ journal.pone.0002208 .S.D.,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
http://dx.doi.org/10.1371/journal.pcbi.1003702 .,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
http://dx.doi.org/10.1371/journal.pone.0011631 .,Non-OADS,/arxiv_data1/oa_pdf/a3/6c/main.PMC4266775.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
The http://dx.doi.org/10.1016/j.ijpddr.2014.09.004 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
tBLASTn and BLASTn analyzes were per- formed using the NCBI databank http://blast.ncbi.nlm.nih.gov.,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.09.",OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/ journal.pone.0005651 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1186/1471-2164- 12-215 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1042/BJ20041140 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1000769 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1074/jbc.M110.210336 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1038/nature08160 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.tibs.2004.03.006 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.ppat.1003448 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.pbio.1000017 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1002/ajmg.a.36101 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/S0140-6736(13)61949-2 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.drudis.2009.01.011 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.pt.2010.09.001 .264 M. Morel et al.,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/0166-6851(81)90053-0 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"5, 72. http://dx.doi.org/10.3389/fendo.2014.00072 .",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1097/QCO.0b013e328318978f .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1016/j.exppara.2011.05.007 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"5, 170. http://dx.doi.org/10.3389/ fgene.2014.00170 .",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"12, 5. http://dx.doi.org/10.1186/1741-7007-12-5 .",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/ S1535-6108(03)00303-9 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1111/j.1742-4658.2006.05610.x .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1016/S0378-1119(02)00760-6 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.ijpara.2006.06.004 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/ j.exppara.2007.04.006 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1038/sj.onc.1209087 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/ j.exppara.2007.06.002 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"http://dx.doi.org/ 10.1016/j.ijpara.2009.04.002 .Marumoto, T., Honda, S., Hara, T., Nitta, M., Hirota, T., Kohmura, E., Saya, H., 2003.",OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.pntd.0000504 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"5, 238. http://dx.doi.org/10.3389/fgene.2014.00238 .",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.jinsphys.2009.10.013 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1073/pnas.1204384109 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.actatropica.2009.01.012 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/ 10.1371/journal.pntd.0002924 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1126/science.1106148 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.pntd.0000505 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/j.ijpara.2010.01.001 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1074/jbc.M507057200 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1038/ nature12031 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"BMC Genomics 14, 361. http://dx.doi.org/10.1186/1471-2164-14-36 .",OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.pntd.0002226 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1371/journal.ppat.1004138 .,Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1016/S0166- 6851(02)00249-9 .,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"http://dx.doi.org/10.1074/jbc.M313738200 .Yang, L., Dan, H.C., Sun, M., Liu, Q., Sun, X.M., Feldman, R.I., Hamilton, A.D., Polokoff, M., Nicosia, S.V., Herlyn, M., Sebti, S.M., Cheng, J.Q., 2004.",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
"64, 4394– 4399. http://dx.doi.org/10.1158/0008-5472.CAN-04-0343 .",Non-OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-05- 1278 .266 M. Morel et al.,OADS,/arxiv_data1/oa_pdf/f3/c7/main.PMC4266776.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/47/main.PMC4266777.pdf
"In the genus Leishmania , metabolism of amino acids play an important role throughout differentiation from promastigotes to http://dx.doi.org/10.1016/j.ijpddr.2014.06.001 2211-3207/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/f6/47/main.PMC4266777.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f6/47/main.PMC4266777.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/86/main.PMC4266778.pdf
(1999) generated 12 S. mansoni http://dx.doi.org/10.1016/j.ijpddr.2014.09.006 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/7c/86/main.PMC4266778.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author at: Dept.,Non-OADS,/arxiv_data1/oa_pdf/7c/86/main.PMC4266778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/b7/main.PMC4266779.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.005Safety and Health at Work 5 (2014) 203 e209,Non-OADS,/arxiv_data1/oa_pdf/da/b7/main.PMC4266779.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4266780.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.001Safety and Health at Work 5 (2014) 222 e226,Non-OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4266780.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/6b/main.PMC4266781.pdf
http://dx.doi.org/10.1016/j.ijpddr.2014.07.004 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/ae/6b/main.PMC4266781.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: ECD, extracellular domain; cis-ACBD, cis-1-aminocyclobutane- 1,3-dicarboxylate; GABA, c-aminobutyric acid; GABA AR, type A c-aminobutyric acid receptor; GluCl, glutamate-gated chloride channel; GlyR, glycine receptor; iGluR,(tetrameric) ionotropic glutamate receptor; pLGIC, pentameric ligand-gated ionchannel (or Cys-loop receptor); TMD, transmembrane domain.",Non-OADS,/arxiv_data1/oa_pdf/ae/6b/main.PMC4266781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/38/main.PMC4266782.pdf
...................................................................................................... 3 0 6 http://dx.doi.org/10.1016/j.ijpddr.2014.09.007 2211-3207/ /C2112014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/4a/38/main.PMC4266782.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Tel.,Non-OADS,/arxiv_data1/oa_pdf/4a/38/main.PMC4266782.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/9d/main.PMC4266783.pdf
"In less than three years, more than 90 institutions have joined WIPO Re:Search, leading to over 70 research agree- http://dx.doi.org/10.1016/j.ijpddr.2014.10.001 2211-3207/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/82/9d/main.PMC4266783.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author at: Department of Infectious Diseases, 501 D.W. Brooks Drive, Athens, GA 30602, USA.",Non-OADS,/arxiv_data1/oa_pdf/82/9d/main.PMC4266783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
"However, reports of resistance to several currently available http://dx.doi.org/10.1016/j.ijpddr.2014.08.003 2211-3207/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
"All of the aforementioned changes are contained in WormAssay revision 1.4, whose source and executable code can be found at https://code.google.com/p/wormassay .",Non-OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
"Microscopic parasite stage assays utilized an Olympus IX51 inverted microscope with the Canon Vixia HF M52 attached via a Martin Microscope adapter, model MM99-58 ( http:// www.martinmicroscope.com ), and a Diagnostic Instruments DBX 1.0X C-mount adapter ( http://www.spotimaging.com ).",Non-OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
"Dose response analysis was performed with GraphPad Prism ver- sion 6.00 using a variable slope nonlinear regression model (Graph- Pad Software, La Jolla, California, USA, http://www.graphpad.com ).",OADS,/arxiv_data1/oa_pdf/0e/fe/main.PMC4266792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/d5/main.PMC4266793.pdf
Sporulation involves a meiotic division fol- lowed by a mitotic division that results in the formation of four sporocysts; a mitotic division then occurs within each sporocyst to form two genetically identical haploid sporozoites ( Canning http://dx.doi.org/10.1016/j.ijpddr.2014.10.002 2211-3207/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/d5/main.PMC4266793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/2d/d5/main.PMC4266793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/a6/main.PMC4266794.pdf
"The in vivo mechanism of hemozoin formation has been contested for many years, though emerging evidence implicates the involvement of neutral lipids present within the digestive food vacuole as the http://dx.doi.org/10.1016/j.ijpddr.2014.08.002 2211-3207/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/a6/main.PMC4266794.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/73/a6/main.PMC4266794.pdf
Derivatives of scaffold G have previously been reported in the PubChem database ( http://pubchem.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/73/a6/main.PMC4266794.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.08.",OADS,/arxiv_data1/oa_pdf/73/a6/main.PMC4266794.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
"However, the existence of chloroquine- sensitive (CQS) strains associated with K76T mutation suggests that other genes could also be involved in CQ resistance http://dx.doi.org/10.1016/j.ijpddr.2014.07.003 2211-3207/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.",OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
Dis.. http://dx.doi.org/ 10.1093/infdis/jiu216 .,OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
Dis.. http://dx.doi.org/10.1093/infdis/jiu358 .,OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
http://www.who.int/malaria/mpac/ sep2012/iptp_sp_erg_meeting_report_july2012.pdf .J.,Non-OADS,/arxiv_data1/oa_pdf/d7/68/main.PMC4266795.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/8d/main.PMC4266796.pdf
"The use of doxycycline in ﬁeld trials has demonstrated that this antibiotic can be used suc- cessfully to permanently sterilise adult female worms and, if given http://dx.doi.org/10.1016/j.ijpddr.2014.09.001 2211-3207/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ec/8d/main.PMC4266796.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ec/8d/main.PMC4266796.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.09.",OADS,/arxiv_data1/oa_pdf/ec/8d/main.PMC4266796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/57/main.PMC4266797.pdf
http://dx.doi.org/10.1016/j.shaw.2014.08.002Safety and Health at Work 5 (2014) 216 e221,Non-OADS,/arxiv_data1/oa_pdf/83/57/main.PMC4266797.pdf
Available from: https://www.sterkopjewerk.nl/ [in Dutch].,Non-OADS,/arxiv_data1/oa_pdf/83/57/main.PMC4266797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC4266798.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.002Safety and Health at Work 5 (2014) 191 e197,Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC4266798.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/f8/main.PMC4266799.pdf
......................................................................................................... 3 1 4 http://dx.doi.org/10.1016/j.ijpddr.2014.10.003 2211-3207/ /C2112014 Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc.,Non-OADS,/arxiv_data1/oa_pdf/cf/f8/main.PMC4266799.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Tel.,Non-OADS,/arxiv_data1/oa_pdf/cf/f8/main.PMC4266799.pdf
"This interface estimates the percentage of FEC reduction usingBayesian hierarchical models via Markov Chain Monte Carlo sam- pling ( http://www.math.uzh.ch/as/index.php?id=calc ,Torgerson et al., 2014 ) and now provides access for the layperson to more robust methods of computing efﬁcacy.",OADS,/arxiv_data1/oa_pdf/cf/f8/main.PMC4266799.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/9b/main.PMC4266800.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.004Safety and Health at Work 5 (2014) 210 e215,Non-OADS,/arxiv_data1/oa_pdf/ad/9b/main.PMC4266800.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.006Safety and Health at Work 5 (2014) 227 e233,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://www.ihs.com/products/chemical/planning/ceh/toluene.aspx .,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://www.nesdb.go.th/ .,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://ehstoday.com/health/niosh-puts-health-hazards-bed-metal-furniture-manufacturer .,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://toxtown.nlm.nih.gov/text_version/chemicals.php?,OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://toxtown.nlm.nih.gov/text_version/chemicals.php?,OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://grants.nih.gov/ grants/guide/rfa- ﬁles/RFA-OH-04-001.html .,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
Available from: http://www.atsdr.cdc.gov/csem/toluene/docs/toluene.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7c/43/main.PMC4266801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
......................................................................................... 3 3 4 http://dx.doi.org/10.1016/j.ijpddr.2014.07.006 2211-3207/ /C2112014 Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc.,Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Top, DNA topoisomerase; CL, cutaneous leishmaniasis; VL, visceral leishmaniasis; DALYs, disability-adjusted life years; kDNA, kinetoplast DNA; NTD, neglected tropical diseases; NGO, non-governmental organization; lk, linking number; NLS, Nuclear Localization Signal.",Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
A full set of Top enzymes is currently available in the TriTryp Genome database http://tritrypdb.org/tritrypdb/ ; (i) nuclear TopIB and TopIIA enzymes involved in DNA replication and repair that have been fully described as putative drug targets; (ii) mitochon- drial TopIA and TopII that have been described closely linked to kDNA replication; (iii) two putative members of the TopIA subfam- ily TopIII ( aand b) involved in resolving DNA entanglements that can arise during DNA recombination ( Table 1 ).,Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
"Furthermore, regardless previous results (BoseDasgupta et al., 2008 ), it was demonstrated that both sub-Table 1 Tritryps Top-encoding genes annotated into GeneDB database ( http://www.gened- b.org/Homepage ).",OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
"The T. brucei genome contains three type IA topoisomerase-encod- ing genes: one in chromosome 10 (annotated as true TopIA) and two in chromosome 11, both annotated as TopIII ( http://www.ge- nedb.org/genedb/tryp ).",Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
"Similarly, the putative gene encoding L. donovani TopIII a(LdTopIII a) is 2844 bp long and encodes a 104-kDa mono- mer, whereas the 2601-bp gene encoding TopIIIb (LdTopIII b) pro- duces a 95-kDa protein ( http://www.genedb.org/Homepage/ Ldonovani_BPK282A1 ).",Non-OADS,/arxiv_data1/oa_pdf/d7/ef/main.PMC4266802.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4266803.pdf
......................................................................... 1 9 2 http://dx.doi.org/10.1016/j.ijpddr.2014.07.002 2211-3207/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4266803.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4266803.pdf
Yet clear targets have been set to eliminate and control several of these diseases ( http://www.unitingto combatntds.org/downloads/press/ london_declaration_on_ntds.,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4266803.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/f1/main.PMC4266804.pdf
"has enabled the evaluation of several pharmacological targets since complete genomic sequences allow the identiﬁcation of protein- coding genes ( Ivens et al., 2005 ).In silico high-throughput virtual screening and docking procedures using 3D X-ray structured http://dx.doi.org/10.1016/j.ijpddr.2014.05.001 2211-3207/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/1a/f1/main.PMC4266804.pdf
"This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Abbreviations: NTD, Neglected Tropical Diseases; TDR, Special Programme for Research and Training in Tropical Diseases; HTS, high throughput screening; HCS,High Content Screening.",Non-OADS,/arxiv_data1/oa_pdf/1a/f1/main.PMC4266804.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
"Clinically relevant proof of resistance has not been reported yet, however, results of http://dx.doi.org/10.1016/j.ijpddr.2014.07.005 2211-3207/ /C2112014 Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc.",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.",OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0000478 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0002949 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.ppat.1003448 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0002923 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
"Poverty 3 (1), 6. http://dx.doi.org/10.1186/2049-9957-3-6 .",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
2013. http://dx.doi.org/10.1002/14651858.CD000528.pub2 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/ 10.1371/journal.pone.0068110 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0000504 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0000114 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/journal.pntd.0001602 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
"10, 153. http://dx.doi.org/10.1186/1471- 2334-10-153 .",Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
http://dx.doi.org/10.1371/ journal.pone.0087594 .,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
Available from: < http://www.who.int/mediacentre/factsheets/fs115/en/ >.,Non-OADS,/arxiv_data1/oa_pdf/d8/8c/main.PMC4266805.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
A recent investigation of Wolbachia distribution http://dx.doi.org/10.1016/j.ijpddr.2014.08.001 2211-3207/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
"Scaffolds encoding A. viteae CPL family members were downloaded from the 959 nematodes project page ( http://nematodes.org/genomes/acanthocheilonema_ viteae/ ), and manual gene predictions were generated for ortholo- gous CPLs.",OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
The orthologous A. viteae cathepsin L- like proteins were predicted based on the recently publically available genome ( http://nematodes.org/genomes/acanthocheilo- nema_viteae/ ).,OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.08.",OADS,/arxiv_data1/oa_pdf/f6/90/main.PMC4266806.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/8a/main.PMC4266807.pdf
Thus http://dx.doi.org/10.1016/j.ijpddr.2014.07.001 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/b7/8a/main.PMC4266807.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/b7/8a/main.PMC4266807.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
"The World Intellectual Property Organization (WIPO), a UN agency, was established in 1967 to promote the use of an interna- tional intellectual property (IP) system to stimulate innovation and http://dx.doi.org/10.1016/j.ijpddr.2014.09.002 2211-3207/ /C2112014 Australian Society for Parasitology.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
"< http://www.tipharma.com/pharmaceutical-news.html?tx_ttnews%5Btt_ news%5D=538&cHash=30a69bcbef42e365b1a39c30837076ce > (accessed Aug. 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
"< http://unohrlls.org/about-ldcs/ > (accessed Aug. 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
"< http://www.who.int/ intestinal_worms/more/en/ > (accessed June 20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/main.PMC4266808.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
http://dx.doi.org/10.1016/j.shaw.2014.08.001Safety and Health at Work 5 (2014) 175 e180,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
"Relevant articles in the ﬁelds of dermatology, industrial hy- giene, and exposure assessment were found using various databases such as Google Scholar ( http://scholar.google.com ), Sci- enceDirect http://scholar.google.com ), ScienceDirect ( www.",OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
"sciencedirect.com ), and PubMed ( http://www.ncbi.nlm.nih.gov/ pubmed ).",OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
An English version is available at: http://www.baua.,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
Available from: http://www.hse.gov.uk/statistics/ causdis/dermatitis/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
Available from: http://www.hse.gov.uk/statistics/ causdis/dermatitis/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
Available from: http://www.hse.gov.uk/statistics/ causdis/dermatitis/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
Available from: http://www.hse.,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
Available from: http://www.baua.de/nn_54598/en/Topics-from-A-to-Z/ Hazardous-Substances/TRGS/pdf/TRGS-401.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6b/a3/main.PMC4266809.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.003Safety and Health at Work 5 (2014) 198 e202,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.galileo.org/robotics/intro.html .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://humanresources.about.com/od/glossarye/g/employee- motivation.htm .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://en.wikipedia.org/wiki/Service_industries .,OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://qz.com/147887/a- chinese-province-is-trying-to-solve-its-labor-problems-with-robots .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://news.thomasnet.com/IMT/2013/02/05/are- robots-killing-jobs-or-creating-them .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.inc.com/drew-greenblatt/6-ways-robots-create- jobs.html .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.studymode.com/essays/Robotics-In- Healthcare-Personalizing-Care-And-46056144.html .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.kineticconsulting.co.uk/robots.html .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.informationweek.com/healthcare/ mobile-wireless/10-medical-robots-that-could-change-heal/240143983 .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://online.wsj.,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Avail- able from: http://www.medlabmag.com/article/1094/Fall_2012/RoboCourier_ from_Swisslog/ .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.bestic.,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.informationweek.com/mobile/10-medical-robots-that- could-change-healthcare/d/d-id/1107696?page_number ¼5.,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://www.hsi.gatech.edu/hrl/project_nurse.shtml .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://online.wsj.com/article/ SB10001424127887324345804578424560856966992.html?mod ¼WSJ_WSJ_ US_News_5 .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: http://singularityhub.com/2010/09/02/hospital- to-lay-off-workers-hiring-new-robots/ .,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Available from: https://oig.hhs.gov/reports-and- publications/archives/oas/cms_archive.asp#2006 .,OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
Avail- able from: http://www.hsi.gatech.edu/hrl/project_nurse.shtml .Saf Health Work 2014;5:198 e202 202,Non-OADS,/arxiv_data1/oa_pdf/21/fd/main.PMC4266810.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/34/main.PMC4266811.pdf
http://dx.doi.org/10.1016/j.shaw.2014.07.007Safety and Health at Work 5 (2014) 234e 237,Non-OADS,/arxiv_data1/oa_pdf/5f/34/main.PMC4266811.pdf
Available from: http://monographs.iarc.fr/ENG/ Monographs/vol100C/index.php .,Non-OADS,/arxiv_data1/oa_pdf/5f/34/main.PMC4266811.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs343/en/ .,Non-OADS,/arxiv_data1/oa_pdf/5f/34/main.PMC4266811.pdf
Available from: http://www.who.int/occupational_health/ publications/asbestosrelateddiseases.pdf .,OADS,/arxiv_data1/oa_pdf/5f/34/main.PMC4266811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
http://dx.doi.org/10.1016/j.ijpddr.2014.07.007 2211-3207/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
"WormBase ( www.worm- base.org ) has expanded its data repository to include parasitic nematodes, with the genomes, annotated gene models and inferred function, and related ﬁles available for public access via ftp download (ftp://ftp.sanger.ac.uk/pub2/wormbase/live_re- lease).",OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
Tool Description Source Guidelines MINSEQE RNA-seq guidelineshttp://www.fged.org/projects/ minseqe/ Encode Genome AnnotationAssessmentProject (EGASP)Genome annotationguidelinesGuigo et al.,OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
(2013) Advice/Protocols SEQAnswers HTS and bioinformaticswww.seqanswers.com Galaxy Project Bioinformatic advice/lectureswww.galaxyproject.org Current Protocols inBioinformaticsCommand- basedprotocolshttp://cda.currentprotocols.com/ Nature Protocols Command- basedprotocolswww.nature.com/nprot/ Applications Read quality FastQC/ Trimmomatichttp:// www.bioinformatics.babraham.ac.uk/projects/fastqc/ /Bolger et al.,Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
"The Galaxy Project(http://galaxyproject.org/ ) provides arguably the best of GUI-based resources currently available, allowing users free access to a remote server for their analyses and a web-based interface.",Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
http://dx.doi.org/ 10.1016/j.ijpddr.2014.06.002 .,OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
"1-106. doi: 10.1895/ wormbook.1.161.1, http://www.wormbook.org .",Non-OADS,/arxiv_data1/oa_pdf/46/ac/main.PMC4266812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/ef/main.PMC4266813.pdf
"Despite the structural differences between the avermectins and milbemycins, the primary mechanism of action is similar and results in paralysis and death of nematodes through activation of http://dx.doi.org/10.1016/j.ijpddr.2014.06.002 2211-3207/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/08/ef/main.PMC4266813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/08/ef/main.PMC4266813.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.ijpddr.2014.06.",OADS,/arxiv_data1/oa_pdf/08/ef/main.PMC4266813.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Q.H.S., Y.L.D., Y.Z.",Non-OADS,/arxiv_data1/oa_pdf/54/98/srep07499.PMC4266859.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/1d/srep07502.PMC4266860.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7502 | DOI: 10.1038/srep07502 6",Non-OADS,/arxiv_data1/oa_pdf/e0/1d/srep07502.PMC4266860.pdf
"Patch pipettes were pulled from glass capillaries GB150T-8P (Science Products, Hofheim, Germany) at a vertical Puller (PC-10, Narishige, Tokyo,Japan) and had resistances between 2 and 4 M Vwhen filled with standard internal solution (in mM: 120 Cs-glutamate, 8 NaCl, 1 MgCl 2, 10 HEPES, 10 Cs-BAPTA, 3.1 CaCl 2(100 nM free Ca21, calculated with WebMaxC (http://www.stanford.edu/ ,cpatton/webmaxcS.htm)), pH adjusted to 7.2 with CsOH).",Non-OADS,/arxiv_data1/oa_pdf/46/d7/srep07500.PMC4266863.pdf
Available from: (WHO/NMH/NHD/ MNM/11.1) http://www.who.int/vmnis/indicators/haemoglobin.,OADS,/arxiv_data1/oa_pdf/33/8e/IJEM-18-1.PMC4266864.pdf
Available from: http://www.fao.org/docrep/w0073e/w0073e05.htm#P3355_389439.,Non-OADS,/arxiv_data1/oa_pdf/33/8e/IJEM-18-1.PMC4266864.pdf
"Preventing chronic diseases:  A vital investement, WHO Global report: Available from: http://www.who.int/chp/chronic disease report.",Non-OADS,/arxiv_data1/oa_pdf/38/3b/IJEM-18-17.PMC4266865.pdf
Available  from: http://www.who.int/dietphysicalactivity/childhood_why/en/index.html [Last accessed on 2013 Nov 22].,Non-OADS,/arxiv_data1/oa_pdf/38/3b/IJEM-18-17.PMC4266865.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/IJEM-18-17.PMC4266865.pdf
Available from http://ispub.com/IJNW/6/2/7073.,Non-OADS,/arxiv_data1/oa_pdf/38/3b/IJEM-18-17.PMC4266865.pdf
Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/pdfs/HP2020objectives.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/53/IJEM-18-26.PMC4266866.pdf
Available from: http://www.cdc.gov/nccdphp/dnpa/growthcharts/training/modules/module3/text/page2a.htm.,OADS,/arxiv_data1/oa_pdf/0d/53/IJEM-18-26.PMC4266866.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/cvd_ped/peds_guidelines_full.pdf [Last accessed on 2012 Oct 02].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
Available from: http://www.who.int/nutrition/publications/programming_chronicdisease.pdf [Last accessed on 2002 Sep 12].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
Available from: http://www.landesbioscience.com/pdf/14GertlerVickers.pdf [Last accessed date 2014 Aug 05].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
Available from: http://www.landesbioscience.com/pdf/14GertlerVickers.pdf [Last accessed date 2014 June 05].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
Available from: http://www.cnpp.usda.gov/publications/dietaryguidelines/2010/policydoc/policydoc.pdf [Last accessed on 2010 Dec 02].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
Available from: http://www.continuingeducation.com/PDF/RD69_ELT-CAN-10.pdf [Last accessed on 2014 Mar 02].,Non-OADS,/arxiv_data1/oa_pdf/5f/d5/IJEM-18-39.PMC4266867.pdf
"Available from: http://www.gfmer.ch/Endo/Lectures_10/Puberty_%20Physiology.htm last accessed August 17, 2012 49.",Non-OADS,/arxiv_data1/oa_pdf/ea/cc/IJEM-18-53.PMC4266869.pdf
Available from: http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5989 [Last accessed on 2014 Oct 1].,Non-OADS,/arxiv_data1/oa_pdf/5e/84/IJEM-18-6.PMC4266870.pdf
Available from: http://www.nos.org.uk/document.doc?id = 1352 [Last accessed  on 2014 Jan 03].,Non-OADS,/arxiv_data1/oa_pdf/23/36/IJEM-18-9.PMC4266875.pdf
Available from: http://www.emedicine.medscape.com/article/1113394-clinical#a0217.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/IJEM-18-93.PMC4266876.pdf
Available from: http://www.british-thyroid-association.org.,Non-OADS,/arxiv_data1/oa_pdf/19/95/IJEM-18-97.PMC4266877.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/2f/main.PMC4266935.pdf
http://dx.doi.org/10.1016/j.scog.2014.09.002 2215-0013/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/80/2f/main.PMC4266935.pdf
Published by Elsevier Inc. Th is is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/2f/main.PMC4266935.pdf
Contents lists available at ScienceDirect Schizophrenia Research: Cognition journal homepage: http://www.schizrescognition.com/,Non-OADS,/arxiv_data1/oa_pdf/80/2f/main.PMC4266935.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
http://dx.doi.org/10.1016/j.pmedr.2014.08.001 2211-3355/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
http://www.cms.gov/medicare- coverage-database/details/medcac-meeting-details.aspx?MEDCACId=45&year= All&bc=AAAIAAAAAAAAAA%3d%3d& (Accessed November 20 2013).,OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
"http://www.resdac.org/resconnect/articles/156 (Accessed February 28 2013).Rutter, C.M., Johnson, E., Miglioretti, D.L., Mandelson, M.T., Inadomi, J., Buist, D.S., 2012.",Non-OADS,/arxiv_data1/oa_pdf/06/91/main.PMC4266938.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/bf/main.PMC4267059.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.10.005 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/08/bf/main.PMC4267059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 81 e88,Non-OADS,/arxiv_data1/oa_pdf/08/bf/main.PMC4267059.pdf
http://dx.doi.org/10.1016/j.bbr.2014.07.027 .,OADS,/arxiv_data1/oa_pdf/08/bf/main.PMC4267059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC4267062.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.10.007 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC4267062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 109 e115,Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC4267062.pdf
http://dx.doi.org/10.1002/dev.21230 .,Non-OADS,/arxiv_data1/oa_pdf/39/7b/main.PMC4267062.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005777).,Non-OADS,/arxiv_data1/oa_pdf/f6/72/bmjopen-2014-005777.PMC4267073.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.sg83p.,OADS,/arxiv_data1/oa_pdf/f6/72/bmjopen-2014-005777.PMC4267073.pdf
"Further information about the study and data can be found at http://www.cls.ioe.ac.uk/ Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non- commercially, and license their derivative works on different terms, providedthe original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/c3/25/bmjopen-2014-005468.PMC4267074.pdf
Can Womens Health Netw 2005;8. http://www.cwhn.ca/ node/39483 20.,Non-OADS,/arxiv_data1/oa_pdf/9a/04/bmjopen-2014-006859.PMC4267075.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 48.,Non-OADS,/arxiv_data1/oa_pdf/9a/04/bmjopen-2014-006859.PMC4267075.pdf
"The databases are held securely in a linked, de-identi ﬁed form and analysed at the Institute for Clinical Evaluative Sciences (ICES, http://www.ices.on.ca).",OADS,/arxiv_data1/oa_pdf/4d/ff/bmjopen-2014-006634.PMC4267076.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/ff/bmjopen-2014-006634.PMC4267076.pdf
AEH and AL met to discuss these themes and agreed on the de ﬁnitions of the emerging ihttp://www.screening.nhs.uk/news.php?id=12156.iiwww.qsrinternational.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
More work is needed to determine the prevalence of the views ofpatients and clinicians on the appropriate design and delivery of DRS services to maximise attendance; hos- pital staff may provide insightful alternatives for service ivhttp://diabeticeye.screening.nhs.uk/languages.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
http://www.thelancet.com/journals/langlo/article/ PIIS2214 –109X(13)70113-X/fulltext.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
http://www.sciencedirect.com/ science/article/pii/S1871402112001129 17.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
http://diabeticeye.screening.nhs.uk/statistics 18.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0032182 21.,Non-OADS,/arxiv_data1/oa_pdf/ce/7c/bmjopen-2014-005498.PMC4267079.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005040).,Non-OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
http://www.who.int/hiv/mediacentre/02-Global_Summary_2006_EpiUpdate_eng.pdf 2. WHO U.,OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
2014. http://www.who.int/mediacentre/factsheets/fs164/en/.,Non-OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
http://www.ccsa.ca/Eng/Topics/Populations/IDU/Pages/InjectionDrugUsersOverview.aspx 8.,OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/estimat2011-eng.php 19.,Non-OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
http://www.catie.ca/en/printpdf/pif/spring-2013/what-syph-going-responding-syphilis-outbreaks-canada 20.,Non-OADS,/arxiv_data1/oa_pdf/79/7a/bmjopen-2014-005040.PMC4267080.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/eb/bmjopen-2014-005791.PMC4267081.pdf
2011 [cited 15 October 2014].http://www.aapor.org/AM/Template.cfm?Section=Standard_Definitions2&Template=/CM/ContentDisplay.cfm&ContentID=3156 22.,OADS,/arxiv_data1/oa_pdf/c7/eb/bmjopen-2014-005791.PMC4267081.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/openhrt-2014-000051.PMC4267108.pdf
2009. http://www.ucr.uu.se/ swedeheart 18.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/openhrt-2014-000051.PMC4267108.pdf
2009. http://www.ucr.uu.se/ swedeheart 19.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/openhrt-2014-000051.PMC4267108.pdf
2009. http://www.ucr.uu.se/swedeheart30.,Non-OADS,/arxiv_data1/oa_pdf/2f/d7/openhrt-2014-000051.PMC4267108.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Verrall GM, Kalairajah Y, Slavotinek JP, et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/54/bjsports-2014-094017.PMC4267196.pdf
Local sunrise and sunset times were taken from NOAA’s marine weatherdatabase (http://www.weather.gov/view/states.php?state 5MA).,OADS,/arxiv_data1/oa_pdf/be/d8/srep07508.PMC4267198.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/srep07508.PMC4267198.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/70/srep07501.PMC4267199.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2d/54/srep07505.PMC4267200.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/08/52/srep07427.PMC4267201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7427 | DOI: 10.1038/srep07427 7",Non-OADS,/arxiv_data1/oa_pdf/08/52/srep07427.PMC4267201.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ae/e6/srep07498.PMC4267202.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Figure 7 |(a) the frequency dependence of RL (line, Black: 3.0 mm, Red: 4.2 mm, Blue: 5.0 mm, Cyan: 5.5 mm, Magenta: 7.0 mm), the minimum reflection loss for every thickness (symbol and line) and (b) the dependence of matching thickness ( tmat) and calculated thickness ( tcal)o n the matching frequency ( fm).",Non-OADS,/arxiv_data1/oa_pdf/e5/31/srep07493.PMC4267203.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/83/ef/srep07494.PMC4267204.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7494 | DOI: 10.1038/srep07494 7",Non-OADS,/arxiv_data1/oa_pdf/83/ef/srep07494.PMC4267204.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/e8/srep07506.PMC4267205.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7506 | DOI: 10.1038/srep07506 10",Non-OADS,/arxiv_data1/oa_pdf/0c/e8/srep07506.PMC4267205.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/54/srep07503.PMC4267213.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7503 | DOI: 10.1038/srep07503 7",Non-OADS,/arxiv_data1/oa_pdf/3f/54/srep07503.PMC4267213.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi   .org/10.1016/j.jaci.2009.10.03 8 Friedl, P., K. Wolf, and J. Lammerding.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.1016/j.ceb.2010.10.01 5 Gebhardt, T., L.M.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/ni.171 8 Gebhardt, T., P.G.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/nature1033 9 Goel, N., J.J. Docherty, M.M.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/   S0166-0934(02)00160- X Gotoh, K., Y. Tanaka, A. Nishikimi, A. Inayoshi, M. Enjoji, R. Takayanagi, T.  Sasazuki, and Y. Fukui.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1182/blood-2007-09-11216 9 Grégoire, C., L. Chasson, C. Luci, E. Tomasello, F. Geissmann, E. Vivier,  and T. Walzer.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
http://dx.doi.org/10.1111/j.1600-065X.2007.00563.,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.4049/   jimmunol.120279 2 Harada, Y., Y. Tanaka, M. Terasawa, M. Pieczyk, K. Habiro, T. Katakai,  K. Hanawa-Suetsugu, M. Kukimoto-Niino, T. Nishizaki, M. Shirouzu,   et al.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1002/jmv.189041050 6 Honda, T., J.G.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.immuni   .2013.11.01 7 Imai, K., T. Morio, Y. Zhu, Y. Jin, S. Itoh, M. Kajiwara, J. Yata, S. Mizutani,  H.D.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1182/   blood-2003-05-148 0 Jabara, H.H., D.R.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/   ni.230 5 Jaffe, A.B., and A.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.21.020604.15072 1 Jiang, X., R.A. Clark, L. Liu, A.J.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/nature1085 1REFERENCES Akbar, H., X. Shang, R. Perveen, M. Berryman, K. Funk, J.F.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1371/   journal.pone.002211 7 Ariotti, S., J.B. Beltman, G. Chodaczek, M.E.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.17.1.18 9 Blaschke, F., P. Stawowy, S. Goetze, O. Hintz, M. Gräfe, U. Kintscher, E.  Fleck, and K. Graf.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/S0006-291X   (02)02033- 8 Bokoch, G.M.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1146/annurev.biochem.72.121801   .16174 2 Chu, E.Y., A.F.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1001/   archdermatol.2011.26 2 Côté, J.F., and K. Vuori.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.1242/jcs.0021 9 Côté, J.F., and K. Vuori.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.tcb.2007.05.00 1 Crawford, G., A. Enders, U. Gileadi, S. Stankovic, Q. Zhang, T. Lambe, T.L.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1182/blood-2013-02-48233 1 Cunningham, A.L., R.R.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1172/   JCI11167 8 Darzynkiewicz, Z., and X. Huang.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"88:1031– 1040. http://dx.doi.org/10.1189/jlb.041019 7 Dotta, L., L. Tassone, and R. Badolato.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.2174/15665241179567796 3 Drijkoningen, M., C. De Wolf-Peeters, H. Degreef, and V. Desmet.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1007/   BF0051396 1 Dustin, M.L.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.24.110707.17522 6 Ebert, L.M., S. Meuter, and B. Moser.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.4049/jimmunol.176.7.433 1 Engelhardt, K.R., S. McGhee, S. Winkler, A. Sassi, C. Woellner, G.  Lopez-Herrera, A. Chen, H.S.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
http://dx.doi   .org/10.1046/j.1440-1711.2002.01071.,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1146/annurev-immunol-   032712-09595 4 Mukhopadhyay, N.K., D. Gilchrist, G.J.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10   .1016/j.athoracsur.2004.01.04 2 Muraki, R., T .",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1007/BF0160598 7 Neuman, R.E., and M.A.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1136/jcp.49.3.24 3 Nishikimi, A., H. Fukuhara, W. Su, T. Hongu, S. Takasuga, H. Mihara,  Q. Cao, F. Sanematsu, M. Kanai, H. Hasegawa, et al.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1126/   science.117017 9 Nishikimi, A., M. Kukimoto-Niino, S. Yokoyama, and Y. Fukui.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.yexcr   .2013.07.02 4 Pedersen, J.A., and M.A.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1007/   s10439-005-8159- 4 Randall, K.L., T. Lambe, A.L.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"10:1283– 1291. http://dx.doi.org/10.1038/ni.182 0 Randall, K.L., S.S. Chan, C.S.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1084/jem.2011034 5 Ruusala, A., and P .",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.febslet.2004.06.09 5 Sabry, A., P.J.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.11.03 1 Sanal, O., H. Jing, T .",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1007/s10875-   012-9664- 5 Schaefer, B.C., M.L.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10   .1006/cimm.2001.189 5 Simmons, A., and A.A. Nash.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/   j.cellsig.2008.05.00 2 Sixt, M., and T. Lämmermann.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1007/978-1-61779-207-6_1 1Jing, H., Q. Zhang, Y. Zhang, B.J.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/j.bbrc.2007.12.09 3 Kilkenny, M., and R. Marks.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
http://dx.doi.org/10.1111/   j.1440-0960.1996.tb01010.,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/ncb165 9 Kunisaki, Y., A. Nishikimi, Y. Tanaka, R. Takii, M. Noda, A. Inayoshi, K.  Watanabe, F. Sanematsu, T. Sasazuki, T. Sasaki, and Y. Fukui.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.1083/jcb.20060214 2 Lambe, T., G. Crawford, A.L.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.1002/eji.20114175 9 Lämmermann, T., B.L.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/   nature0688 7 Lang, P.A., N. Shaabani, S. Borkens, N. Honke, S. Scheu, S. Booth, D.  Brenner, A. Meryk, C. Barthuber, M. Recher, et al.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/   j.jaci.2012.08.05 0 Li, R., and G.G.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1038/nrm252 2 Lowry, O.H., D.R.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/   10.1038/ni.274 4 Meller, N., S. Merlot, and C. Guda.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1242/   jcs.0267 1 Mizesko, M.C., P.P.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/   j.jaci.2012.12.156 8 Mou, F., M. Praskova, F. Xia, D. Van Buren, H. Hock, J. Avruch, and  D. Zhou.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1084/jem.2011169 2 Mueller, S.N., W. Heath, J.D.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1189/jlb.080444 4 Spinner, M.A., L.A. Sanchez, A.P .",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1182/blood-2013-07-51552 8 Stock, A.T., J.M.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1084/jem.2013218 3 Su, H.C., H. Jing, and Q. Zhang.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
http://dx.doi.org/10.1111/j.1749-6632.2011.06295.,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1016/S0022-3476(05)82002- 5 van Lint, A., M. Ayers, A.G. Brooks, R.M.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"172:392– 397. http://dx.doi.org/10.4049/jimmunol.172.1.39 2 Vintersten, K., C. Monetti, M. Gertsenstein, P. Zhang, L. Laszlo, S. Biechele,  and A. Nagy.",Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1002/gene.2009 5 Wolf, K., S. Alexander, V. Schacht, L.M.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"20:931– 941. http://dx.doi.org/10.1016/j.semcdb.2009.08.00 5 Zaid, A., L.K.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1084/jem.190.9.132 9 Zhang, Q., J.C. Davis, I.T.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
"http://dx.doi.org/10.1056/NEJMoa090550 6 Zhu, J., T. Peng, C. Johnston, K. Phasouk, A.S. Kask, A. Klock, L. Jin,  K. Diem, D.M.",OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
http://dx.doi.org/10.1038/nature1211 0,Non-OADS,/arxiv_data1/oa_pdf/da/96/JEM_20141307.PMC4267229.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)   81973- X Cirrito, J.R., P.C.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.02.00 3 de Lecea, L., T.S.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10   .1073/pnas.95.1.32 2 Holtzman, D.M., A. Goate, J. Kelly, and R. Sperling.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1093/   hmg/ddh01 9 Ju, Y.E., and D.M.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1001/jamaneurol.2013.349 0 Ju, Y.E., B.P.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"10:115– 119. http://dx.doi.org/10.1038/nrneurol.2013.26 9 Kamenetz, F., T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo,  S. Sisodia, and R. Malinow.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)   00124- 7 Kang, J.E., M.M.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1126/science.118096 2 Kim, J., J.M.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"64:632– 644. http://dx.doi.org/10.1016/j.neuron.2009.11.01 3 Koenigsknecht-Talboo, J., M. Meyer-Luehmann, M. Parsadanian, M. Garcia- Alloza, M.B.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"28:14156– 14164. http://dx.doi.org/10.1523/JNEUROSCI.4147-08.200 8 Matsuki, T., M. Nomiyama, H. Takahira, N. Hirashima, S. Kunita, S. Takahashi,   K. Yagami, T.S.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.02.04 3 Ooms, S., S. Overeem, K. Besse, M.O.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1001/   jamaneurol.2014.117 3 Radde, R., T. Bolmont, S.A. Kaeser, J. Coomaraswamy, D. Lindau, L.  Stoltze, M.E.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1038/   sj.embor.740078 4antibody for GFAP at 1:1,000 dilution, and signal was then amplified using  the Vectastain ABC kit at 1:400 (Vector Laboratories) followed by visualization  with DAB-nickel.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1038/nn.280 1 Carter, M.E., O. Yizhar, S. Chikahisa, H. Nguyen, A. Adamantidis, S. Nishino,  K. Deisseroth, and L. de Lecea.",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1038/nn.268 2 Chemelli, R.M., J.T.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1126/   scitranslmed.300429 1 Sperling, R.A., P.S.",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/j.jalz.2011.03.00 3 Spira, A.P., A.A. Gamaldo, Y.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1073/   pnas.101046110 7 Vyazovskiy, V.V., U. Olcese, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1016/j.neuron   .2009.08.02 4 Vyazovskiy, V.V., U. Olcese, E.C.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/   10.1038/nature1000 9 Xie, L., H. Kang, Q. Xu, M.J. Chen, Y. Liao, M. Thiyagarajan, J.  O’Donnell, D.J.",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1126/science.124122 4 Yamada, K., J.K. Holth, F. Liao, F.R.",OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
"http://dx.doi.org/10.1084/jem.2013168 5 Yan, P., A.W.",Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
29:10706– 10714. http://dx.doi.org/10.1523/JNEUROSCI.2637-09.200 9,Non-OADS,/arxiv_data1/oa_pdf/37/87/JEM_20141788.PMC4267230.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"After six months it is available under a   Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20140987/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1002/(SICI)1097- 0215(20000201)85:3<319::AID-IJC4>3.0.CO;2- B Balabanian, K., B. Lagane, J.L.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"105:2449– 2457. http://dx.doi.org/10.1182/blood-2004-06-228 9 Campbell, J.J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P .",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1038/2349 5 Campo, E., S.H.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"117:5019– 5032. http://dx.doi.org/10.1182/blood-2011-01-29305 0 Cao, Y., Z.R.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1038/   leu.2014.18 7 Chen, J., M. Petrus, B.R.",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi   .org/10.1182/blood-2010-04-27741 8 Chong, B.F ., J.E.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.4049/jimmunol.172.3.157 5 Cronshaw, D.G., C. Owen, Z.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.4049/jimmunol.172.12.776 1 D’Ambrosio, D., C. Albanesi, R. Lang, G. Girolomoni, F .",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.4049/jimmunol   .169.5.230 3 Diaz, G.A.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
http://dx.doi.org/10.1111/ j.0105-2896.2005.00226.,Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi   .org/10.1182/blood-2010-12-31946 7sequences are underlined): shCCR4-4A11_F, 5 -GATCCC GAATGAAGTT - GTAG GTAAT TTCAAGAGAATTACCTACAACTTCATTCTTTTT -3 ;  and shCCR4-4A11_R, 5 -AGCTAAAAA GAATGAAGTTGTAGG TA- ATTCTCTTGAAATTACCTACAACTTCATTCGG-3 .",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1074/jbc.272.23.1503 6 Imai, T., D. Chantry, C.J.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1074/jbc.273.3.176 4 Iqbal, J., D.D.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"115:1026– 1036. http://dx.doi.org/10.1182/blood-2009-06-22757 9 Ishida, T., A. Utsunomiya, S. Iida, H. Inagaki, Y. Takatsuka, S. Kusumoto,  G. Takeuchi, S. Shimizu, M. Ito, H. Komatsu, et al.",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1200/JCO.2011.37.347 2 Kawai, T., U. Choi, N.L.",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1111/cas.1216 7 Luttrell, L.M., and R.J. Lefkowitz.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1038/nrc211 1Pease, J.E., and R. Horuk.",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1517/17460441   .2014.89732 4 Roccaro, A.M., A. Sacco, C. Jimenez, P. Maiso, M. Moschetta, Y. Mishima,  Y. Aljawai, I. Sahin, M. Kuhne, P. Cardarelli, et al.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"123:4120– 4131. http://dx.doi.org/10.1182/blood-2014-03-56458 3 Schmitz, R., R.M.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1038/   nature1137 8 Treon, S.P., Y. Cao, L. Xu, G. Yang, X. Liu, and Z.R.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1182/blood-2014-01-55090 5 Vissers, J.L., F .C.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1002/1521- 4141(200103)31:3<812::AID-IMMU812>3.0.CO;2- L Yamagishi, M., and T. Watanabe.",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"3:334. http://dx.doi.org/10.3389/fmicb   .2012.0033 4 Y amamoto, K., A. Utsunomiya, K. T obinai, K. Tsukasaki, N. Uike, K. Uozumi,   K. Yamaguchi, Y .",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/   10.1200/JCO.2009.25.357 5 Y oshie, O.",Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
"http://dx.doi.org/10.1080/1042819040000760 7 Y oshie, O., R. Fujisawa, T. Nakayama, H. Harasawa, H. Tago, D. Izawa, K.  Hieshima, Y .",OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
http://dx.doi.org/   10.1182/blood.V99.5.150 5,Non-OADS,/arxiv_data1/oa_pdf/f9/d3/JEM_20140987.PMC4267233.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1371/journal.pone.001309 9 Arase, H., E.S.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1126/   science.107088 4 Balish, A.L., J.M.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/nature0576 2 Beaulieu, A.M., C.L.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/ni.287 6 Bezman, N.A., C.C.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/ni.239 5(as marked by up­regulation of Ly49H or KLRG1), suggest ­ ing that they are not exposed to latent MCMV in the host  within 1–4 d after transfer.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/   10.1038/ng0501­4 2 Lodoen, M.B., and L.L.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/   10.1016/j.coi.2006.05.00 2 Lopez­Vergès, S., J.M.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/   10.1128/JVI.00654­1 1 McGill, J., J.W.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1189/jlb.050936 8 Mekker, A., V.S.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1371/ journal.ppat.100285 0 Mendelson, M., Y .",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"84:3789– 3797. http://dx.doi.org/10.1128/JVI.01815­0 9 Merrick, J.C., B.T.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j.it.2013.02.00 5 Min­Oo, G., N.A.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1084/jem   .2013245 9 Miyagi, T., M.P.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1084/jem.2007040 1 Mocci, S., S.A. Dalrymple, R. Nishinakamura, and R. Murray.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
http://dx.doi.org/10.1111/j.1600­065X.1997.tb00996.,Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1089/   vim.2005.18.26 7 Mueller, S.N., T. Gebhardt, F .R.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1146/annurev ­immunol ­032712 ­09595 4 Nabekura, T., M. Kanaya, A. Shibuya, G. Fu, N.R.J.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j   .immuni.2013.12.01 1 Oldstone, M.B.A., J.R. Teijaro, K.B.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/   j.virol.2012.09.03 9 Orange, J.S.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/   S1286­4579(02)00038­ 2 Orange, J.S., and C.A.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1084/jem.2010076 2 Brown, M.G., A.O.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1189/jlb.121163 5 Carrero, J.A., and E.R.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"113:157– 174. http://dx.doi.org/10.1016/B978­0­12­394590­7.00001­ 4 Chaix, J., M.S.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"181:1627– 1631. http://dx.doi.org/10.4049/jimmunol.181.3.162 7 Cicin­Sain, L., J.D.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1371/journal.ppat   .100284 9 Cooper, M.A., J.M.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1073/   pnas.081319210 6 Dokun, A.O., S. Kim, H.R.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/ni71 4 Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D.  Cosman, A. Moretta, N.M. Valiante, and P. Parham.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.4049/jimmunol.178.5.268 8 Dreyfus, D.H. 2013.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.02.03 9 Foley, B., S. Cooley, M.R.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1182/blood­2011­10­38699 5 Francois, S., J. Peng, T. Schwarz, J. Duppach, K. Gibbert, U. Dittmer, and  A.R.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"10:58. http://dx.doi.org/10.1186/1742­4690­10­5 8 Gumá, M., A. Angulo, C. Vilches, N. Gómez­Lozano, N. Malats, and M.  López­Botet.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi   .org/10.1182/blood­2004­05­205 8 Hendricks, D.W., H.H.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/   10.4049/jimmunol.130321 1 Jost, S., and M. Altfeld.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1146/   annurev­immunol­032712­10000 1 Julkunen, I., T. Sareneva, J. Pirhonen, T. Ronni, K. Melén, and S. Matikainen.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
http://dx.doi.org/10.1016/S1359­6101(00)00026­ 5,OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/nri146 1 Paust, S., and U.H.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/ni.203 2 Paust, S., H.S.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/ni.195 3 Romee, R., S.E.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j.smim   .2004.08.00 4 Selin, L.K., K. Vergilis, R.M.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1084/jem.183.6.248 9 Serbina, N.V., C. Shi, and E.G.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/B978 ­0­12­394590 ­7.00003 ­8 Sinclair, J., and P. Sissons.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1099/   vir.0.81891­ 0 Smith, H.R.C., J.W.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/   j.immuni.2014.04.01 0 Sun, J.C., J.N.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1038/   nature0766 5 Sun, J.C., S. Madera, N.A.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j.jim.2014.03.02 3 Tripathy, S.K., P.A.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1084/jem.2007244 6 Virgin, H.W., E.J.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.03 6 Waggoner, S.N., M. Cornberg, L.K.",OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
"http://dx.doi   .org/10.1182/blood­2009­09­24546 4 Zawislak, C.L., A.M. Beaulieu, G.B.",Non-OADS,/arxiv_data1/oa_pdf/9c/0f/JEM_20141172.PMC4267234.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/   j.coi.2007.04.01 3 Huang, J.H., L.I.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/   10.4049/jimmunol.178.12.774 7 Hugues, S., L. Fetler, L. Bonifaz, J. Helft, F. Amblard, and S. Amigorena.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi   .org/10.1038/ni113 4 Kabashima, K., T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, N. Yoshida, K.  Katagiri, T. Kinashi, T. Tanaka, M. Miyasaka, et al.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10 .1038/   ni943 Le Floc’h, A., Y. Tanaka, N.S.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1084/jem.2013132 4 Linterman, M.A., W. Pierson, S.K.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/nm.242 5 Lukacs-Kornek, V., D. Malhotra, A.L.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/0162-3109(89)90052- 0 Morris, G.P., and P.M. Allen.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/ni.219 0 Oldstone, M.B.A. 2009.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1371/journal.ppat.100052 3 Oxenius, A., M.F.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1002/(SICI)1521- 4141(199801)28:01<390::AID-IMMU390>3.0.CO;2- O Pace, L., A. Tempez, C. Arnold-Schrauf, F. Lemaitre, P. Bousso, L. Fetler,  T. Sparwasser, and S. Amigorena.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1126/science.122704 9 Pratama, A., and C.G.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/   icb.2013.6 9 Rachmilewitz, J., and A. Lanzavecchia.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/S1471-   4906(02)02342- 6 Sabatino, J.J. Jr., J. Huang, C. Zhu, and B.D.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1084/   jem.2006264 7 Sanui, T., A. Inayoshi, M. Noda, E. Iwata, M. Oike, T. Sasazuki, and Y.  Fukui.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
http://dx.doi.org/10.1016/S1074-7613(03)00169- 9at 37°C.,OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/   10.1002/eji.20073766 3 Bousso, P. 2008.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi   .org/10.1038/nri237 9 Cahalan, M.D., and I. Parker.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/j.coi.2006.05.01 3 Fazilleau, N., L.J.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"10:375– 384. http://dx.doi.org/10.1038/ni.170 4 Germain, R.N.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/   10.1038/ni.240 4 Gitlin, A.D., Z. Shulman, and M.C.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/nature1330 0 Gollmer, K., F .",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1182/blood-2009-01-20092 3 Harenberg, A., I. Girkontaite, K. Giehl, and K.-D. Fischer.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
http://dx.doi.org/10.1002/eji.20042576 9,Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/ni121 0 Shulman, Z., A.D. Gitlin, J.S.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1126/science.125786 1 Shulman, Z., A.D. Gitlin, S. Targ, M. Jankovic, G. Pasqual, M.C.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1126/science.124168 0 Su, L.F., B.A.",Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.10.02 1 Tadokoro, C.E., G. Shakhar, S. Shen, Y. Ding, A.C. Lino, A. Maraver,  J.J. Lafaille, and M.L.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1084/jem.2005078 3 Tang, Q., J.Y.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1038/ni128 9 Tubo, N.J., A.J.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/j.cell.2013.04.00 7 Vinuesa, C.G., and J.G.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
"http://dx.doi.org/10.1016/j.immuni   .2011.11.00 1 Y ang, C.-W ., and E.R.",OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
http://dx.doi.org/10.1084/jem.2012218 3,Non-OADS,/arxiv_data1/oa_pdf/23/67/JEM_20140137.PMC4267235.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
13Article 2667supplemental material is available at http://www.jem.org/cgi/content/full/   jem.20132681/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.4049/jimmunol.178.7.406 2 Bellavia, D., A.F.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/   10.1093/emboj/19.13.333 7 Burchill, M.A., J. Yang, C. Vogtenhuber, B.R.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"178:280– 290. http://dx.doi.org/10.4049/jimmunol.178.1.28 0 Burchill, M.A., J. Yang, K.B.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi   .org/10.1016/j.immuni.2007.11.02 2 Cheng, G., A. Yu, and T.R.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
http://dx.doi.org/10.1111/j.1600-065X.2011.01004.,Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1084/jem.194.6.73 3 Gupta, S., S. Manicassamy, C. Vasu, A. Kumar, W. Shang, and Z.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi   .org/10.1016/j.molimm.2008.08.27 5 Hill, J.A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and  C. Benoist.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.09.01 0 Hsieh, C.S., H.M. Lee, and C.W.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1084/jem.2009141 1 Jones, M.E., and Y .",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.10.01 4 Jones, M.E., and Y .",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1007/   s12026-010-8182- x Jones, M.E., M. Kondo, and Y. Zhuang.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10   .1016/j.mce.2008.05.00 4 Kee, B.L.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"9:175– 184. http://dx.doi.org/10.1038/nri250 7 Kim, D., M. Xu, L. Nie, X.C.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00264- 9 Lio, C.W., and C.S.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.11.02 1 Long, M., S.G. Park, I. Strickland, M.S.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.09.02 2 Malek, T.R.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"26:453– 479. http://dx.doi.org/10.1146/annurev.immunol.26.021607.09035 7 Maruyama, T., J. Li, J.P. Vaque, J.E.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1038/ni.196 5 Medoff, B.D., B.P.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1038/ni.292 8 Moran, A.E., K.L.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1084/jem   .2011030 8 Murre, C. 2005.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1038/ni126 0Ruan, Q., V .",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi   .org/10.1016/j.immuni.2009.10.00 6 Schwartz, R., I. Engel, M. Fallahi-Sichani, H.T.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.4049/jimmunol.181.5.328 5 Vang, K.B., J. Yang, A.J.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.07.01 3 Yang, Y ., H.C. Liou, and X.H.",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi.org/10.1182/blood-2006-11-05575 6 Zhang, F ., G. Meng, and W .",OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
"http://dx.doi   .org/10.4049/jimmunol.130269 4 Zheng, Y., S. Josefowicz, A. Chaudhry, X.P.",Non-OADS,/arxiv_data1/oa_pdf/f5/41/JEM_20132681.PMC4267236.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
Online supplemental material is available at http://www.jem.org/cgi/content/   full/jem.20140455/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1101/gad.199801 0 Beecham, A.H., N.A.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/ng.277 0 Berghout, J., D. Langlais, I. Radovanovic, M. Tam, J.D.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1371/journal.ppat.100349 1 Bongfen, S.E., I.-G. Rodrigue-Gervais, J. Berghout, S. T orre, P .",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1371/journal.pone.003101 2 Broman, K.W ., H. Wu, S. Sen, and G.A.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/   10.1093/bioinformatics/btg11 2 Brown, H., T.T.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1046/j.1365-2990.1999.00188.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10   .1038/ng.24 9 de Souza, J.B., and E.M. Riley .",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/S1286-4579(02)01541- 1 DeGrendele, H.C., P .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1126/science.278.5338.67 2 Dimas, A.S., S. Deutsch, B.E.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10   .1126/science.117414 8 Fischer, A., B. Schmid, D. Ellinghaus, M. Nothnagel, K.I.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1053/j.gastro.2004.01.06 3 Longley, R., C. Smith, A. Fortin, J. Berghout, B. McMorran, G. Burgio, S.  Foote, and P .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi   .org/10.1007/s00335-010-9302- 6 Majithia, V ., and S.A. Geraci.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/   j.amjmed.2007.04.00 5 Malone, C.J., L. Misner, N. Le Bot, M.-C. Tsai, J.M.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00985- 1 Martin, J.-E., S. Assassi, L.-M. Diaz-Gallo, J.C. Broen, C.P .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1093/hmg/ddt24 8 Matsushita, E., N. Asai, A. Enomoto, Y .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/415673 a Mishra, S.K., and C.R.J.C.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/nrneurol.2009.2 3 Miyakoda, M., D. Kimura, M. Y uda, Y .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.4049/jimmunol.181.2.142 0 Newton, C.R., T.T.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1136/jnnp.69.4.43 3 Ng, S.-L., B.A.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10   .1371/journal.pgen.100200 3 Nitcheu, J., O. Bonduelle, C. Combadiere, M. T efit, D. Seilhean, D. Mazier,  and B. Combadiere.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.4049/   jimmunol.170.4.222 1 Oshita, A., S. Kishida, H. Kobayashi, T. Michiue, T. Asahara, M. Asashima, and  A. Kikuchi.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1111/j.1365-2443.2003.00692.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/nature0911 4 Porcherie, A., C. Mathieu, R. Peronet, E. Schneider, J. Claver, P .-H. Commere,  H. Kiefer-Biasizzo, H. Karasuyama, G. Milon, M. Dy, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"208:2225– 2236. http://dx.doi.org/10.1084/jem.2011084 5 Quinlan, A.R., and I.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btq03 3 Rahman, A., and D.A.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1056/NEJMra07129 7Am.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1164/   rccm.201204-0708O C Gelfand, J.M., R.S.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/j.jaad.2004.07.04 5 Green, A., G. Brutti, C.C.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/   S0140-6736(99)07125- 1 Grundberg, E., K.S.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"44:1084– 1089. http://dx.doi.org/10.1038/ng.239 4 Hansen, D.S.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1371/journal.ppat.100304 5 Hansen, D.S., M.-A.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"18:391– 402. http://dx.doi.org/10.1016/S1074-7613(03)00052- 9 Hansen, D.S., N.J. Bernard, C.Q.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/nature1158 2 Juran, B.D., G.M.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1093/hmg/dds35 9 Knoops, B., J. Goemaere, V .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi   .org/10.1089/ars.2010.358 4 Koch, M.W ., L.M.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/   10.1038/nrneurol.2012.22 6 Krieg, C., O. Boyman, Y .-X.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/ni141 8 Lamb, T.J., D.E.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1017/S146239940601058 1 Lawrence, T., D.A.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/nri91 5 Le-Niculescu, H., I. Niesman, T .",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10   .1016/0014-5793(95)01170- J Li, H., and R. Durbin.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi   .org/10.1093/bioinformatics/btp32 4,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/S1474-4422(10)70094- 6 Raychaudhuri, S., E.F .",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/ng.23 3 Rénia, L., S.M.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1016/j.ijpara.2006   .02.00 7 Richer, E., S.T.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1007/s00335-008-9114- 0 Richer, E., C. Prendergast, and D.E.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.4049/jimmunol.100089 0 Sallusto, F ., J. Geginat, and A. Lanzavecchia.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/ng.69 4 Sun, H.-N., S.-U.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10   .1038/ng.99 8 Tsoi, L.C., S.L.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/ng.246 7 Veiga-Fernandes, H., U. Walter, C. Bourgeois, A. McLean, and B. Rocha.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1038/7690 7 Villegas-Mendez, A., R. Greig, T.N.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.4049/   jimmunol.120068 8 Walenta, J.H., A.J.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1083/jcb.152   .5.923 Wang, K., M. Li, and H. Hakonarson.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/10.1093/nar/gkq60 3 Wang, M.H., C. Fiocchi, X. Zhu, S. Ripke, M.I.",OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
"http://dx.doi.org/   10.1007/s00439-013-1395- z Yañez, D.M., D.D.",Non-OADS,/arxiv_data1/oa_pdf/cd/0c/JEM_20140455.PMC4267237.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20141132/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.1038/ni.168 2 Hanyu, R., V.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1073/   pnas.110903610 9 Hervé, J., L. Dubreil, V. Tardif, M. Terme, S. Pogu, I. Anegon, B. Rozec,  C. Gauthier, J.M.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.4049/jimmunol.120139 1 Hu, Z., R. Chen, Z. Cai, L. Yu, Y. Fei, L. Weng, J. Wang, X. Ge, T. Zhu, J.  Wang, and C. Bai.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/   cmi.2011.5 6 Kwan, J., and N. Killeen.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.4049/jimmunol.172.7.399 9 Lo, C.G., Y. Xu, R.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1084/jem.2004150 9 Ma, Q., D. Jones, and T.A.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"10:463– 471. http://dx.doi.org/10.1016/S1074-7613(00)80046- 1 Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J.  Milligan, R. Thornton, G.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1126/   science.107023 8 Matloubian, M., C.G.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/nature0228 4 McElroy, J.F., and J.M.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/nature0668 5 Milligan, G. 2009.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
http://dx.doi.org/10.1111/j.1476-5381.2009.00169.,Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.immuni.2007   .07.00 7 Ngo, V.N., H.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1084/jem.188.1.18 1 Nguyen, K.D., S.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1126/   science.124063 6 Nijhuis, L.E., B.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1371/journal.pone.008508 6 Okada, T., V.N.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi   .org/10.1084/jem.2002020 1 Pham, T.H., P. Baluk, Y. Xu, I. Grigorova, A.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.1146/annurev-immunol-020711-07501 5 Arima, Y., M. Harada, D. Kamimura, J.H.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.cell   .2012.01.02 2 Arnon, T.I., Y. Xu, C. Lo, T. Pham, J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1126/science.120824 8 Barnden, M.J., J. Allison, W.R. Heath, and F.R.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
http://dx.doi.org/10.1046/ j.1440-1711.1998.00709.,Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/nrd324 8 Chelmicka-Schorr, E., M.N.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/0165-5728(89)90138- 0 Curtis, A.M., M.M.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1146/annurev-immunol-020711-07501 1 Elenkov, I.J., R.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)80059- 8 Fribourg, M., J.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.09.05 5 González-Maeso, J., R.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/   nature0661 2 Grebe, K.M., H.D.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10   .4049/jimmunol.090339 5 Grigorova, I.L., S.R.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1084/jem.2009161 9 Pham, T.H., T. Okada, M. Matloubian, C.G.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.11.01 7 Prezeau, L., M.L.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10   .1016/j.coph.2009.10.00 9 Rosen, H., and E.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1038/nri165 0 Sallusto, F., J. Geginat, and A. Lanzavecchia.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.22.012703.10470 2 Sanders, V.M.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.1038/nri338 6 Scheiermann, C., Y. Kunisaki, D. Lucas, A. Chow, J.E.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.05.02 1Schmidt, T.H., O. Bannard, E.E.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"210:1099– 1107. http://dx.doi.org/10.1084/jem.2012257 4 Schwab, S.R., and J.G.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/   10.1038/ni154 5 Silver, A.C., A. Arjona, W.E.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.12.01 7 Sinha, R.K., C. Park, I.Y.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.12.01 8 Smith, D.J.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1146/   annurev-immunol-032713-12022 7 von Andrian, U.H., and T.R.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10   .1038/nri122 2 Wiegmann, K., S. Muthyala, D.H. Kim, B.G.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
"http://dx.doi.org/10.1016/0165-5728(94)00153- F Wong, C.H., C.N.",OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
http://dx.doi.org/10.1126/science.121030 1,Non-OADS,/arxiv_data1/oa_pdf/fc/67/JEM_20141132.PMC4267238.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1016/j.jim.2004.06.02 2 Alvarez-Errico, D., E. Lessmann, and J. Rivera.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/nri201 8 Brdicka, T., M. Imrich, P. Angelisová, N. Brdicková, O. Horváth, J. Spicka,  I. Hilgert, P. Lusková, P. Dráber, P. Novák, et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi   .org/10.1084/jem.2002140 5 Brockmeyer, C., W. Paster, D. Pepper, C.P.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1074/jbc.M110.20123 6 Fu, G., S. Vallée, V. Rybakin, M.V.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/ 10  .1038/ni.176 6 Fujimoto, T., H. Matsuzaki, M. Tanaka, and S. Shirasawa.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1016/j.bbrc   .2013.02.12 8 Galli, S.J., S. Nakae, and M. Tsai.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
http://dx.doi.org/   10.1038/ni115 8Immunoprecipitation and immunoblot analysis.,Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/   nature0720 4 Garman, S.C., J.P. Kinet, and T.S.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1146/annurev.immunol   .17.1.97 3 Gilfillan, A.M., and C. Tkaczyk.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/   10.1038/nri178 2 Gu, H., K. Saito, L.D.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/   3508407 6 Izawa, K., Y. Yamanishi, A. Maehara, M. Takahashi, M. Isobe, S. Ito, A.  Kaitani, T. Matsukawa, T. Matsuoka, F. Nakahara, et al.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.01 8 Kalesnikoff, J., and S.J.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/ni.f.21 6 Kinet, J.P. 1999.",Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.17.1.93 1 Kopf, M., A.J.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1084/   jem.192.1.5 3 Kraft, S., and J.P. Kinet.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1016/j.bbrc.2013.02.09 9 McPherson, V.A., S. Everingham, R. Karisch, J.A.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10   .1128/MCB.00904-0 8 Metcalfe, D.D., D. Baram, and Y.A.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi   .org/10.1189/jlb.041022 1 Paster, W., C. Brockmeyer, G. Fu, P.C.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10   .1016/j.it.2005.01.00 1 Rivera, J., and A.M. Gilfillan.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1084/jem.2003057 4 Siraganian, R.P.",Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1016/   j.coi.2003.09.01 0 Su, A.I., T. Wiltshire, S. Batalov, H. Lapp, K.A.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/ni144 1 Volná, P., P. Lebduska, L. Dráberová, S. Símová, P. Heneberg, M.  Boubelík, V. Bugajev, B. Malissen, B.S.",Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1084/   jem.2004121 3 Wang, D., M. Zheng, L. Lei, J. Ji, Y. Yao, Y. Qiu, L. Ma, J. Lou, C.  Ouyang, X. Zhang, et al.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1038/ni.230 1 Williams, C.M., and S.J.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/10.1084/jem.192.3.45 5 Xiao, W., J. Kashiwakura, H. Hong, H. Yasudo, T. Ando, M. Maeda- Yamamoto, D. Wu, Y. Kawakami, and T. Kawakami.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
"http://dx.doi.org/   10.1016/j.immuni.2011.04.01 0 Zhu, M., Y. Liu, S. Koonpaew, O. Granillo, and W. Zhang.",OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
http://dx.doi.org/10.1084/   jem.2004122 3,Non-OADS,/arxiv_data1/oa_pdf/1a/84/JEM_20140470.PMC4267239.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1182/blood-   2007-08-10620 3 Brauweiler, A., K. Merrell, S.B.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.4049/   jimmunol.178.6.335 3 Broxmeyer, H.E., C.M.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/jem.2004138 5 Carlson, C.M., B.T.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"442:299– 302. http://dx.doi.org/10.1038/nature0488 2 Carsetti, R., M.M.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
http://dx.doi   .org/10.1111/j.0105-2896.2004.0109.,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/ni154 2 Clausen, B.E., C. Burkhardt, W .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1023/A:   100894282896 0 Cyster, J.G., and S.R.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/jem.20130056 Ding, L., and S.J.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"495:231– 235. http://dx.doi.org/10.1038/nature1188 5 Donovan, E.E., R. Pelanda, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1002/eji.20093985 8 Eash, K.J., A.M. Greenbaum, P .K.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10   .1172/JCI4164 9 Egawa, G., S. Nakamizo, Y .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"Rep.  3:1932. http://dx.doi.org/10.1038/srep0193 2 Fabre, S., V .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.4049/jimmunol.181.5.298 0 Glodek, A.M., M. Honczarenko, Y .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
http://dx.doi.org/10   .1084/jem.2002147 7In vitro antagonist treatments.,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20140457/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10   .1084/jem.2009221 0 Alon, R., and S.W .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1080/   1073968080202607 6 Arnon, T .I., R.M.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
http://dx.doi.org/10.1038/nature1173 8,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"193:741– 754. http://dx.doi.org/10.1084/jem.193.6.74 1 Kuwata, N., H. Igarashi, T. Ohmura, S. Aizawa, and N. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/nature0688 7 Lapidot, T., and O. Kollet.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/sj.leu.240268 4 Leuker, C.E., M. Labow, W .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/jem.193.6.75 5 Li, Y ., H. Li, D. Ni, and M. Weigert.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/jem.2002156 0 Lichtman, M.A., and P .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi   .org/10.1182/blood-2003-02-066 3 Ma, Q., D. Jones, and T.A.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80046- 1 Madisen, L., T.A.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/   10.1038/nn.246 7 Mazo, I.B., J.C. Gutierrez-Ramos, P .S.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/   10.1084/jem.2004118 5 Papayannopoulou, T., G.V .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1182/blood-2002-   09-274 1 Pelanda, R., E. Hobeika, T. Kurokawa, Y .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1002/gene.1007 0 Pereira, J.P ., J.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/ni.171 0 Pereira, J.P ., Y .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1371/journal.pone.000927 7 Regard, J.B., H. Kataoka, D.A.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"32:426– 436. http://dx.doi.org/10.1016/j.immuni.2010.03.00 5 Serbina, N.V ., and E.G.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/nature0372 4 Grigorova, I.L., S.R.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/   10.1038/ni.168 2 Gubbels Bupp, M.R., B. Edwards, C. Guo, D. Wei, G. Chen, B. Wong, E.  Masteller, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/   10.1002/eji.20093942 7 Guinamard, R., N. Signoret, M. Ishiai, M. Marsh, T .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"196:871) http://dx.doi.org/   10.1084/jem.189.9.146 1 Hargreaves, D.C., P .L.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/jem.194.1.4 5 Hart, G.T., X. Wang, K.A.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.4049/   jimmunol.110153 0 Hartley, S.B., M.P .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"72:325– 335. http://dx.doi.org/10.1016/0092-8674(93)90111- 3 Hendrix, C.W ., C. Flexner, R.T. MacFarland, C. Giandomenico, E.J.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"44:1667– 1673. http://dx.doi.org/10.1128/AAC.44.6.1667-1673.200 0 Hernandez, P .A., R.J. Gorlin, J.N.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10   .1038/ng114 9 Honczarenko, M., R.S.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1098/rspb.1966.007 9 Hwang, I.Y ., C. Park, T. Luong, K.A.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1371/journal.pone.007259 6 Iliff, J.J., M. W ang, Y .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1126/scitranslmed.300374 8 Jenne, C.N., A. Enders, R. Rivera, S.R.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1084/   jem.2009052 5 Kerdiles, Y .M., D.R.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/ni.168 9 Koni, P .A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/   ni152 3 Wang, A., A.M. Fairhurst, K. Tus, S. Subramanian, Y .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.4049/jimmunol.080192 0 Wang, Y ., L. Cui, W .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"6:32. http://dx.doi.org/10.1186/1476-9255-6-3 2 Wardemann, H., S. Y urasov, A. Schaefer, J.W .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10   .1126/science.108690 7 Woolf, E., I. Grigorova, A. Sagiv, V .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/ni149 9 Zachariah, M.A., and J.G.",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
http://dx.doi.org/10.1126/science.118822 2receptor CCR2.,OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1038/   ni130 9 Shi, C., T .",Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.2353/ajpath.2010.10011 9 Sugiyama, T., H. Kohara, M. Noda, and T. Nagasawa.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.10.01 6 Tamamura, H., A. Omagari, K. Hiramatsu, K. Gotoh, T .",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
"http://dx.doi.org/10.1016/   S0960-894X(01)00323- 7 Tavassoli, M., and J.M.",OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
http://dx.doi.org/10.1084/jem.2003110 4,Non-OADS,/arxiv_data1/oa_pdf/c1/d3/JEM_20140457.PMC4267240.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1126/science.124329 2 Bárcena, C., V. Quesada, A.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"15:51.  http://dx.doi.org/10.1186/1471-2350-15-5 1 Brachmann, S.M., K. Ueki, J.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1128/MCB.25.5.1596-1607.200 5 Brown, J.R., J.C. Byrd, S.E.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1182/blood-2013-11-53504 7 Burke, J.E., O. Vadas, A. Berndt, T. Finegan, O. Perisic, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
http://dx.doi.org/10.1016/j.str.2011.06.00 3 Cancer Genome Atlas Research Network.,OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1038/nature0738 5 Chudasama, K.K., J. Winnay, S. Johansson, T. Claudi, R. König, I.  Haldorsen, B. Johansson, J.R.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1016/j.ajhg.2013.05.02 3 Conley, M.E., A.K.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1007/s10875-014-0012- 9 Deau, M.C., L. Heurtier, P .",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1172/JCI7574 6 Dhand, R., K. Hara, I. Hiles, B. Bax, I. Gout, G. Panayotou, M.J. Fry, K.  Y onezawa, M. Kasuga, and M.D.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
http://dx.doi   .org/10.1016/j.ajhg.2013.06.00 5Immunoblotting and immunoprecipitation.,OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1182/blood-2013-11-53854 6 Fruman, D.A., F. Mauvais-Jarvis, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/   10.1038/8171 5 Geering, B., P.R.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/   10.1073/pnas.070037310 4 Geering, B., P .R.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1042/BST035019 9 Gilbert, J.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1016/S1470-2045(14)70052- X Jaiswal, B.S., V .",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.10.01 6 Kahl, B.S., S.E.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi   .org/10.1182/blood-2013-11-53755 5 Keppler-Noreuil, K.M., J.C. Sapp, M.J. Lindhurst, V .E.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/   10.1016/j.jaci.2014.02.02 0 Lannutti, B.J., S.A. Meadows, S.E.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1182/blood-   2010-03-27530 5 Lee, J.H., M. Huynh, J.L.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1038/ng.232 9 Lindhurst, M.J., V .E.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi   .org/10.1038/ng.233 2 Lucas, C.L., H.S.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1038/   ni.277 1 Mauvais-Jarvis, F ., K. Ueki, D.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1172/JCI021330 5 Parsons, D.W., S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P.  Mankoo, H. Carter, I.M.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"321:1807– 1812. http://dx.doi.org/10.1126/science.116438 2 Rivière, J.B., G.M.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1038/ng.233 1 Sun, M., P. Hillmann, B.T.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi   .org/10.1016/j.ajhg.2013.05.01 9 Ueki, K., D.A.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1128/MCB.22   .3.965-977.200 2 Ueki, K., D.A.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1074/jbc.M30560220 0 Urick, M.E., M.L.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/   10.1158/0008-5472.CAN-11-054 9 Vanhaesebroeck, B., K. Ali, A. Bilancio, B. Geering, and L.C.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
"http://dx.doi.org/10.1016/j.tibs.2005.02.00 8 Wong, K.K., J.A.",OADS,/arxiv_data1/oa_pdf/5f/6c/JEM_20141759.PMC4267241.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
Online supplemental material is available at http://www.jem.org/cgi/   content/full/jem.20141764/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1182/blood-2011-05-35478 7 Bhati, M., D.K.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"23:260– 272. http://dx.doi.org/10.1002/pro.241 2 Birkinshaw, R.W., L. Kjer-Nielsen, S.B.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi.org/10.1016/j.coi.2013.09.00 7the manufacturer’s instructions.,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1016/j.immuni   .2008.11.01 1 Gras, S., Z. Chen, J.J.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1084/jem   .2010060 3 Gras, S., S.R.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi.org/10.1111/j.1600- 065X.2012.01159.,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/308149a 0 Hochstenbach, F., and M.B.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1107/S090744490904733 7 Kjer-Nielsen, L., N.A.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1084/jem.2005177 7 Kjer-Nielsen, L., O. Patel, A.J.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/   10.1038/ni122 5 Lefranc, M.P., and T.H.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi   .org/10.1016/0923-2494(90)90058- 7 Luoma, A.M., C.D.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.11.00 1 Mangan, B.A., M.R.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.4049/jimmunol   .130012 1 Matulis, G., J.P. Sanderson, N.M. Lissin, M.B.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1084/jem.171.4.117 1 Miossec, C., A. Caignard, L. Ferradini, S. Roman-Roman, F. Faure, H.  Michalaki, F. Triebel, and T. Hercend.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1002/   eji.183021043 0 O’Brien, R.L., C.L.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi   .org/10.1111/j.1600-065X.2006.00477.,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/ni115 5 Borg, N.A., K.S.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/   nature0590 7 Born, W.K., M. Kemal Aydintug, and R.L.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/   cmi.2012.4 5 Bowen, S., P. Sun, F. Livak, S. Sharrow, and R.J. Hodes.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.4049/jimmunol.130239 8 Bricogne, G., E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P.  Roversi, A. Sharff, O.S.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"Avail - able at: https://www.globalphasing.com/buster/ (accessed June 29, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1146/ annurev.immunol.22.012703.10460 8 Brossay, L., O. Naidenko, N. Burdin, J. Matsuda, T. Sakai, and M.  Kronenberg.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1107/   S090744490201548 2 Corbett, A.J., S.B.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/nature1316 0 DeLano, W.L.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"Available at:  http://www.pymol.org (accessed June 29, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1084/jem.2014048 4 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1107/S090744491000749 3 Gapin, L. 2014.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi   .org/10.4049/jimmunol.140011 9 Girardi, E., and D.M.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi.org/10.1111/j.1600-065X.2012.01166.,Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/ni.237 1 Godfrey, D.I., J. McCluskey, and J. Rossjohn.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi   .org/10.1038/ni0805-75 4 Godfrey, D.I., J. Rossjohn, and J. McCluskey.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi.org/10.1016/j.immuni.2008.02.00 4,OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/ni151 0 Turner, S.J., P.C.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/nri197 7 Uldrich, A.P., J.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/ni.271 3 Vantourout, P., and A. Hayday.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/ni.266 5 Wang, G.C., P. Dash, J.A.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1126/scitranslmed.300364 7 Wun, K.S., G. Cameron, O. Patel, S.S. Pang, D.G.",Non-OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.02.00 1 Wun, K.S., F. Ross, O. Patel, G.S.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1074/jbc.M112.41232 0 Xiong, N., and D.H. Raulet.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2006   .00478. xPatel, O., D.G.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi   .org/10.1038/ni.237 2 Patel, O., L. Kjer-Nielsen, J.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"4:2142. http://dx.doi.org/10.1038/   ncomms314 2 Pellicci, D.G., O. Patel, L. Kjer-Nielsen, S.S. Pang, L.C.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.04.01 8 Peyrat, M.A., F. Davodeau, I. Houde, F. Romagné, A. Necker, C. Leget,  J.P. Cervoni, N. Cerf-Bensussan, H. Vié, M. Bonneville, et al.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
"http://dx.doi.org/10.1038/nri332 8 Sandstrom, A., C.M.",OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
http://dx.doi.org/10.1016/j.immuni.2014.03.00 3,OADS,/arxiv_data1/oa_pdf/a1/be/JEM_20141764.PMC4267242.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/   10.1093/nar/25.9.176 6 Asp, P., R. Blum, V. Vethantham, F. Parisi, M. Micsinai, J. Cheng, C. Bowman,  Y. Kluger, and B.D.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/0014-   4827(83)90431- 7 Blau, H.M., C. Webster, G.K. Pavlath, and C.P.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1007/978-1-4684-4907-5_ 7 Brack, A.S., and T.A.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
http://dx.doi.org/10.1046/ j.1365-2613.2003.00354.,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/j.phrs.2011.06.00 2 De Luca, A.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_ M.2.1.003.pdf (accessed November 17, 2014).",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://www.treat-nmd.eu/downloads/file/sops/dmd/   MDX/DMD_M.2.1.001.pdf (accessed November 13, 2014).",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_   M.2.2.001.pdf (accessed November 14, 2014).",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1124/jpet.102.04134 3 Disatnik, M.H., J. Dhawan, Y. Yu, M.F.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
http://dx.doi   .org/10.1007/BF0195486 6All the data produced were quality checked with array QualityMetrics  package under R version 2.15.1 Bioconductor software to detect possible  outliers.,OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20140317/DC1.,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"30:243– 252. http://dx.doi.org/10.1002/stem.77 5 Oliver, J.R., S. Jiang, and M.G.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/j.taap.2005.05.00 7 Pan, M.R., G. Peng, W.C. Hung, and S.Y.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1074/jbc.M111.25629 7 Panda, A.C., K. Abdelmohsen, J.H.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi   .org/10.1128/MCB.00423-1 4 Patel, H., J. Chen, K.C.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.08.04 7 Rando, T.A., M.H.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/S0960-8966(97)00124- 7 Robson, L.G., V. Di Foggia, A. Radunovic, K. Bird, X. Zhang, and S.  Marino.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1371/journal   .pone.002711 6 Ryan, S.D., N. Dolatabadi, S.F.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
http://dx.doi.org/10.1111/j.1474-9726.2011.00709.,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1152/ajpcell.00342.200 8 Soriano, P. 1999.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1038/500 7 Spassov, A., T. Gredes, T. Gedrange, D. Pavlovic, A. Lupp, and C. Kunert- Keil.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi   .org/10.1016/j.etp.2010.04.00 6 Tidball, J.G., and M. Wehling-Henricks.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"102:1677– 1686. http://dx.doi.org/10.1152/japplphysiol.01145.200 6 Urso, M.L., A.G. Scrimgeour, Y.W.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10   .1152/japplphysiol.00180.200 6 van der Laak, J.A., M.M.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0320(20000401)39:4<275:: AID-CYTO5>3.0.CO;2- 8Facchino, S., M. Abdouh, W. Chatoo, and G. Bernier.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"30:10096– 10111. http://dx.doi.org/10.1523/JNEUROSCI.1634-10.201 0 Faist, V., J. Koenig, H. Hoeger, and I. Elmadfa.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1007/s00424005076 4 Faist, V., J. König, H. Höger, and I. Elmadfa.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1159/00004670 7 Fukada, S., S. Higuchi, M. Segawa, K. Koda, Y. Yamamoto, K. Tsujikawa,  Y. Kohama, A. Uezumi, M. Imamura, Y. Miyagoe-Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/j.yexcr.2004.02.01 8 Fulle, S., F .",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/j.exger.2004.11.00 6 Gavet, O., and J. Pines.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/   10.1016/j.devcel.2010.02.01 3 Gayraud-Morel, B., F. Chrétien, P. Flamant, D. Gomès, P.S.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi   .org/10.1016/j.ydbio.2007.08.05 9 Ginjala, V., K. Nacerddine, A. Kulkarni, J. Oza, S.J.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi   .org/10.1128/MCB.00981-1 0 He, S., T. Iwashita, J. Buchstaller, A.V.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/   10.1016/j.ydbio.2009.01.02 0 Ismail, I.H., C. Andrin, D. McDonald, and M.J. Hendzel.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1083/jcb.20100303 4 Jackson, M.J. 2009.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/   10.1016/j.addr.2009.07.01 8 Jacobs, J.J., K. Kieboom, S. Marino, R.A. DePinho, and M. van Lohuizen.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"397:164– 168. http://dx.doi.org/10.1038/1647 6 Juan, A.H., A. Derfoul, X. Feng, J.G.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/   10.1101/gad.202791 1 Kägi, J.H., and P. Hunziker.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1007/BF0291724 3 Kirby, D.M., D.R.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1016/S0091-679X(06)80004- X Liu, J., L. Cao, J. Chen, S. Song, I.H.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1002/prca.20060070 2 Wang, Y.X., and M.A.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
http://dx.doi.org/10.1111/ j.1440-1681.2006.04394.,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1113/jphysiol .2007   .14833 8Won, M.H., T.C.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1002/dvdy.2101 2 Yadirgi, G., V. Leinster, S. Acquati, H. Bhagat, O. Shakhova, and S. Marino.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1002/stem.61 4 Zbinden, S., J. Wang, R. Adenika, M. Schmidt, J.U.",OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"http://dx.doi.org/10.1161/ATVBAHA.109.20094 9 Zhuang, W ., J.C. Eby, M. Cheong, P .K.",Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
http://dx.doi.org/10.1002/mus.103 3,Non-OADS,/arxiv_data1/oa_pdf/72/63/JEM_20140317.PMC4267246.pdf
"In particular, improvements of this trait in ‘Koshihikari’, which is a leading cultivar in Japan, are strongly needed (http://www.maff.go.jp/j/seisan/kankyo/ondanka/pdf/h22_tekiou_gijyutu_gaiyo.pdf).",Non-OADS,/arxiv_data1/oa_pdf/08/52/64_273.PMC4267301.pdf
"In the Rice Annotation Project Database (http://rapdb.dna.affrc.go.jp/), there are five predicted genes (Os07g0616800, Os07g0616900, Os07g0617000,  Os07g0617100, and Os07g0617500) within this region.",OADS,/arxiv_data1/oa_pdf/08/52/64_273.PMC4267301.pdf
The Rice Expression Profile Database (http://ricexpro.dna.affrc.go.jp/) provides gene expression profiles from mi­croarray analyses.,OADS,/arxiv_data1/oa_pdf/08/52/64_273.PMC4267301.pdf
"Based on the sequences published on the SoyBase website (http://soybase.agron.iastate.edu/), 506 SSR primer pairs were syn­thesized for genotyping the F 2 population.",OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
"According to the relative po­sitions of these markers on the reference genetic maps (http://soybase.agron.iastate.edu/), 129 markers showing clear polymorphic bands and distributing evenly on the soy­bean genome were used to genotype the F 2:3 population.",OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
"Most markers constructed in the linkage groups and the map position in this study corresponded well with the soybean composite map (http://soybase.agron.iastate.edu/), with some variation in linkage distance among the markers.",OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
"Several QTLs on linkage groups A1, A2, B1, C1, C2,  D1b, E, G, I, J, L, N and O were reported in SoyBase (http://soybase.agron.iastate.edu/) for pod number at different de­velopmental stages.",OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
"Although many seed weight QTLs  distributing on all linkage groups have been reported in SoyBase (http://soybase.agron.iastate.edu/), linkage groups F, G and L were most frequently associated with seed weight in soybean.",OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
URL http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/50/e5/64_282.PMC4267302.pdf
The probe design fundamentals  were described in the NimbleGen technical note (http://www.roche-biochem.jp/products/2010/08/array/pdf/probe_design_2008_06_04.pdf).,OADS,/arxiv_data1/oa_pdf/e9/27/64_291.PMC4267303.pdf
"Indeed, the map distance be-tween the two SSR markers RM7451 and RM7033, which were completely and tightly linked to S22A and S22B, respectively, was 5.4 cM (r  = 5.37%) after conversion us - ing the Kosambi’s mapping function (Kosambi 1944) on the rice standard linkage map (http://rgp.dna.affrc.go.jp/publicdata/geneticmap2000/index.html) (Fig.",OADS,/arxiv_data1/oa_pdf/89/6b/64_309.PMC4267305.pdf
"Primers with Ol, Na, BRAS, and CB prefixes were from http://www.brassica.info/resource/markers.php, and those prefixed with BnGMS, BnEMS, BrGMS, and BoGMS were developed by Huazhong Agriculture University (Cheng et  al.",OADS,/arxiv_data1/oa_pdf/d6/20/64_321.PMC4267306.pdf
"For markers that were not  located on the existing genetic maps, their chromosome information was inferred by aligning their sequences with the genome sequences of B. rapa and B. oleracea by using  BLASTn (http://brassicadb.org/brad/index.php) (Cheng et  al.",OADS,/arxiv_data1/oa_pdf/d6/20/64_321.PMC4267306.pdf
"Nei’s genetic distance matrix among individuals was used  to construct dendrograms using the UPGMA (unweighted pair-group method with arithmetic means) method imple - mented in PowerMarker, and the dendrograms were drawn using the program MEGA5 (http://www.megasoftware.net/mega.html) (Tamura et al.",OADS,/arxiv_data1/oa_pdf/d6/20/64_321.PMC4267306.pdf
"Four SSR markers were newly developed based on the  sequence at the top of apple chromosome 8 (Malus ×   domestica whole genome v1.0, Genome Database for Rosaceae, http://www.rosaceae.org/).",OADS,/arxiv_data1/oa_pdf/31/59/64_351.PMC4267310.pdf
"2010, Soybase [http://soybase.org/]), two insertion/deletion (In/Del) markers (Sca184_394k and SRM1; Suzuki et al.",OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
"2010,  Soybase [http://soybase.org/]) in order to survey the candi - date genetic region and validate the effect of the major QTL using progeny of the RHL and another F 2 population derived from a cross between ‘Kanto-115’ and ‘Hyoukei- kuro 3’.",Non-OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
The marker order was estimated from information of Soybase [http://soybase.org/] and graphical genotypes of the 27 RILs (Supplemental Table 4).,OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
"The analysis using the progeny of the RHL delimited the candidate re-gion for qHbs3-1 between BARCSOYSSR_03_0165 and BARCSOYSSR_03_0185, a physical distance of approxi-mately 330 kb according to information from Phytozome (http://www.phytozome.net/) and 28 annotated putative genes are located in this region.",OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
(http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
"(http://statgen.ncsu.edu/qtlcart/WQTLCart.htm) Watanabe, S., T. Tajuddin, N. Yamanaka, M. Hayashi and K. Harada  (2004) Analysis of QTLs for reproductive development and seed quality traits in soybean using recombinant inbred lines.",OADS,/arxiv_data1/oa_pdf/c1/46/64_362.PMC4267311.pdf
"The control hybrid, Zhengdan958, was the one of most successful temperate hybrids and still the leading hybrid now in China with a total of growing area of over 33 Mha (http://baike.baidu.com/view/264391.htm Internet news in Chinese, accessed on June 9, 2013).",Non-OADS,/arxiv_data1/oa_pdf/30/4d/64_389.PMC4267314.pdf
assigned from DDBJ (http://www.ddbj.nig.ac.jp).,OADS,/arxiv_data1/oa_pdf/fb/dd/64_404.PMC4267316.pdf
This  hypothesis can be tested in further research using the genomic sequence database of both soybean and common bean (http://www.phytozome.net) and the results of synteny studies (McClean et al.,OADS,/arxiv_data1/oa_pdf/fb/dd/64_404.PMC4267316.pdf
TIFF images (300 dpi) were analyzed using Tomato Analyzer (http://www.oardc.ohiostate.edu/vanderknaap/tomato_analyzer.htm).,OADS,/arxiv_data1/oa_pdf/3a/17/64_416.PMC4267318.pdf
"In: The 87th Statistical  Yearbook of Ministry of Agriculture, Forestry and Fisheries (2011–2012), Ministry of Agriculture, Forestry and Fisheries of Japan, Tokyo, p. 188. http://www.maff.go.jp/e/tokei/kikaku/nenji_e/   87nenji/index.html#nse004 Mitsui, H., K. Fujita, T. Sueyoshi and H. Fushihara (2003) New straw­ berry cultivar ‘Fukuoka S 6’ and ‘Fukuoka S 7’ for forcing culture.",Non-OADS,/arxiv_data1/oa_pdf/79/b9/64_427.PMC4267320.pdf
"http://www.hinsyu.maff.go.jp/info/sinsakijun/botanical_taxon_e.html#F Taimatsu, T., T. Nobuoka, T. Nishimoto and H. Yasukawa (2000) ‘Asuka  Ruby’.",OADS,/arxiv_data1/oa_pdf/79/b9/64_427.PMC4267320.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/95/04/asjsm-05-22767.PMC4267484.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/02/68/asjsm-05-23073.PMC4267485.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/17/0b/asjsm-05-23044.PMC4267486.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/af/9d/asjsm-05-22768.PMC4267487.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/asjsm-05-23072.PMC4267488.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0e/77/asjsm-05-22963.PMC4267489.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3d/83/asjsm-05-23070.PMC4267490.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e1/7e/asjsm-05-23187.PMC4267492.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommer - cial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3e/b3/asjsm-05-23184.PMC4267493.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dku348.PMC4267502.pdf
June 2013. http://www.who.int/hiv/pub/guidelines/ arv2013/download/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dku348.PMC4267502.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/50/dku358.PMC4267505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/56/ppa-8-1691.PMC4267512.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1691–1697Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1691OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7257 5lung vital capacity and oxygen saturation  in adults with cerebral palsy  renée lampe1,2 T obias Blumenstein2 Varvara T urova2 Ana Alves-Pinto2 1Markus Würth stiftungsprofessur,  T echnical University of Munich, Munich,  germany; 2research Unit for cerebral  Palsy and children neuroorthopaedics  of the Buhl-strohmaier Foundation,  Orthopedic Department of the clinic  “rechts der isar” of the Technical  University of Munich, Munich, germanyBackground:  Individuals with infantile cerebral palsy have multiple disabilities.",Non-OADS,/arxiv_data1/oa_pdf/20/56/ppa-8-1691.PMC4267512.pdf
"Also, during the feeding of persons with severe disabilities who  also suffer from gastrointestinal reflux, aspiration could happen and lead to aspira - tion pneumonia.4 The oxygen saturation (OS) level, as measured by pulse oximetry, correspondence: renée lampe Orthopedic Department of the clinic  “rechts der isar” of the Technical  University of Munich, ismaninger str 22,  Munich, 81675, germany email renee.lampe@irz.tu-muenchen.d eJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lampe et al Running head recto: Lung vital capacity and OS in cerebral palsy DOI: http://dx.doi.org/10.2147/PPA.S72575",Non-OADS,/arxiv_data1/oa_pdf/20/56/ppa-8-1691.PMC4267512.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/20/56/ppa-8-1691.PMC4267512.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/83/ndt-10-2325.PMC4267513.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2325–2330Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2325OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S7376 5association of Per3 length polymorphism  with bipolar i disorder and schizophrenia correspondence: ganapathy Marimuthu Department of animal Behaviour  and Physiology, school of Biological  sciences, Madurai Kamaraj University,  Madurai 625 021, Tamil Nadu, india Tel +91 979 1696463 Fax +91 452 2459181 email emailboxgm@gmail.co m ramanujam Karthikeyan1 ganapathy Marimuthu1 chellamuthu  ramasubramanian2 gautham arunachal2 ahmed s Bahammam3 David Warren spence4 Daniel P cardinali5 gregory M Brown6 seithikurippu r Pandi- Perumal7 1Department of animal Behaviour  and Physiology, school of Biological  sciences, Madurai Kamaraj University,   Madurai, india; 2Ms chellamuthu  Trust and research Foundation,   KK Nagar, Madurai, india; 3University  sleep Disorders center, college  of Medicine, National Plan for science  and T echnology, King saud University,   riyadh, saudi arabia; 4independent  researcher, T oronto, Ontario,   canada; 5Department of  Teaching  and research, Faculty of Medical  sciences, Pontificia Universidad  católica argentina, Buenos aires,   argentina; 6centre for addiction and  Mental health, University of T oronto,   T oronto, Ontario, canada; 7center for  healthful Behavior change (chBc),   Division of health and Behavior,   Department of Population health,   NYU langone Medical center, clinical  and Translational research institute,   New Y ork, New Y ork, UsaBackground:  Sleep–wake disturbances have frequently been reported in bipolar disorder and  schizophrenia, and are considered to be caused by an underlying circadian rhythm disorder.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/ndt-10-2325.PMC4267513.pdf
"Sleep perturbations, reductions in sleep onset latency, early morning awakenings,  and specifically disturbed rapid eye movement sleep have been observed in patients  with the diagnosis of bipolar disorder (BD).7,8 Indeed, several reports have provided  evidence suggesting that the desynchronization of the internal timekeeping system  can be an important contributing factor in the onset of BD.9,10 Abnormal sleep–wake cycles, including changes in circadian phase (both advances  and delays), discontinuous and compartmentalized sleep episodes, and disassembly Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Karthikeyan et al Running head recto: Per3  length polymorphism and bipolar I disorder and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S73765",Non-OADS,/arxiv_data1/oa_pdf/7f/83/ndt-10-2325.PMC4267513.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/ndt-10-2325.PMC4267513.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/83/ndt-10-2325.PMC4267513.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2493–2505Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2493Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5096 3Dapagliflozin for the treatment of type 2 diabetes:  a review of the literature Mujahid A Saeed1 Parth Narendran2 1Department of Diabetes, University  Hospital Birmingham NHS Foundation  Trust, 2School of Clinical and  Experimental Medicine, University  of Birmingham, Birmingham, UKObjective:  Dapagliflozin was the first drug in a class of therapies that took a new approach to  glycemic control in adults with type 2 diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
"It is estimated that only about  half of the diabetic population reach the proposed glycemic targets.11 Reasons for Correspondence: Mujahid Saeed Department of Diabetes, Fifth floor,  Diabetes Centre, Nuffield House,  University Hospitals Birmingham NHS  Foundation Trust, Queen Elizabeth  Hospital Birmingham, Mindelsohn way,  Edgbaston, Birmingham, West Midlands  B15 2WB, UK email mujahid.saeed@uhb.nhs.u k Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Saeed and Narendran Running head recto: Dapagliflozin for T2D DOI: http://dx.doi.org/10.2147/DDDT.S50963",Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from:  http://www.nice.org.uk/guidance/CG63.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.nice.org.uk/Guidance/CG87.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from:  http://www.idf.org/global-guideline-type-2-diabetes-2012.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.sign.ac.uk/guidelines/fulltext/116.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from:  http://www.diabetes.org.uk/About_us/News_Landing_Page/Diabetes- and-obesity-rates-soar.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm380829.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.astrazeneca.com/Media/ Press-releases/Article/20140324--forxiga-japan-approval.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.scottishmedicines.org.uk/SMC_ Advice/Advice/799_12_dapagliflozin_Forxiga/dapagliflozin_Forxiga.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.medicines.org.uk/ emc/medicine/27188/SPC/Forxiga +5+mg+%26+10+mg+film+coated +tablets.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Avail - able from: http://www.ema.europa.eu/ema/index.jsp?curl =pages/ medicines/human/medicines/002322/human_med_001546.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
Available from: http://www.nice.org.uk/Guidance/ TA288.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/dddt-8-2493.PMC4267514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2143–2150Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2143OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6623 2Jennifer Cove1  nicola Jacobi2  helen Donovan3  Martin Orrell4  Josh stott5  Aimee spector5 1Department of Clinical, educational  and health Psychology, University  College london, london,   2Department of Psychology, City  University, london, 3Clinical  Psychology service, south essex  Partnership nhs Foundation Trust,   Bedford, 4Department of Psychiatry,   5Department of Clinical,  educational  and health Psychology, University  College london, london, UK Correspondence: Jennifer Cove   Psychological Medicine service,  royal Brompton hospital, Mezzanine  Floor, Fulham road Wing, london,  sW3 6nP , UK   T el +44 20 7351 8060   email j.cove@rbht.nhs.u k effectiveness of weekly cognitive stimulation  therapy for people with dementia and the additional  impact of enhancing cognitive stimulation therapy  with a carer training program Purpose of the study:  Cognitive stimulation therapy (CST) is a widely used, evidence-based  intervention for people with dementia (PwD).",Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
"CST leads to improved cognition and quality of life when com - pared to treatment as usual3 and has positive effects on the behavior of PwD.2 CST is  also cost effective,4 shows comparable benefits to acetylcholinesterase inhibitor drugs2 Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Cove et al Running head recto: Weekly CST and carer training DOI: http://dx.doi.org/10.2147/CIA.S66232",Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
Available from: http://www.alzheimers.org.,Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
Available from: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/bf/e4/cia-9-2143.PMC4267515.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2463–2473Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2463Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S7386 2scientometrics of anesthetic drugs and their  techniques of administration, 1984–2013 Kamen V Vlassakov igor Kissin Department of anesthesiology,   Perioperative and Pain Medicine,   Brigham and Women’s hospital,   harvard Medical school, Boston,   Ma, UsaAbstract:  The aim of this study was to assess progress in the field of anesthetic drugs over  the past 30 years using scientometric indices: popularity indices (general and specific), rep - resenting the proportion of articles on a drug relative to all articles in the field of anesthetics  (general index) or the subfield of a specific class of anesthetics (specific index); index of  change, representing the degree of growth in publications on a topic from one period to the  next; index of expectations, representing the ratio of the number of articles on a topic in the  top 20 journals relative to the number of articles in all ( .5,000) biomedical journals covered  by PubMed; and index of ultimate success, representing a publication outcome when a new  drug takes the place of a common drug previously used for the same purpose.",Non-OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
"As indicated in  Goodman and Gilman’s Pharmacological Basis of Therapeutics , “the inhalational correspondence: igor Kissin Department of anesthesiology,   Brigham and Women’s hospital,   75 Francis street, Boston,  Ma 02115, Usa Tel +1 617 732 5052 Fax +1 617 734 0682 email kissin@zeus.bwh.harvard.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Vlassakov and Kissin Running head recto: Scientometrics of anesthetics DOI: http://dx.doi.org/10.2147/DDDT.S73862",Non-OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
The articles were counted using the National Library of  Medicine’s PubMed website ( http://www.ncbi.nlm.nih.gov/ pubmed /) which covers over 21 million journal articles in  biomedicine.,OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/48/dddt-8-2463.PMC4267516.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/72/copd-9-1365.PMC4267517.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1365–1375International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1365OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7276 2ease-of-use preference for the ellIPT a® dry  powder inhaler over a commonly used single-dose  capsule dry powder inhaler by inhalation device- naïve Japanese volunteers aged  40 years or older Yuko Komase1 akimoto asako2 akihiro Kobayashi3 raj sharma4 1Department of respiratory Internal  Medicine, st Marianna University  school of Medicine, Y okohama City  seibu hospital, Y okohama, Kanagawa,   Japan; 2Ma respiratory Department,   Development and Medical affairs  Unit, glaxo smithKline KK, T okyo,   Japan;  3Biomedical Data sciences  Department, glaxo smithKline KK,   T okyo, Japan;  4global respiratory  Franchise Medical Department, gsK,   stockley Park, UK Correspondence: Yuko Komase   Department of respiratory Internal  Medicine, st Marianna University school  of Medicine, Yokohama City seibu  hospital, Yokohama, Kanagawa, Japan   Tel +814 5366 1111  Fax +814 5366 1190  email yukomase@marianna-u.ac.j pBackground:  In patients receiving inhaled medication, dissatisfaction with and difficulty in  using the inhaler can affect treatment adherence.",Non-OADS,/arxiv_data1/oa_pdf/1c/72/copd-9-1365.PMC4267517.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1c/72/copd-9-1365.PMC4267517.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/72/copd-9-1365.PMC4267517.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/4f/dddt-8-2449.PMC4267519.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 2449–2462Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2449Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7146 6Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Zhu et al Running head recto: MSC-based NK4 gene therapy for gastric cancer DOI: http://dx.doi.org/10.2147/DDDT.S71466 Mesenchymal stem cell-based NK4 gene therapy  in nude mice bearing gastric cancer xenografts Abstract:  Mesenchymal stem cells (MSCs) have been recognized as promising delivery vehicles  for gene therapy of tumors.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/dddt-8-2449.PMC4267519.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/f5/4f/dddt-8-2449.PMC4267519.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f5/4f/dddt-8-2449.PMC4267519.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/4f/dddt-8-2449.PMC4267519.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 539–547International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  539OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7089 2The spectral analysis of photoplethysmography to  evaluate an independent cardiovascular risk factor Pratiksha G Gandhi1 Gundu hr rao2 1IPc heart care centre, Mumbai,   India; 2University of Minnesota,   Minneapolis, M n, Usa correspondence: Pratiksha G Gandhi   T el +91 902 253 0033 (India)   Fax +1 909 450 9625 (Us)   email chairpersonipc@yahoo.co.i nBackground:  In this study, we evaluate homeostatic markers correlated to autonomic nervous  and endothelial functions in a population of coronary artery disease (CAD) patients versus a  control group.",Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
The method is  described on the manufacturer’ s web site ( http://www.ldteck.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
The sample size (n$30 and α=0.05%) was determined using MedCalc  statistical software ( http://www.medcalc.org/publications/ journals.ph p).,OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
A  vailable  from: http://internalmedicineblog.jamainternalmed.com/2014/03/13/ how-accurate-is-the-new-ahaacc-cardiovascular-risk-calculator /.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
Available from: http://www.mayoclinic.org/ diseases-conditions/autonomic-neuropathy/basics/tests-diagnosis/ con-2002905 3.,Non-OADS,/arxiv_data1/oa_pdf/86/0d/ijgm-7-539.PMC4267520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/fa/ijgm-7-549.PMC4267521.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2014:7 549–556International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  549OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7402 3antihypertensive combination therapy in primary  care offices: results of a cross-sectional survey   in switzerland susanne roas1 Felix Bernhart2 Michael schwarz3 Walter Kaiser4 Georg noll5 1Department of Internal Medicine,   University hospital, Zurich, 2Private  Practice, Biberist, 3ambulatorium  Wiesendamm, Basel, 4healthworld  (schweiz) aG, steinhausen,   5herzKlinik hirslanden, Zurich,   switzerland correspondence: Georg noll   herzKlinik hirslanden, Witellikerstrasse  40, ch 8032 Zurich, switzerland   Tel +41 44 387 9700   Fax +41 44 387 9710   email georg.noll@hirslanden.c hBackground:  Most hypertensive patients need more than one substance to reach their target  blood pressure (BP).",Non-OADS,/arxiv_data1/oa_pdf/24/fa/ijgm-7-549.PMC4267521.pdf
Available from:  http://www.swisshypertension.ch/guidelines.htm .,Non-OADS,/arxiv_data1/oa_pdf/24/fa/ijgm-7-549.PMC4267521.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/24/fa/ijgm-7-549.PMC4267521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/fa/ijgm-7-549.PMC4267521.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/19/eb/10.1177_2325967114542580.PMC4267539.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 445–452Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  445REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/MDER.S5142 6Non-invasive imaging of microcirculation:   a technology review Sam Eriksson1,2 Jan Nilsson1,2 Christian Sturesson1,2 1Department of Surgery, Clinical  Sciences Lund, Lund University, 2Skåne  University Hospital, Lund, Sweden Correspondence: Christian Sturesson   Department of Surgery, Skåne University  Hospital, S-221 85 Lund, Sweden   Tel +46 46 172 347   Fax +46 46 172 335   Email christian.sturesson@med.lu.s eAbstract:  Microcirculation plays a crucial role in physiological processes of tissue oxygenation  and nutritional exchange.",Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
"Note:  Courtesy of Microvision Medical http://www.microvisionmedical.com /.17 Abbreviation:  LED, light emitting diodes.is shown.",Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
"Note:  Courtesy of Moor instruments http://gb.moor.co.uk /.70 such as functional tests and increased the susceptibil - ity to motion artifacts.5,36,40 However, in recent years, the  introductions of high-speed complementary metal-oxide  semiconductor cameras in combination with new ways of  mapping algorithms, have shortened measurement times for  LDPI substantially.41–43 The experience of these high-speed  detectors in clinical settings is still small as compared to the  standard mapping techniques.",Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
Available from:  http://gb.moor.co.uk /.,Non-OADS,/arxiv_data1/oa_pdf/52/79/mder-7-445.PMC4267586.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/7c/mder-7-437.PMC4267587.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 437–444Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  437ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S7103 5Biomechanical evaluation of three fixation  modalities for preperitoneal inguinal hernia   repair: a  24-hour postoperative study in pigs Gaëtan Guérin Xavier Bourges Frédéric T urquier Covidien-Surgical Solutions, Research  and Development, Trévoux, France Correspondence: Gaëtan Guérin   Covidien-Surgical Solutions, Research   and Development,  116 Avenue du  Formans,  01600, Trévoux, France   Tel +33 474 089 000  Fax +33 474 089 230  Email gaetan.guerin@covidien.co mPurpose:  Tacks and sutures ensure a strong fixation of meshes, but they can be associated with  pain and discomfort.",Non-OADS,/arxiv_data1/oa_pdf/1c/7c/mder-7-437.PMC4267587.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/1c/7c/mder-7-437.PMC4267587.pdf
The database and source code are available in a public github repository: https://github.com/tjbrunette/endonuclease .,OADS,/arxiv_data1/oa_pdf/36/1b/gku1096.PMC4267613.pdf
"For the identified endonucleases, flanking DNA and intron–exon boundary annotations were then extracted from the Genbank ftp://ftp.ncbi.nih.gov/genbank and Refseq ftp://ftp.ncbi.nlm.nih.gov/refseq/release/complete/ databases.",OADS,/arxiv_data1/oa_pdf/36/1b/gku1096.PMC4267613.pdf
"InDrosophilamelanogaster , the PPR proteins are poorly characterized and Flybase ( http://flybase.org ) contains 7 annotated putative PPR proteins.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/gku1132.PMC4267620.pdf
"At variance with theannotatedreferencesequenceFBgn0027794reportedin Flybase( http://flybase.org ),wefoundtwonon-synonymous mutations (C835G and T2783C).",OADS,/arxiv_data1/oa_pdf/e0/4e/gku1132.PMC4267620.pdf
All data aredeposited at GEO( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/83/0b/gku1146.PMC4267623.pdf
All data are de- posited atGEO ( http://www.ncbi.nlm.nih.gov/geo/ ).,OADS,/arxiv_data1/oa_pdf/83/0b/gku1146.PMC4267623.pdf
"In total 74 million reads wereobtainedbypaired-endreading(50base),subjectedto trimmingusingFASTXtoolkit( http://hannonlab.cshl.edu/ fastx toolkit/index.html ), quality control (reads <=30 bp in size after trimming were removed) and mapped to thepublishedCtgenome (2011) using Bowtie 2 ( 10)w i t hd e - faultparameters.",OADS,/arxiv_data1/oa_pdf/29/e6/gku1147.PMC4267624.pdf
Genomic repeat analysis Repetitive elements in the genome of Ctwere mined and classified using RepeatModeller de novo repeat identification package ( http://www.repeatmasker.org/ RepeatModeler.html ).,OADS,/arxiv_data1/oa_pdf/29/e6/gku1147.PMC4267624.pdf
"The resulting data set of de novo identifiedrepeatswascombinedwithacollectionofrepeti-tiveDNAdepositedtothepublicrepeatdatabase,RepBase (http://www.girinst.org/server/RepBase/index.php ), and integrated into a single library.",OADS,/arxiv_data1/oa_pdf/29/e6/gku1147.PMC4267624.pdf
"This repeat library was then used to screen the C. thermophilum genome using RepeatMasker ( http://www.repeatmasker.org/ ).RESULTS An integrated approach for annotation To achieve a much more accurate and reliable genome an- notation,theintegrationofexperimentalevidenceobtained at the RNA and protein levels is invaluable as it validates the gene, pseudo-gene, intron, exon, START and STOPpredictions inferred from sequence data.",OADS,/arxiv_data1/oa_pdf/29/e6/gku1147.PMC4267624.pdf
Experimental data and updated rean- notation data are publicly available at the EMBL Genome Browser database (based on Genome Maps ( 28)) and can be accessed under: http://ct.bork.embl.de/ctbrowser/ .T h e updated reannotation data are further available at NCBI (Bioproject ID PRJNA47065).,OADS,/arxiv_data1/oa_pdf/29/e6/gku1147.PMC4267624.pdf
Reactionsof BamHI and SalI were then examined using the DNA 7500 microfluidic chip prepared as per the manufacturers protocol with data being collected on the Agilent Bioan-alyzer2100platform( http://www.genomics.agilent.com/en/ Bioanalyzer-TapeStation-/?pgid =AG-PG-1 ).,OADS,/arxiv_data1/oa_pdf/3a/b9/gku1157.PMC4267626.pdf
Bioinformatic analysis Thesequencesofhumanandmouselipoproteinlipase(Lpl) geneswereretrievedfromGenebank( http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/gku1160.PMC4267628.pdf
The sequences of human and mouse mature miRNAs were retrieved from miRBase ( http://www.mirbase.org/ ).,OADS,/arxiv_data1/oa_pdf/4b/51/gku1160.PMC4267628.pdf
( D)Anorthogonalviewof(C).Allgraphicalfiguresin thispaperwerepreparedusingtheprogramPyMol( http://www.pymol.org ).,Non-OADS,/arxiv_data1/oa_pdf/6b/ab/gku1248.PMC4267659.pdf
MATERIALS AND METHODS Development ofCMs Annotated mitochondrial and plastid rrn5genes (alter- natively designated rrfin plastid genomes) were retrieved from GenBank (complete mitochondrial and plastid genome sections: http://www.ncbi.nlm.nih.gov/genomes/ GenomesGroup.cgi?taxid=2759&opt=organelle and http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.,OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
They will be also included in our automated organelle genome annota- tion tool MFannot ( http://megasun.bch.umontreal.ca/cgi- bin/mfannot/mfannotInterface.pl ).,OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
Media composition can be found at http://megasun.bch.umontreal.ca/People/lang/ FMGP/methods.html .,Non-OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
"Nucleic acid purification, construction of libraries and se- quencing For sequencing of the mitochondrial genomes reported here,mtDNAswereisolatedviaCsCl-bisbenzimideequilib-riumgradientcentrifugation,sequencedbytheSangertech- nology,assembledwithPhred /Phrap(28,29)andannotated with the MFannot tool ( http://megasun.bch.umontreal.",OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
"Used were not only rrn5loci from completemitochondrialgenomesequencesavailableinGenBank(Supple- mentary Table S1), but also from 10 partial mitochondrial sequences ob-tained from the 1000-plant genome database ( Laminariajaponica ,Petalo- niafascia ,Punctarialatifolia ,Sargassumhemiphyllum ,Sa.henslowianum , Sa.integerrimum ,Sa.thunbergii ,Sa.vachellianum ,Scytosiphondotyi and Sc.lomentaria ;http://onekp.com ).Quebec Innovation Center in Montreal, generating 18–39 millionIlluminaHiSeq2500(upto150ntreadlengthfor A. godoyi,M.jakobiformis andM.californiana )and6.8million Illumina MiSeq paired-end reads (up to 250 nt read lengthforJ.bahamiensis ).TheappliedprocedureyieldsRNA-Seq data that allow accurate mapping of 5S rRNA termini and precise determinationof RNAsteady-state levels.",OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
"Transcriptomedatasets,readprocessingandgeneexpression analyses Transcriptomedatafor Pyropiayezoensis (32),Phaeodacty- lum tricornutum (33),Thalassiosira pseudonana (34),Ec- tocarpus siliculosus (35)a n dToxoplasma gondii (36)w e r e downloadedfromtheNCBISequenceReadArchivev1.0at http://www.ncbi.nlm.nih.gov/Traces/sra .",Non-OADS,/arxiv_data1/oa_pdf/6d/0d/gku1266.PMC4267664.pdf
"While significant progress has been made toward constructing DNA reference li- brariesusefulfortaxonomicidentification,e.g.theInterna-tional Barcode of Life (iBOL, http://ibol.org ) project, such endeavorsareprimarilyfocusedoncarefullyselectedmark- ers, e.g.CO1barcode for the animals, leaving other tax- onomically informative genes aside.",Non-OADS,/arxiv_data1/oa_pdf/13/34/gku917.PMC4267667.pdf
De novo assembly and taxonomic assignments of mitochon- drial scaffolds ScriptsandShellcommandlinesareprovidedin‘Appendix 2 Supplementarynotes.pdf’.Allrelevantscriptfilesandse- quence alignments are available at: http://sourceforge.net/ projects/mt10k/files/?source =navbar .,OADS,/arxiv_data1/oa_pdf/13/34/gku917.PMC4267667.pdf
"Unassigned CO1se- quenceswerealsocomparedwiththeBarcodeofLifeData Systems (BOLD, http://boldsystems.org ) for further taxo- nomicassignments.Taxonomicassignmentofscaffoldswasmade primarily based on CO1(when available) and con- firmedbyotherproteincodinggenesassembledonthesame scaffold on a majority consensus basis (section S2 in Ap-pendix2).",OADS,/arxiv_data1/oa_pdf/13/34/gku917.PMC4267667.pdf
AVAILABIL- ITY: The ptRNApred software is open for public useonhttp://www.ptrnapred.org/ .,Non-OADS,/arxiv_data1/oa_pdf/09/02/gku918.PMC4267668.pdf
"A detailed list of the sequences is provided on the classi- fier’swebsite http://www.ptrnapred.org/ .Fortestingitsper- formanceonRNaseP,329RNasePsequencesweredown- loaded from ‘The Ribonuclease P Database’ ( 48).",OADS,/arxiv_data1/oa_pdf/09/02/gku918.PMC4267668.pdf
The code is freely available viahttp://gtfold.sourceforge.net/proﬁling.html .,OADS,/arxiv_data1/oa_pdf/43/22/gku959.PMC4267672.pdf
AVAILABILITY The RNAStructProfiling C code is freely available via http://gtfold.sourceforge.net/profiling.html .,OADS,/arxiv_data1/oa_pdf/43/22/gku959.PMC4267672.pdf
"3Dysfunction of the dopaminergic system has been implicated in tics and comorbid disorders, and evidence from animalstudies suggests that prenatal stress may cause changes in theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
Morbidity in Children with Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
Morbidity in Children with Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Curr Opin Neurol 2011;24:119–125, doi: http://dx.doi.org/10.1097/WCO.",OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"BMC Pregnancy Childbirth 2014;14:53, doi: http://dx.doi.org/10.1186/1471-2393-14-53.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"J Dev Behav Pediatr 2010; 31:100–106, doi: http://dx.doi.org/10.1097/DBP.0b013e3181cc7cbc.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Pediatrics 2011;128:344–355, doi: http://dx.doi.org/10.1542/peds.2010-1036 5.Latimer K, Wilson P, Kemp J, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Child Care Health Dev 2012;38:611–628, doi: http://dx.doi.org/10.1111/j.1365-2214.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Pediatr Neurol 2011; 45:100–108, doi: http://dx.doi.org/10.1016/j.pediatrneurol.2011.03.003.",OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"J Pediatr 2013;163:217–223, doi: http://dx.doi.org/10.1016/j.jpeds.2012.12.030.",OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Clin Pract Epidemiol Ment Health 2010;6:86–93, doi: http://dx.doi.org/10.2174/1745017901006010086.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Psychol Rep 2002;90:355–359, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Am J Psychiatry 2006;163:1066–1073, doi: http://dx.doi.org/10.1176/appi.ajp.163.6.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Severe psychosocial stress and heavy cigarette smoking during pregnancy: An examination of thepre- and perinatal risk factors associated with ADHD and Tourette syndrome.Eur Child Adolesc Psychiatry 2014;19:755–764, doi: http://dx.doi.org/10.1007/ s00787-010-0115-7.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Dev Med Child Neurol 2013;56:157–163, doi: http://dx.doi.org/10.1111/dmcn.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
"Int Rev Neurobiol 2013;112:239–279, doi: http://dx.doi.org/ 10.1016/B978-0-12-411546-0.00009-3.Cubo E, Hortigu ¨ela M, Jorge-Roldan S, et al.",OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
Morbidity in Children with Tic Disorders Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/74/6c/tre-04-272-6352-1.PMC4268040.pdf
©2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/ab/nihms640441.PMC4268106.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and five figures and can be found with this article online  at http://dx.doi.org/10.1016/j.celrep.2014.10.068 .,OADS,/arxiv_data1/oa_pdf/93/ab/nihms640441.PMC4268106.pdf
"Published online October 22, 2013 http://dx.doi.org/ 10.1016/j.cmet.2013.09.017 Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF- κB signaling pathways.",OADS,/arxiv_data1/oa_pdf/93/ab/nihms640441.PMC4268106.pdf
"For example,  Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0  License ( http://www.creativecommons.org/licenses/by-nc/3.0/ ) which permits non-commercial use, reproduction and distribution of  the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page ( http:// www.uk.sagepub.com/aboutus/openaccess.htm ).",Non-OADS,/arxiv_data1/oa_pdf/7a/7e/nihms-641884.PMC4268126.pdf
Supplementary Material The online appendices are available at http://hsr.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/69/85/10.1177_1355819614545675.PMC4268174.pdf
"Suggested risk of bias criteria for EPOC reviews, http://www.epoc.cochrane.org/epoc- author-resources (2008, accessed 23 July 2014).",OADS,/arxiv_data1/oa_pdf/69/85/10.1177_1355819614545675.PMC4268174.pdf
Supplementary Material The online appendix is available at http://hsr.sagepub.com/ supplemental-data References 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/08/10.1177_1355819614546032.PMC4268175.pdf
"The impact of competi- tion on management quality: evidence from public hospitals,http://cep.lse.ac.uk/pubs/download/dp0983.pdf (2010).",Non-OADS,/arxiv_data1/oa_pdf/e2/08/10.1177_1355819614546032.PMC4268175.pdf
"Hospital quality competition under fixed prices, http://www.york.ac.uk/ media/che/documents/papers/researchpapers/ CHERP80_hospital_quality_competition_fixedprices.pdf(2012).",Non-OADS,/arxiv_data1/oa_pdf/e2/08/10.1177_1355819614546032.PMC4268175.pdf
"Hospital epi- sode statistics, admitted patient care – England, 2011–12,http://www.hscic.gov.uk/catalogue/PUB08288.",Non-OADS,/arxiv_data1/oa_pdf/e2/08/10.1177_1355819614546032.PMC4268175.pdf
"Super Output Area mid- year population estimates for England and Wales, Mid- 2011 (Census Based), http://www.ons.gov.uk/ons/rel/ sape/soa-mid-year-pop-est-engl-wales-exp/mid-2011–census-based-/index.html (2013).",OADS,/arxiv_data1/oa_pdf/e2/08/10.1177_1355819614546032.PMC4268175.pdf
Available from:  http://www.who.int/ith/en.,OADS,/arxiv_data1/oa_pdf/25/71/JRMS-19-799.PMC4268184.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/25/71/JRMS-19-799.PMC4268184.pdf
Available from: http://www.journal.ksph.kz/contents/ v7n3-4_2008eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/19/JRMS-19-819.PMC4268188.pdf
Available from: http://www.euro.who.int/_data/assets/pdf_ file/0014/120164/E94240.pdf.,OADS,/arxiv_data1/oa_pdf/a7/19/JRMS-19-819.PMC4268188.pdf
"22,23 Amino-acid substitution analysis For the non-synonymous variants identiﬁed in FPR1 , functional effects of the amino-acid substitutions wereevaluated and predicted by two web-based analyzing programs: PolyPhen (polymorphism phenotyping, http://genetics.bwh.harvard.edu/pph/, provided byFPR1 ,CFH,HTRA1 and smoking in AMD and PCV XY Liang et al 1503 Eye",OADS,/arxiv_data1/oa_pdf/a1/99/eye2014226a.PMC4268466.pdf
"the Bork Group and the Sunyaev Lab, Brighamand Women’s Hospital, Harvard Medical School, Boston,MA, USA) and SIFT (Sorting Intolerant from Tolerant,http://sift.jcvi.org/ , provided in the public domain by the J Craig Venter Institute, Rockville, MD, USA).",Non-OADS,/arxiv_data1/oa_pdf/a1/99/eye2014226a.PMC4268466.pdf
"Linkage disequilibrium (LD) plots andhaplotype-based association analyses were generated by Haploview (v4.2, http://www.broadinstitute.org/).",OADS,/arxiv_data1/oa_pdf/a1/99/eye2014226a.PMC4268466.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Eye website (http://www.nature.com/eye)FPR1 ,CFH,HTRA1 and smoking in AMD and PCV XY Liang et al 1510 Eye",Non-OADS,/arxiv_data1/oa_pdf/a1/99/eye2014226a.PMC4268466.pdf
This is an open access articleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/58/main.PMC4268473.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2013.11.002 2049-0801/ /C2112013 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/58/main.PMC4268473.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/9e/main.PMC4268474.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.04.001 2049-0801/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/9e/main.PMC4268474.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/90/main.PMC4268475.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.02.018 2049-0801/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/90/main.PMC4268475.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com Annals of Medicine and Surgery 3 (2014) 1 http://dx.doi.org/10.1016/j.amsu.2014.03.004 2049-0801/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/39/main.PMC4268476.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/d8/main.PMC4268477.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.03.002 2049-0801/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/38/d8/main.PMC4268477.pdf
Surg Endosc 2007;21(7):1235 e7.http://dx.doi.org/ 10.1007/s00464-007-9308-7 .,Non-OADS,/arxiv_data1/oa_pdf/38/d8/main.PMC4268477.pdf
J Surg Res 2012;175(2):191 e8.http://dx.doi.org/ 10.1016/j.jss.2011.03.029 .,OADS,/arxiv_data1/oa_pdf/38/d8/main.PMC4268477.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/24/main.PMC4268478.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.03.001 2049-0801/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/24/main.PMC4268478.pdf
Available at: http://urn.kb.se/resolve?urn ¼urn:nbn:se:hj:diva-4325.,Non-OADS,/arxiv_data1/oa_pdf/64/26/10.1177_1471301211418161.PMC4268479.pdf
Available at http://guidance.nice.org.uk/CG42.,Non-OADS,/arxiv_data1/oa_pdf/64/26/10.1177_1471301211418161.PMC4268479.pdf
This is an open access articleundertheCCBY-NC-SAlicense(http://creativecommons.org/licenses/by-nc-sa/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2013.12.001 2049-0801/ /C2112013 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://www.rcsed.ac.uk/training-careers/ postgraduate/foundation-doctors/training-pathway.aspx .,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://www.mmc.nhs.uk/specialty_training_landing_pag/ specialty_training_in_sem.aspx .,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
"Available from:, http://www.asit.org/assets/documents/MEE___Core_Surgical_ Training_and_Experience_in_Surgical_Specialties_in_England_1.doc ;2 0 1 0 .",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://www.foundationprogramme.nhs.uk/pages/home .,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: https://www.gov.uk/maximum-weekly-working-hours/weekly- maximum-working-hours-and-opting-out .,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://bma.org.uk/practical-support-at-work/ewtd/ewtd- juniors .,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://www.surgeryrecruitment.nhs.uk/how- to-apply/competition-ratios .R.K.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
Available from: http://surgicalcareers.rcseng.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/main.PMC4268480.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/ad/main.PMC4268481.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.05.001 2049-0801/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/ad/main.PMC4268481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/59/main.PMC4268482.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2014.03.003 2049-0801/Crown Copyright /C2112014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/be/59/main.PMC4268482.pdf
This is an open access articleundertheCCBY-NC-SAlicense(http://creativecommons.org/licenses/by-nc-sa/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/b3/main.PMC4268483.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2013.11.001 2049-0801/ /C2112013 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/b3/main.PMC4268483.pdf
Available from: http://www.shotuk.org/wp- content/uploads/2012/07/SHOT-Summary_FinalWebVersion2012_06_261.,Non-OADS,/arxiv_data1/oa_pdf/04/b3/main.PMC4268483.pdf
Available from: http://www.transfusionguidelines.org.uk/?publication ¼bbt& section ¼22&pageid ¼1473 .,Non-OADS,/arxiv_data1/oa_pdf/04/b3/main.PMC4268483.pdf
Available from:  http://www.guinnessworldrecords.com/world-records/3000/ heaviest-man-living.,Non-OADS,/arxiv_data1/oa_pdf/b0/f7/SJA-8-101.PMC4268505.pdf
Available from: http://www.commonwealthsurgical.com/pdf/ Bariatric.Diet.Stages.SLEEVE.07312013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/f7/SJA-8-101.PMC4268505.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/b2/main.PMC4268559.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/25/b2/main.PMC4268559.pdf
http://dx.doi.org/10.1016/j.jgr.2014.06.006J Ginseng Res 39 (2015) 54 e60,OADS,/arxiv_data1/oa_pdf/25/b2/main.PMC4268559.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/0b/main.PMC4268560.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/15/0b/main.PMC4268560.pdf
http://dx.doi.org/10.1016/j.jgr.2014.07.001J Ginseng Res 39 (2015) 14 e21,OADS,/arxiv_data1/oa_pdf/15/0b/main.PMC4268560.pdf
Available at: http://www.cancer.gov/ cancertopics/types/colon-and-rectal [accessed 21.03.14].,Non-OADS,/arxiv_data1/oa_pdf/15/0b/main.PMC4268560.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/e3/main.PMC4268561.pdf
http://dx.doi.org/10.1016/j.jgr.2014.07.002J Ginseng Res 39 (2015) 7 e13,OADS,/arxiv_data1/oa_pdf/37/e3/main.PMC4268561.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/42/main.PMC4268562.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/97/42/main.PMC4268562.pdf
http://dx.doi.org/10.1016/j.jgr.2014.08.001J Ginseng Res 39 (2015) 22 e28,OADS,/arxiv_data1/oa_pdf/97/42/main.PMC4268562.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/97/cc/main.PMC4268563.pdf
http://dx.doi.org/10.1016/j.jgr.2014.10.006J Ginseng Res 39 (2015) 1 e6,OADS,/arxiv_data1/oa_pdf/97/cc/main.PMC4268563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/fe/main.PMC4268564.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/89/fe/main.PMC4268564.pdf
http://dx.doi.org/10.1016/j.jgr.2014.06.004J Ginseng Res 39 (2015) 76 e80,OADS,/arxiv_data1/oa_pdf/89/fe/main.PMC4268564.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/ec/main.PMC4268565.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/ed/ec/main.PMC4268565.pdf
http://dx.doi.org/10.1016/j.jgr.2014.07.003J Ginseng Res 39 (2015) 29 e37,OADS,/arxiv_data1/oa_pdf/ed/ec/main.PMC4268565.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/ad/main.PMC4268566.pdf
http://dx.doi.org/10.1016/j.jgr.2014.06.005J Ginseng Res 39 (2015) 69 e75,OADS,/arxiv_data1/oa_pdf/ac/ad/main.PMC4268566.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
http://dx.doi.org/10.1016/j.jgr.2014.06.002J Ginseng Res 39 (2015) 61 e68,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
Mediators In ﬂamm 2012;2012:979105. http://dx.doi.org/10.1155/2012/979105 .,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
Mediators In ﬂamm 2012;2012:512926. http://dx.doi.org/10.1155/2012/512926 .,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
Mediators In ﬂamm 2012;2012: 732860. http://dx.doi.org/10.1155/2012/732860 .,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
Mediators In ﬂamm 2014;2014:352371. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
Mediators In ﬂamm 2013;2013:895975. http://dx.doi.org/10.1155/2013/895975 .,OADS,/arxiv_data1/oa_pdf/91/b7/main.PMC4268567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/main.PMC4268568.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/a2/10/main.PMC4268568.pdf
http://dx.doi.org/10.1016/j.jgr.2014.06.001J Ginseng Res 39 (2015) 46 e53,OADS,/arxiv_data1/oa_pdf/a2/10/main.PMC4268568.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.qChi-Yeon Lim and Jeong-Min Moon equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/75/17/main.PMC4268570.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/75/17/main.PMC4268570.pdf
http://dx.doi.org/10.1016/j.jgr.2014.07.004J Ginseng Res 39 (2015) 38 e45,Non-OADS,/arxiv_data1/oa_pdf/75/17/main.PMC4268570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/0f/main.PMC4268573.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright /C2112014, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/5d/0f/main.PMC4268573.pdf
http://dx.doi.org/10.1016/j.jgr.2014.08.002J Ginseng Res 39 (2015) 81 e88,OADS,/arxiv_data1/oa_pdf/5d/0f/main.PMC4268573.pdf
The study was conducted  between April 2013 and March 2014 using the http://www.freeonlinesurveys.com/Web server.,Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
The study was conducted between April 2013 and March 2014 using the http://www.freeonlinesurveys.com/Web server.,Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
A vailable from: http://www.who.int/medicines/ publications/pharmacopoeia/Radgenmono.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
Available from http://www.pharmacy -gui de-onl ine.,Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
A vailable at http://interactive.snm.org/index.,Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
"Available at http://www.bpsweb.org/specialties/How to cite this article: Parasuraman S, Mueen Ahmed KK, Hashim TS,  Muralidharan S, Kumar KJ, Ping WY, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/93/JBCP-6-19.PMC4268625.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs365/ en/.,Non-OADS,/arxiv_data1/oa_pdf/a8/27/JBCP-6-29.PMC4268627.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/b2/srep07519.PMC4268633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7519 | DOI: 10.1038/srep07519 12",Non-OADS,/arxiv_data1/oa_pdf/57/b2/srep07519.PMC4268633.pdf
A HER2- specific Affibody molecule is currently evaluated in the clinic formolecular imaging of breast cancer 26and an Affibody-based inhib- itor of complement protein C5 entered phase I clinical trials in 2014 (http://clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/97/0a/srep07518.PMC4268634.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: SK, EG and FYF are employees at Affibody AB, Solna, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/97/0a/srep07518.PMC4268634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7518 | DOI: 10.1038/srep07518 14",Non-OADS,/arxiv_data1/oa_pdf/97/0a/srep07518.PMC4268634.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/2a/srep07515.PMC4268635.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7523 | DOI: 10.1038/srep07523 6",Non-OADS,/arxiv_data1/oa_pdf/c1/49/srep07523.PMC4268638.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7509 | DOI: 10.1038/srep07509 10",Non-OADS,/arxiv_data1/oa_pdf/a4/75/srep07509.PMC4268647.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7522 | DOI: 10.1038/srep07522 10",Non-OADS,/arxiv_data1/oa_pdf/8c/f5/srep07522.PMC4268650.pdf
(2011) Available at: http://agora.ex.nii.,Non-OADS,/arxiv_data1/oa_pdf/4e/e6/srep07517.PMC4268652.pdf
(2014) Available at: http://www.jodc.go.jp/.,Non-OADS,/arxiv_data1/oa_pdf/4e/e6/srep07517.PMC4268652.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/e6/srep07517.PMC4268652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7526 | DOI: 10.1038/srep07526 6",Non-OADS,/arxiv_data1/oa_pdf/73/06/srep07526.PMC4268653.pdf
Preprint at http://arxiv.org/abs/1411.1953 (2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/86/ncomms6571.PMC4268700.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/ncomms6571.PMC4268700.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsand permissions.,Non-OADS,/arxiv_data1/oa_pdf/0c/86/ncomms6571.PMC4268700.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6571 8 NATURE COMMUNICATIONS | 5:5571 | DOI: 10.1038/ncomms6571 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0c/86/ncomms6571.PMC4268700.pdf
Red dots indicate the reference divergence times from the TimeTree (http://www.timetree.org/).,OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
"SOAP denovo2 (http://soap.genomics.org.cn/, version 2.04.4) 2 with optimized parameters (pregraph -K 27 -p 16 -d 1; contig –M 3; scaff -F -b 1.5 -p 16) was used to construct contigs and original scaffolds.",OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
"(3) Estimating divergence time: to estimate the divergence time between mudskippers and other teleosts, as well as among the fourmudskipper species, MCMCTree (http://abacus.gene.ucl.ac.uk/software/paml.html) from the PAML package 52was used on 4D genes of each species and phylogenetic tree (mentioned in Supplementary Note 5 Phylogenetic tree construction) togetherwith the molecular clock model.",OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
We set several reference divergence times (marked by red dots in several branches) from TimeTree database53(http://www.timetree.,OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: You, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6594 8 NATURE COMMUNICATIONS | 5:5594 | DOI: 10.1038/ncomms6594 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f3/a8/ncomms6594.PMC4268706.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, October  2012    doi:10.3969/j.issn.1673 -5374 .2012.0 28.001   [ http://www.crter.org/nrr -2012 -qkquanwen.html ]  Hansebout  CR, Su C X, Reddy  K, Zhang  D, Jiang C , Rathbone  MP, Jiang  S. Enteric glia mediate neuronal outgrowth through release   of neurotrophic factors .",Non-OADS,/arxiv_data1/oa_pdf/71/c9/NRR-7-2165.PMC4268714.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.002   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Huang  WD, Liu XB, Fei Z, Zhang YL , Yang J .",Non-OADS,/arxiv_data1/oa_pdf/20/2b/NRR-7-2176.PMC4268715.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.003   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Huang M N, Guo  ZP, Liu K, Mei  XF, Fang SQ , Zeng  JH, Wang  YS, Yuan Y J.",OADS,/arxiv_data1/oa_pdf/c9/86/NRR-7-2182.PMC4268716.pdf
"NEURAL REGENERATION R ESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.004   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Yang HP, Wu DP , Zhang XJ, Wang X, Peng Y, Hu ZP .",OADS,/arxiv_data1/oa_pdf/a2/21/NRR-7-2189.PMC4268718.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.005   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Wang J, Ge J , Yang L, Zhang HY, Li XL, Xue D .",Non-OADS,/arxiv_data1/oa_pdf/a0/3a/NRR-7-2199.PMC4268719.pdf
"1673- 5374.2012.028.006   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Ouyang L , Shi RY, Xiao YH, Meng  JR, Guo YH, Lu GM.",Non-OADS,/arxiv_data1/oa_pdf/32/e9/NRR-7-2206.PMC4268720.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.007   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Jin MH, Song PL, Li N, Li XJ, Chen JJ.",OADS,/arxiv_data1/oa_pdf/0f/ff/NRR-7-2213.PMC4268721.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:1 0.3969/j.issn.1673- 5374.2012.028.008   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Sun B, Feng X, Ding X, Bao L, Li YF, He J, Jin MF .",OADS,/arxiv_data1/oa_pdf/d1/b1/NRR-7-2221.PMC4268722.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 28, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.028.009   [http://www.crter.org/nrr -2012- qkquanwen.html ]  Ransome MI.",Non-OADS,/arxiv_data1/oa_pdf/ac/5b/NRR-7-2227.PMC4268723.pdf
29.001   [ http://www.crter.org/nrr -2012 -qkquanwen.html ]  Geuna S. Peripheral nerve regeneration research: why is it getting so “cool”?,Non-OADS,/arxiv_data1/oa_pdf/d9/50/NRR-7-2245.PMC4268724.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.002   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Gärtner  A, Pereira  T, Simões  MJ, Armada- da-Silva  PA, França  ML, Sousa R, Bompasso  S, Raimondo S, Shirosaki  Y, Kakamura Y,  Hayakawa  S, Osakah  A, Porto B, Luís  AL, Varejão  AS, Maurício AC .",OADS,/arxiv_data1/oa_pdf/85/ff/NRR-7-2247.PMC4268725.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.003    [http://www.crter.org/nrr -2012- qkquanwen.html ]  Fregnan F, Muratori L, Simões A R, Giacobini -Robecchi MG , Raimondo S .",Non-OADS,/arxiv_data1/oa_pdf/23/c4/NRR-7-2259.PMC4268726.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.004    [http://www.crter.org/nrr -2012- qkquanwen.html ]  Geuna S, Tos P, Battiston B.",Non-OADS,/arxiv_data1/oa_pdf/e4/50/NRR-7-2267.PMC4268727.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.005    [http://www.crter.org/nrr -2012- qkquanwen.html ]  Papalia  I, Ronchi  G, Muratori  L, Mazzucco  A, Magaudda L , Geuna S. Direct muscle neurotization after end-to-end and end- to-side  neurorrhaphy: An experimental study in the rat forelimb model .",Non-OADS,/arxiv_data1/oa_pdf/57/81/NRR-7-2273.PMC4268728.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.006   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Sinis  N, Lamia A , Gudrun H , Schoeller T , Werdin  F. Sensory reinnervation of free flaps in reconstruction of the breast and the upper and  lower extremity .",Non-OADS,/arxiv_data1/oa_pdf/7b/c4/NRR-7-2279.PMC4268729.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.007   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Ye FG,  Li HY, Qiao GX, Chen F,  Tao H, Ji AY, Hu  YL.",Non-OADS,/arxiv_data1/oa_pdf/34/b4/NRR-7-2286.PMC4268730.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.008   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Zhang JR, Wang YB, Zhang JC.",Non-OADS,/arxiv_data1/oa_pdf/8a/2e/NRR-7-2293.PMC4268731.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.009   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Liu G Y, Zhang  Q, Jin  Y, Gao  ZL.",OADS,/arxiv_data1/oa_pdf/f4/40/NRR-7-2299.PMC4268732.pdf
"29.010   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Kong Q, Liu K, Wu LX, Wang L. Heme oxygenase- 1 inhibits neuropathic pain in rats with diabetic mellitus .",Non-OADS,/arxiv_data1/oa_pdf/25/62/NRR-7-2305.PMC4268733.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 29, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.29.0 11   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Zhang L, Qiu ZQ, Luo JH, Shu WQ .",OADS,/arxiv_data1/oa_pdf/fa/33/NRR-7-2313.PMC4268735.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.001   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Dong XH, Zhang DS, Zhang L, Li W, Meng X Y. Osthole improves synaptic plasticit y in the hippocampus and cognitive function of   Alzheimer’s disease rat s via regulating glutam ate.",Non-OADS,/arxiv_data1/oa_pdf/2e/9e/NRR-7-2325.PMC4268736.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.002   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Mao JH, Hu YE, Zhou AL, Zheng B, Liu Y, Du YM, Li J, Lu JY, Zhou PC.",OADS,/arxiv_data1/oa_pdf/43/c5/NRR-7-2333.PMC4268737.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.003   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Xue B, S un LQ, Li XJ, Wang X, Zhang Y, Mu YM, Liang LL.",Non-OADS,/arxiv_data1/oa_pdf/c1/6e/NRR-7-2340.PMC4268738.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.004   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Zhang  DS, Fu MD, Song CL, Wang CY , Lin XC, Liu Y L. Expressions of apoptosis -related proteins in rats with focal cerebral ischemia after  Angong Niuhuang sticker point application .",OADS,/arxiv_data1/oa_pdf/c9/38/NRR-7-2347.PMC4268739.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.005   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Wang Z, Xue RL, Lei X, Lv JR, Wu G, Li W, Xue L, Lei XM, Zhao HX, Gao H, Wei X.",OADS,/arxiv_data1/oa_pdf/09/61/NRR-7-2355.PMC4268741.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.006   [ http://www.crter.org/nrr -2012- qkquanwen.html ]  Huang Y, Zeng T J, Zhang GF, Li GL, Lu N, Lai XS, Lu YJ, Chen JR.",Non-OADS,/arxiv_data1/oa_pdf/d3/dc/NRR-7-2362.PMC4268742.pdf
"Data analysis   The fMRI data were processed with the software Statis- tical Parametric Mapping (SPM2, http://www.fil.ion.ac.uk ) Figure 4  Block design of true needling at the Waiguan (TE5) and sham points .",OADS,/arxiv_data1/oa_pdf/d3/dc/NRR-7-2362.PMC4268742.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.007    [http://www.crt er.org/nrr -2012- qkquanwen.html ]  Peng L, Liu M , Chang XR, Yang Z, Yi SX, Yan J, Peng Y.",Non-OADS,/arxiv_data1/oa_pdf/82/bb/NRR-7-2370.PMC4268743.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 30, O ctober  2012    doi:10.3969/j.issn.1673 -5374.2012.30.009   [http://www.crter.org/nrr -2012- qkquanwen.html ]  Wang HL, Fan DS, Hong TP.",Non-OADS,/arxiv_data1/oa_pdf/f1/6a/NRR-7-2384.PMC4268745.pdf
"30.010   [http://www.crter.org/nrr -2012- qkquanwen.html ]  Du Y, Yang XX, Song H, Chen B, Li L, Pan Y, Wu Q, Li J. Neuroimaging diagnosis for cerebral infarction:  an 8-year bibliometric analysis .",Non-OADS,/arxiv_data1/oa_pdf/c5/29/NRR-7-2392.PMC4268746.pdf
This  is  an  open  access  article  under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/37/main.PMC4268771.pdf
The  ROS  inducer  /H9252-lapachone  causes  cytotoxicity  in http://dx.doi.org/10.1016/j.toxrep.2014.05.011 2214-7500/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/37/main.PMC4268771.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/37/main.PMC4268771.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/b5/main.PMC4268774.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.11.004 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/b5/main.PMC4268774.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 134 e146,Non-OADS,/arxiv_data1/oa_pdf/c5/b5/main.PMC4268774.pdf
PLoS One 8. http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/c5/b5/main.PMC4268774.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5729–5751International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5729RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7247 9Closing the gap: accelerating the translational  process in nanomedicine by proposing  standardized characterization techniques  Ali A Khorasani1–3 James L weaver4 Carolina Salvador-Morales2,3 1Department of Chemistry and  Biochemistry, 2Bioengineering  Department, 3Krasnow Institute  for Advanced Study, George Mason  University, Fairfax, vA, USA; 4Division  of Applied Regulatory Science, Center  for Drug evaluation and Research,   Food and Drug Administration, Silver  Spring, MD, USAAbstract:  On the cusp of widespread permeation of nanomedicine, academia, industry, and  government have invested substantial financial resources in developing new ways to better treat  diseases.",Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
"As such, the US National Nanotechnology Initiative, which includes  a number of government departments working together to invest in nanotechnol - ogy research, has a 2015 proposed annual budget of $1.54 billion.1 The National  Science Foundation provides $412.4 million of funding in this area, and the US Food  and Drug Administration (FDA) proposed $17.0 million in its FY2015 budget as a  part of the National Nanotechnology Initiative.1 Similar programs in the European  Union, Japan, the People’s Republic of China, Taiwan, and Korea spent a total of  $3.5 billion annually.2 This spending reflects the governments’ recognition of the need Correspondence: Carolina Salvador- Morales Department of Bioengineering, George  Mason University, 4400 University  Drive MS 1G5, Fairfax, vA 22030, USA Tel +1 703 993 5895 Fax +1 703 993 2077 email csalvado@gmu.eduJournal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2014 Volume: 9 Running head verso: Khorasani et al Running head recto: Accelerating the translational process in nanomedicine DOI: http://dx.doi.org/10.2147/IJN.S72479",Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
"The specific guidance documents can  be accessed at http://www.fda.gov/Drugs/GuidanceCom - plianceRegulatoryInformation/Guidances/default.ht m, and  are subdivided into logically related categories.",Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
"As mentioned above,  it is important that nanomaterials fit to a certain degree of  Table 3  Major US Food and Drug Administration regulatory guidance documents Class Title URL General Considering whether an FDA-regulated product   involves the application of nanotechnologyhttp://www.fda.gov/RegulatoryInformation/Guidances/ ucm257698.ht m  Safety M3(R2) nonclinical safety studies for the conduct   of human clinical trials and marketing authorization   for pharmaceuticalshttp://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM073246.pd f  Pharmacology/toxicology Content and format of investigational INDs for   Phase I studies of drugs, including well characterized,   therapeutic, biotechnology-derived productshttp://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM074980.pd f  Pharmacology/toxicology Toxicokinetics: the assessment of systemic   exposure in toxicity studies (ICH S3A)http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM074937.pdf   Pharmacology/toxicology Pharmacokinetics: guidance for repeated   dose tissue distribution studies (ICH S3B)http://www.fda.gov/downloads/Drugs/Guidance  ComplianceRegulatoryInformation/Guidances/ UCM074938.pdf   Pharmacology/toxicology Immunotoxicity studies for human   pharmaceuticals (ICH S8)http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM074965.pdf   Abbreviations:  FDA, US Food and Drug Administration; IND, Investigational New Drug; ICH, International Conference on Harmonisation.",Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Available from: http://www.whitehouse.gov/sites/default/files/ microsites/ostp/NNI_FY15_Final.pdf.,OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Available from: http://www.wtec.org/nano2/Nanotechnology_Research_ Directions_to_2020 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Available from: http://www.witec.de/products/raman/ rise-microscopy /.,Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Available from:  http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulator yInformation/Guidances/ucm070273.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/24/ijn-9-5729.PMC4268909.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5753–5769International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5753OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7318 5selective inhibition of liver cancer growth  realized by the intrinsic toxicity of a quantum  dot–lipid complex correspondence: li chen Department of Pharmacology, college  of Basic Medical sciences, Jilin University,  126 Xinmin street, changchun,  130021, People’s republic of china Tel +86 431 8561 9799 Fax +86 431 8561 9483 email chen_lab@163.co m  hong Zhang Van’t hoff Institute for Molecular  sciences, University of amsterdam,  science Park 904, 1098 Xh amsterdam,  the Netherlands email h.zhang@uva.n l Dan shao1,* Jing li1,* Fengying guan1 Yue Pan1 Xuanang Xiao1 Ming Zhang1 hong Zhang2 li chen1,3 1Department of Pharmacology,   college of Basic Medical sciences,   Jilin University, changchun,   People’s  republic of china; 2Van’t  hoff Institute for Molecular  sciences, University of amsterdam,   amsterdam, the Netherlands; 3school  of Nursing, Jilin University, changchun,   People’s  republic of china *These authors contributed equally  to this workAbstract:  Using the intrinsic toxicity of nanomaterials for anticancer therapy is an emerging  concept.",Non-OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
These compounds display unique Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Shao et al Running head recto: Inhibition of liver cancer growth by a quantum dot–lipid complex DOI: http://dx.doi.org/10.2147/IJN.S73185,OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
Available from: http://www.nature.com/app_notes/ nmeth/2006/061710/full/an2079.html.,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/9e/ijn-9-5753.PMC4268910.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/1a/ijn-9-5711.PMC4268911.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 5711–5727International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5711OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7435 3Preparation and characterization of self-assembled  nanoparticles based on low-molecular-weight  heparin and stearylamine conjugates for controlled  delivery of docetaxel Dong-hwan Kim1 Ubonvan T ermsarasab1 hyun-Jong cho2 In-soo Y oon3 Jae-Y oung lee1 hyun Tae Moon1 Dae-Duk Kim1 1college of Pharmacy and research  Institute of Pharmaceutical sciences,   seoul National University, seoul,   republic of Korea; 2college of  Pharmacy, Kangwon National  University, chuncheon, republic  of Korea; 3college of Pharmacy  and Natural Medicine research  Institute, Mokpo National University,   Jeonnam, republic of KoreaAbstract:  Low-molecular-weight heparin (LMWH)–stearylamine (SA) conjugates  (LHSA)-based self-assembled nanoparticles were prepared for intravenous delivery of docetaxel  (DCT).",Non-OADS,/arxiv_data1/oa_pdf/cc/1a/ijn-9-5711.PMC4268911.pdf
"They have various derivable groups that can be modified with other correspondence: Dae-Duk Kim college of Pharmacy and research  Institute of Pharmaceutical sciences,  seoul National University, seoul 151-742,  republic of Korea Tel +82 2 8807 870 Fax +82 2 8739 177 email ddkim@snu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Kim et al Running head recto: LMWH-based self-assembled nanoparticles for anticancer drug delivery DOI: http://dx.doi.org/10.2147/IJN.S74353",Non-OADS,/arxiv_data1/oa_pdf/cc/1a/ijn-9-5711.PMC4268911.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cc/1a/ijn-9-5711.PMC4268911.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/1a/ijn-9-5711.PMC4268911.pdf
Avail-able at: http://www.tga.gov.au/pdf/auspar/auspar-yondelis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/cf/WO-18-22862.PMC4268992.pdf
http://www.rtog.org/ResearchAssociates/AdverseEventReporting/AcuteRadi-ationMorbidityScoringCriteria.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/WO-18-22865.PMC4268995.pdf
http://www.rtog.org/ResearchAssociates/AdverseEventReporting/Lat-eRadiationMorbidity ScoringSchema.aspx.,OADS,/arxiv_data1/oa_pdf/f9/9f/WO-18-22865.PMC4268995.pdf
Avail- able at: http://dontdip.tamu.edu/quitting/anotherreasonquit.Htm.,Non-OADS,/arxiv_data1/oa_pdf/eb/bf/WO-18-22229.PMC4268996.pdf
5. http://www.britishpainsociety.org/book_opioid_main.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/WO-18-23108.PMC4269001.pdf
11. http://www.medicines.ie/medicine/14383/SPC/Targin%2b - 10mg%2b5mg%2band%2b20mg%2b10mg%2bprolonged%2bre- lease%2btablets/#POSOLOGY .,Non-OADS,/arxiv_data1/oa_pdf/d0/53/WO-18-23108.PMC4269001.pdf
Pragmat Obs Res 2013. http://www.dovepress.com/cancer-pain-therapy-with-a-fixed-combina-tion-of-prolonged-release-oxyc-peer-reviewed-article-POR.,Non-OADS,/arxiv_data1/oa_pdf/d0/53/WO-18-23108.PMC4269001.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201300321.,Non-OADS,/arxiv_data1/oa_pdf/a5/f6/anie0052-5845.PMC4269183.pdf
The complete list of 144 genotypedSNPs is available at http://pages.medicine.ucsf.edu/lupus/supplemental.html.,Non-OADS,/arxiv_data1/oa_pdf/32/1e/art0066-1882.PMC4269184.pdf
"Other potential covariates were first analyzed for association with venous and arterial thrombosis (see http://pages.medicine.ucsf.edu/lupus/supplemental.html), and thosewith P/H110210.1 were retained for further analysis.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/art0066-1882.PMC4269184.pdf
"In the meta-analysis by ethnicity (Table 3) (see http://pages.medicine.ucsf.edu/lupus/supplemental.html), the OR for arterial thrombosis with rs893629 was2.43 (95% CI 1.58–3.76), P/H110055.3/H1100310 /H110025, without evidence for heterogeneity ( P/H110050.44); however, the Asian American stratum was not included in this analy-sis because there were no cases with the minor allele.The effect was most significant in the African American (OR 2.42, P/H110053.5/H1100310 /H110024) and European American (OR 3.47, P/H110050.024) strata and was nonsignificant among Hispanics (OR 0.75, P/H110050.8).",Non-OADS,/arxiv_data1/oa_pdf/32/1e/art0066-1882.PMC4269184.pdf
"The MAF, genotype counts, and Hardy-Weinberg Pvalues for rs893629 by both ethnicity and study population are shown at http://pages.medicine.ucsf.edu/lupus/supplemental.html.",Non-OADS,/arxiv_data1/oa_pdf/32/1e/art0066-1882.PMC4269184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/5f/main.PMC4269267.pdf
http://dx.doi.org/10.1016/j.ijchv.2014.08.0072214-7632/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/99/5f/main.PMC4269267.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/5f/main.PMC4269267.pdf
Contents lists available at ScienceDirect IJC Heart & Vessels journal homepage: http://www.journals.,Non-OADS,/arxiv_data1/oa_pdf/99/5f/main.PMC4269267.pdf
[Available from] http://www.shapeup.,Non-OADS,/arxiv_data1/oa_pdf/99/5f/main.PMC4269267.pdf
http://dx.doi.org/10.1016/j.febslet.2013.03.002⇑Corresponding author.,OADS,/arxiv_data1/oa_pdf/0c/5d/FEB2-587-1180.PMC4269304.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/96/mdu225.PMC4269341.pdf
"London: Cancer Research UK 2011. http://www.cancerresearchuk.org/cancer-info/cancerstats/ (April 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/5a/96/mdu225.PMC4269341.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/6e/mdu479.PMC4269342.pdf
The software has a web page at http://www.cbs.,Non-OADS,/arxiv_data1/oa_pdf/14/6e/mdu479.PMC4269342.pdf
"Whole-genome sequencing, aligned to the hg19 genome in the BAM format at ×30 of coverage, of two cell lines HCC1143 and HCC1954, match-ing normal blood, and simulated admixtures at tumor cellularity of 20%,40%, 60%, and 80%, were obtained in March 2014 from the TCGA4 bench-mark cohort ( https://cghub.ucsc.edu/datasets/benchmark_download.html ).",OADS,/arxiv_data1/oa_pdf/14/6e/mdu479.PMC4269342.pdf
The results published here are based on data generated by the CancerGenome Atlas pilot project established by the NCI and NHGRI.Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/ .,OADS,/arxiv_data1/oa_pdf/14/6e/mdu479.PMC4269342.pdf
"ClinicalTrials.gov: This is the translational part of the Swedish multicenter and randomized trial TEX, clinicaltrials.gov identi ﬁer nct01433614 ( http://www.clini caltrials.gov/ct 2/show/nct 01433614 ).",Non-OADS,/arxiv_data1/oa_pdf/72/ec/mdu498.PMC4269343.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/ec/mdu498.PMC4269343.pdf
"patients and methods The Swedish multicenter and randomized trial TEX [ 9], ClinicalTrials.gov identi ﬁer NCT01433614 ( http://www.clinicaltrials.gov/ct2/show/NCT01433614 ), enrolled 287 patients with a morphologically con ﬁrmed locoregional or distant breast cancer relapse from December 2002 until June 2007.",Non-OADS,/arxiv_data1/oa_pdf/72/ec/mdu498.PMC4269343.pdf
Details of the HRSTA-2.0 custom human Affymetrix array GPL10379 are available at NCBI GEO depository as GPL10379 ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/72/ec/mdu498.PMC4269343.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/31/mdu510.PMC4269344.pdf
http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryIn formation/Guidances/UCM193282.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ec/31/mdu510.PMC4269344.pdf
Available at: http://www.wma.net/en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/39/93/MA-68-308.PMC4269531.pdf
http://www.epa.gov/airtrends/econ-emissions.html.,Non-OADS,/arxiv_data1/oa_pdf/e5/e9/MA-68-324.PMC4269539.pdf
"Liraglutide effect and action in di - abetes: evaluation of cardiovascular outcome results – a long  term evaluation (LEADER®) (NCT01179048) Available from:  http://www.clinicaltrials.gov/ct2/show/ NCT01179048 (ac - cessed December 18, 2012).7.",Non-OADS,/arxiv_data1/oa_pdf/49/5e/MA-68-313.PMC4269541.pdf
"The effect of liraglutide versus pla - cebo when added to basal insulin analogues with or without  metformin in subjects with type 2 diabetes (NCT01617434)  Available from: http://clinicaltrials.gov/ct2/show/NCT01617434  (accessed December 18, 2012).",Non-OADS,/arxiv_data1/oa_pdf/49/5e/MA-68-313.PMC4269541.pdf
"2014 Oct; 68(5): 339-344Attenuation of Hemodynamic Response to  Laryngoscopy and Endotracheal Intubation with Pre Induction IV Fentanyl Versus Combination of IV Fentanyl and Sub Lingual Nitroglycerin Spray Vijayalakshmi B. Channaiah1, Nicholas S. Kurek2, Ryder Moses2, Sathees B. Chandra3 Krishna Rajendra Hospital and Cheluvamba Hospital, Mysore Medical College, Rajiv Gandhi University, India1 Department of Biological, Chemical and Physical Sciences, Roosevelt University, Chicago, IL 60605, USA2 College of Nursing and Health Sciences, Barry University, Miami, FL 33161, USA3 Corresponding author: Sathees B. Chandra, PhD, Director of Biomedical Sciences Program, Associate Professor of Biomedical Sciences,  College of Nursing and Health Sciences, Barry University , 11300 NE Second Ave, Miami, FL 33161, USA, Phone: 305-981-1196, Fax : 954-367-8696, Email : schandra@barry.edu, Web: http://www.barry.edu/biomedical-sciences/ Abstract Introduction: Endotracheal intubation is one of the most invasive stimuli in anesthesia and it’s often accompanied by a hemodynamic  pressor response.",Non-OADS,/arxiv_data1/oa_pdf/e3/98/MA-68-339.PMC4269544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/ca/bhu203.PMC4269546.pdf
The low- and high-level visual information about objects was derived from the HMax computational model of vision downloaded from http://cbcl.mit.edu/software-datasets/standardmodel .,OADS,/arxiv_data1/oa_pdf/8f/ca/bhu203.PMC4269546.pdf
(2005) and precomputed S2 features from natural image fragments (downloaded http://cbcl.mit.edu/software-datasets/standardmodel ).,OADS,/arxiv_data1/oa_pdf/8f/ca/bhu203.PMC4269546.pdf
"This produces a cortical representation of the regression weights for each predictor, which were then averaged across participants, and displayed on an in ﬂated cortex using Caret ( http://www.nitrc.org/projects/caret/ ).",OADS,/arxiv_data1/oa_pdf/8f/ca/bhu203.PMC4269546.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/8f/ca/bhu203.PMC4269546.pdf
"(2014), 15(4),  459-464 http://dx.doi.org/10.4142/jvs.2014.15.4.459 Received: 27 Dec. 2013, Revised: 24 Mar.",Non-OADS,/arxiv_data1/oa_pdf/cb/c1/jvs-15-459.PMC4269587.pdf
"(2014), 15(4),  465-474 http://dx.doi.org/10.4142/jvs.2014.15.4.465 Received: 27 Mar.",Non-OADS,/arxiv_data1/oa_pdf/ef/33/jvs-15-465.PMC4269588.pdf
"(2014), 15(4),  475-483 http://dx.doi.org/10.4142/jvs.2014.15.4.475 Received: 1 Apr.",Non-OADS,/arxiv_data1/oa_pdf/8d/bb/jvs-15-475.PMC4269589.pdf
"(2014), 15(4),  485-493 http://dx.doi.org/10.4142/jvs.2014.15.4.485 Received: 27 May 2014, Revised: 26 Jun.",Non-OADS,/arxiv_data1/oa_pdf/28/28/jvs-15-485.PMC4269590.pdf
"(2014), 15(4),  495-502 http://dx.doi.org/10.4142/jvs.2014.15.4.495 Received: 19 Feb. 2014, Revised: 22 May 2014, Accepted: 18 Jul.",Non-OADS,/arxiv_data1/oa_pdf/bd/8f/jvs-15-495.PMC4269591.pdf
"(2014), 15(4),  503-509 http://dx.doi.org/10.4142/jvs.2014.15.4.503 Received: 10 Mar.",Non-OADS,/arxiv_data1/oa_pdf/37/06/jvs-15-503.PMC4269592.pdf
"(2014), 15(4),  511-517 http://dx.doi.org/10.4142/jvs.2014.15.4.511 Received: 6 Mar.",Non-OADS,/arxiv_data1/oa_pdf/40/44/jvs-15-511.PMC4269593.pdf
"(2014), 15(4),  519-528 http://dx.doi.org/10.4142/jvs.2014.15.4.519 Received: 9 Jan. 2014, Revised: 27 May 2014, Accepted: 19 Jun.",Non-OADS,/arxiv_data1/oa_pdf/e5/df/jvs-15-519.PMC4269594.pdf
"(2014), 15(4),  529-536 http://dx.doi.org/10.4142/jvs.2014.15.4.529 Received: 24 Apr.",Non-OADS,/arxiv_data1/oa_pdf/23/fc/jvs-15-529.PMC4269595.pdf
"(2014), 15(4),  537-543 http://dx.doi.org/10.4142/jvs.2014.15.4.537 Received: 13 Dec. 2013, Revised: 21 Jun.",Non-OADS,/arxiv_data1/oa_pdf/89/09/jvs-15-537.PMC4269596.pdf
"(2014), 15(4),  545-550 http://dx.doi.org/10.4142/jvs.2014.15.4.545 Received: 30 Dec. 2013, Revised: 21 Mar.",Non-OADS,/arxiv_data1/oa_pdf/17/5f/jvs-15-545.PMC4269597.pdf
"(2014), 15(4),  551-556 http://dx.doi.org/10.4142/jvs.2014.15.4.551 Received: 4 Feb. 2014, Revised: 9 Jun.",Non-OADS,/arxiv_data1/oa_pdf/96/b0/jvs-15-551.PMC4269598.pdf
"(2014), 15(4),  557-561 http://dx.doi.org/10.4142/jvs.2014.15.4.557 Received: 5 Sep. 2013, Revised: 7 May 2014, Accepted: 19 Jun.",Non-OADS,/arxiv_data1/oa_pdf/e9/81/jvs-15-557.PMC4269599.pdf
"(2014), 15(4),  563-568 http://dx.doi.org/10.4142/jvs.2014.15.4.563 Received: 6 Jan. 2014, Revised: 17 Jun.",Non-OADS,/arxiv_data1/oa_pdf/96/c1/jvs-15-563.PMC4269600.pdf
"(2014), 15(4),  569-574 http://dx.doi.org/10.4142/jvs.2014.15.4.569 Received: 4 Feb. 2014, Revised: 4 Jul.",Non-OADS,/arxiv_data1/oa_pdf/a5/2e/jvs-15-569.PMC4269601.pdf
"(2014), 15(4),  575-578 http://dx.doi.org/10.4142/jvs.2014.15.4.575 Received: 12 Feb. 2014, Revised: 17 Mar.",Non-OADS,/arxiv_data1/oa_pdf/64/57/jvs-15-575.PMC4269602.pdf
"(2014), 15(4),  579-582 http://dx.doi.org/10.4142/jvs.2014.15.4.579 Received: 15 Apr.",Non-OADS,/arxiv_data1/oa_pdf/88/88/jvs-15-579.PMC4269603.pdf
"(2014), 15(4),  583-586 http://dx.doi.org/10.4142/jvs.2014.15.4.583 Received: 5 Feb. 2014, Revised: 8 May 2014, Accepted: 19 Jun.",Non-OADS,/arxiv_data1/oa_pdf/54/58/jvs-15-583.PMC4269604.pdf
Available from: http://www.qutenza.com/_ docs/Qutenza%20Treatment%20Guide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6a/90/40122_2014_Article_27.PMC4269612.pdf
Available from: http://clinicaltrials.gov/ct2/ show/record/NCT01416116 .,Non-OADS,/arxiv_data1/oa_pdf/6a/90/40122_2014_Article_27.PMC4269612.pdf
http://www.aerzteblatt.de/int/ article.asp?id=41472 .,Non-OADS,/arxiv_data1/oa_pdf/64/83/40122_2014_Article_29.PMC4269613.pdf
2014. http://www.dak.de/dak/ download/Forsa-Umfrage_zur_Sterbehilfe-1358250.,Non-OADS,/arxiv_data1/oa_pdf/64/83/40122_2014_Article_29.PMC4269613.pdf
http://public.health.,Non-OADS,/arxiv_data1/oa_pdf/64/83/40122_2014_Article_29.PMC4269613.pdf
http://www.sfm.asso.fr .,Non-OADS,/arxiv_data1/oa_pdf/a7/91/40121_2014_Article_35.PMC4269615.pdf
Available from:http://www.cdc.gov/chikungunya/geo/americas.,Non-OADS,/arxiv_data1/oa_pdf/36/d9/40121_2014_Article_43.PMC4269617.pdf
Availablefrom: http://www.cdc.gov/chikungunya/geo/united- states.html .,Non-OADS,/arxiv_data1/oa_pdf/36/d9/40121_2014_Article_43.PMC4269617.pdf
"Number of ReportedCases of Chikungunya Fever in the Americas, by Country or Territory 2013–2014, Epidemiological Week/EW 35 Available from: http://www.paho.org/ hq/index.php?option=com_topics&view=rdmore&tt=PAHO%2FWHO ?Data%2C ?Maps ?and?Statistics &id=5927&tp=&Itemid=40931&lang=en .",Non-OADS,/arxiv_data1/oa_pdf/36/d9/40121_2014_Article_43.PMC4269617.pdf
Available from: http://www.ecdc.europa.eu/en/ publications/publications/antimicrobial-resistance- surveillance-europe-2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/41/40121_2014_Article_44.PMC4269618.pdf
Geneva: WorldHealth Organization; 2013 [updated 2011 July].Available from: http://www.who.int/choice/country/ country_speciﬁc/en/ .,Non-OADS,/arxiv_data1/oa_pdf/bf/41/40121_2014_Article_44.PMC4269618.pdf
http://data.gov.uk/dataset/nhs-reference- costs-2010-11 Accessed Feb 2012.,Non-OADS,/arxiv_data1/oa_pdf/a5/53/40121_2014_Article_34.PMC4269620.pdf
2012. http://www2.nphs.,Non-OADS,/arxiv_data1/oa_pdf/a5/53/40121_2014_Article_34.PMC4269620.pdf
Antibiotic Resistance Threats in the United States.http://www.cdc.gov/drugresistance/threat-report-2013/ (2013).,Non-OADS,/arxiv_data1/oa_pdf/ae/ee/40121_2014_Article_51.PMC4269621.pdf
http://www.cdc.gov/drugresistance/ threat-report-2013/ 6.,Non-OADS,/arxiv_data1/oa_pdf/b6/73/40121_2014_Article_50.PMC4269622.pdf
Available from: http://www.medimmune.,Non-OADS,/arxiv_data1/oa_pdf/b2/a0/40121_2014_Article_46.PMC4269625.pdf
Initial U.S. approval 2013. http://dailymed.nlm.nih.gov/ dailymed/lookup.cfm?setid=63df5af3-b8ac-4e76-98 30-2dbb340af922 .,Non-OADS,/arxiv_data1/oa_pdf/ba/99/40121_2014_Article_29.PMC4269626.pdf
"Once-daily dolutegravir is superior to darunavir/ritonavir in antiretroviral naive adults: 48 week results fromFLAMINGO (ING114915) [Abstract H1464a].Presented at the 53rd interscience conference on antimicrobial agents and chemotherapy (ICAAC), Denver; 2013. http://www.icaaconline.com/php/ icaac2013abstracts/start.htm .",Non-OADS,/arxiv_data1/oa_pdf/ba/99/40121_2014_Article_29.PMC4269626.pdf
http://www.natap.org/2010/ newsUpdates/071910_05.htm .,Non-OADS,/arxiv_data1/oa_pdf/ba/99/40121_2014_Article_29.PMC4269626.pdf
HIV i-Base; 2013. http://www.thebodypro.com/ content/72987/viiv-goes-for-gold-us-premium-prici ng-may-make-dol.html .,Non-OADS,/arxiv_data1/oa_pdf/ba/99/40121_2014_Article_29.PMC4269626.pdf
Clinicians wishing to report on future harms due to antimicrobial shortages can do so at: http://www.surveymonkey.com/s/antimicrobialshortages .,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/40121_2014_Article_40.PMC4269628.pdf
SurveyMonkey /C210.http://www.surveymonkey.com .,OADS,/arxiv_data1/oa_pdf/d0/b1/40121_2014_Article_40.PMC4269628.pdf
http://ctep.Cancer.Gov/proto coldevelopment/electronic_applications/docs/aeguidelines.Pdf .,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/40121_2014_Article_40.PMC4269628.pdf
"Evidence and information forpolicy, World Health Organization, Geneva, July 2003. http://www.who.int/healthinfo/statistics/ bod_maternalsepsis.pdf .",OADS,/arxiv_data1/oa_pdf/cb/ab/40121_2014_Article_31.PMC4269630.pdf
https://www.dshs.state.tx.us/ chs/vstat/annrpts.shtm .,Non-OADS,/arxiv_data1/oa_pdf/cb/ab/40121_2014_Article_31.PMC4269630.pdf
http://www.cdc.gov/nchs/data/data briefs/db35.pdf .,OADS,/arxiv_data1/oa_pdf/cb/ab/40121_2014_Article_31.PMC4269630.pdf
"Agencyfor Healthcare Research and Quality, Rockville.Available from: http://www.hcup-us.ahrq.gov/ reports/statbriefs/sb160.jsp .",OADS,/arxiv_data1/oa_pdf/a7/33/40121_2014_Article_37.PMC4269633.pdf
Available from: http://www.who.int/ healthinfo/statistics/bod_maternalsepsis.pdf .,OADS,/arxiv_data1/oa_pdf/a7/33/40121_2014_Article_37.PMC4269633.pdf
Feb 2013. http://www.fda.gov/ForConsu mers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm118915.htm .,OADS,/arxiv_data1/oa_pdf/72/23/40121_2014_Article_47.PMC4269634.pdf
2009. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/4b/6a/40121_2014_Article_36.PMC4269637.pdf
Available from http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/13300_2014_Article_73.PMC4269639.pdf
Available from: https://newsclient.omxgroup.com/ cdsPublic/viewDisclosure.action?disclosureId=592724&lang=en .,Non-OADS,/arxiv_data1/oa_pdf/4f/e4/13300_2014_Article_73.PMC4269639.pdf
http://www.tga.gov.,Non-OADS,/arxiv_data1/oa_pdf/a0/27/13300_2014_Article_90.PMC4269640.pdf
http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/06/a1/13300_2014_Article_81.PMC4269642.pdf
2014. https://www.invokanahcp.,Non-OADS,/arxiv_data1/oa_pdf/bb/d3/13300_2014_Article_89.PMC4269649.pdf
Available from:http://www.bls.gov/cpi/ .,Non-OADS,/arxiv_data1/oa_pdf/c9/e6/13300_2014_Article_84.PMC4269653.pdf
Available from: http://www.merck.com/product/usa/pi_ circulars/j/januvia/januvia_pi.pdf .,OADS,/arxiv_data1/oa_pdf/c9/e6/13300_2014_Article_84.PMC4269653.pdf
Brussels: International Diabetes Federation; 2013. http://www.idf.org/diabetesatlas .,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
European Medicines Agency.http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-Product_Information/human/00102 6/WC500050017.pdf (2014).,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
European Medicines Agency.http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/0020 20/WC500108241.pdf (2011).,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
http://www.socialstyrelsen.se/ nationalguidelines/nationalguidelinesfordiabetescare(2010).,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
http://thesis.eur.nl/pub/ 12738/Buitenhuis%20R%20351371.pdf (2012).,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
DPP-IV inhibitors and GLP-1 analogues for Type 2 diabetes—how are physician and payer perspectives shaping the European markets?http://decisionresources.com/Products-and-Services/ Report?r=pforeu0611 (2011).,Non-OADS,/arxiv_data1/oa_pdf/fc/0b/13300_2014_Article_87.PMC4269654.pdf
Available at: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/fc/20/13300_2014_Article_88.PMC4269655.pdf
Available at:http://www.hoajonline.com/journals/pdf/2050- 0866-1-17.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/20/13300_2014_Article_88.PMC4269655.pdf
Available at: http://www.idf.org/sites/ default/ﬁles/GERMANY.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/20/13300_2014_Article_88.PMC4269655.pdf
Available at http://www.hscic.gov.uk/ catalogue/PUB08661 .,Non-OADS,/arxiv_data1/oa_pdf/5f/30/13300_2014_Article_79.PMC4269656.pdf
Available at https://statswales.wales.gov.uk/ Catalogue/Health-and-Social-Care/NHS-Primary- and-Community-Activity/GMS-Contract .,Non-OADS,/arxiv_data1/oa_pdf/5f/30/13300_2014_Article_79.PMC4269656.pdf
2011.Available at http://www.ic.nhs.uk/webﬁles/ publications/prescribing%20diabetes%20200506Diabetes Ther (2014) 5:567–578 577,Non-OADS,/arxiv_data1/oa_pdf/5f/30/13300_2014_Article_79.PMC4269656.pdf
"Vasteras, Sweden, 2010. http://www.socialstyrelsen.se/ nationalguidelines/nationalguidelinesfordiabetescare .",Non-OADS,/arxiv_data1/oa_pdf/6d/0e/13300_2014_Article_80.PMC4269657.pdf
http://guidance.nice.org.uk/TA288/ PublicInfo/pdf/English .,Non-OADS,/arxiv_data1/oa_pdf/6d/0e/13300_2014_Article_80.PMC4269657.pdf
http://www.nice.org.uk/ guidance/index.jsp?action=download&o=66677 .,Non-OADS,/arxiv_data1/oa_pdf/6d/0e/13300_2014_Article_80.PMC4269657.pdf
http://www.tlv.se .,Non-OADS,/arxiv_data1/oa_pdf/6d/0e/13300_2014_Article_80.PMC4269657.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Brain oxygenation after TBI L Østergaard et al 1598 Journal of Cerebral Blood Flow & Metabolism (2014), 1585 – 1598 &2014 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/ba/a3/jcbfm2014131a.PMC4269727.pdf
Editor: Christopher Yip./C2112014 The Authors 0006-3495/14/12/3018/12 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.11.003 3018 Biophysical Journal Volume 107 December 2014 3018–3029,Non-OADS,/arxiv_data1/oa_pdf/56/75/main.PMC4269784.pdf
(The tools can be found under the Calcium Spark model and the example histories and workﬂows under Shared Data at http://cvrg.galaxycloud.org .),OADS,/arxiv_data1/oa_pdf/56/75/main.PMC4269784.pdf
(An example Ca2þspark dataset can be viewed at http://cvrg.galaxycloud.org/u/mwalker/h/spark-linescan .),OADS,/arxiv_data1/oa_pdf/56/75/main.PMC4269784.pdf
"(An example dataset for Ca2þspark ﬁdelity and leak estimates is available at http://cvrg.galaxycloud.org/u/mwalker/h/ ﬁdelity-leak , and for ECC gain at http://cvrg.galaxycloud.org/u/mwalker/ h/ecc-gain .)",OADS,/arxiv_data1/oa_pdf/56/75/main.PMC4269784.pdf
http://wias-berlin.de/software/tetgen/ .,Non-OADS,/arxiv_data1/oa_pdf/56/75/main.PMC4269784.pdf
Editor: Jochen Guck./C2112014 The Authors 0006-3495/14/12/2923/9 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.09.050 Biophysical Journal Volume 107 December 2014 2923–2931 2923,Non-OADS,/arxiv_data1/oa_pdf/3a/2e/main.PMC4269786.pdf
Editor: Alan Grodzinsky./C2112014 The Authors 0006-3495/14/12/2767/8 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.10.052 Biophysical Journal Volume 107 December 2014 2767–2774 2767,Non-OADS,/arxiv_data1/oa_pdf/ac/fb/main.PMC4269791.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jidSS Saini et al.,Non-OADS,/arxiv_data1/oa_pdf/a7/1f/jid2014306a.PMC4269803.pdf
"http://www.gene.com/gene/products/information/pdf/xolair-prescribing.pdf, last accessed 3 April 2014 Gober LM, Sterba PM, Eckman JA et al.",OADS,/arxiv_data1/oa_pdf/a7/1f/jid2014306a.PMC4269803.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/SS Saini et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/1f/jid2014306a.PMC4269803.pdf
"Dermatology and Venerology, Farhat Hached University Hospital, Sousse, Tunisia; 4Department of Dermatology and Venerology, Nabeul Regional Hospital, Nabeul, Tunisia; 5Department of Human Genetics, David Geffen School of Medicine, University of California,Los Angeles, Los Angeles, California, USA; 6E´cole Pratique des Hautes E ´tudes, heSam University and Institut du Cerveau et de laMoelle Epinie `re, Sorbonne University, Pitie ´- Salpeˆtrie`re Hospital, Paris, France; 7Department of Pathological Anatomy and Cytology, FarhatHached University Hospital, Sousse, Tunisia and 8Department of Paediatrics, National University of Singapore, Singapore, SingaporeE-mail: ali.saad@rns.tn or bruno@reversade.com SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Abecasis GR, Cherny SS, Cookson WO et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/1b/jid2014311a.PMC4269804.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Disease Control in Cutaneous Leishmaniasis Is Independent of IL-22 Journal of Investigative Dermatology (2015) 135, 308–311; doi:10.1038/jid.2014.282; published online 14 August 2014 TO THE EDITOR Cutaneous leishmaniasis is a parasiticdisease caused by dermatotropic sub-species of Leishmania .",Non-OADS,/arxiv_data1/oa_pdf/2c/1b/jid2014311a.PMC4269804.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Hearing among male ﬁreﬁghters Kang et al 112 Journal of Exposure Science and Environmental Epidemiology (2015), 106 –112 © 2015 Nature America, Inc.",Non-OADS,/arxiv_data1/oa_pdf/5d/8d/jes201472a.PMC4269805.pdf
"Colin R. Lindsay1, Ang Li1, William Faller1,B r a dO z a n n e1, Heidi Welch2, Laura M. Machesky1and Owen J. Sansom1 1Cancer Research UK Beatson Institute, Glasgow, UK and2The Babraham Institute, Cambridge, UKE-mail: o.sansom@beatson.gla.ac.uk SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Barber M, Donald S, Thelen S et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/b0/jid2014323a.PMC4269807.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Rationale for the Development of Speckled Hyperpigmentation in the Areas of Psoriatic Plaquesafter Treatment with Biologic Agents Journal of Investigative Dermatology (2015) 135, 318–320; doi:10.1038/jid.2014.297; published online 21 August 2014 TO THE EDITOR We read with great interest the originalarticle by Wang et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/b0/jid2014323a.PMC4269807.pdf
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS A.M.H.,Non-OADS,/arxiv_data1/oa_pdf/a0/7a/mi201459a.PMC4269809.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLES 220 VOLUME 8 NUMBER 1 |JANUARY 2015 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/a0/7a/mi201459a.PMC4269809.pdf
11-3892. http://diabetes.niddk.nih.gov/dm/pubs/ statistics/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/08/de/40268_2014_Article_66.PMC4269813.pdf
http://www.diabetes.org/diabetes-basics/diabetes-statistics/ .,Non-OADS,/arxiv_data1/oa_pdf/08/de/40268_2014_Article_66.PMC4269813.pdf
http://www.goodrx.com/atorvastatin/price .,Non-OADS,/arxiv_data1/oa_pdf/d2/aa/40268_2014_Article_61.PMC4269817.pdf
"2.11 Prediction of GATAD2B andTEAD1 as Target Genes of miR-520d-5p The potential target genes for miR-520d-5p (MIMAT0002855: cuacaaagggaagcccuuuc) were p redicted using several dat- abases (miRBase: http://www.mirbase.org , DIANA-MI- CROT: http://diana.cslab.ece .ntua.gr/DianaTools/ ,m i R D B : http://mirdb.org , RNA22-HAS: http://cm.jefferson.edu/ rna22v1.0 , TargetMiner: http://www.isical.ac.in/ *bioinfo_ miu,m i r c o R N A .",OADS,/arxiv_data1/oa_pdf/0c/9a/40268_2014_Article_64.PMC4269822.pdf
"o r g : http://www.microrna.org/microrna ,a n d TargetScan-VERT: http://www.targetscan.org/cgi-bin/ targetscan/vert_50 ).",OADS,/arxiv_data1/oa_pdf/0c/9a/40268_2014_Article_64.PMC4269822.pdf
Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet].Rockville: US Agency for Healthcare Research and Quality; 2012. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf .,OADS,/arxiv_data1/oa_pdf/d9/0e/40268_2014_Article_67.PMC4269826.pdf
"All statistical operations were done with R 2.15.1 software (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org ).",OADS,/arxiv_data1/oa_pdf/70/34/40268_2014_Article_73.PMC4269827.pdf
http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/70/34/40268_2014_Article_73.PMC4269827.pdf
"Each wearable node consists of a 900 MHz Mica2Dot MOTE (running TinyOS  operating system), with Chipcon's SmartRF CC1000 radio chip ( http://www.chipcon.com/ ),  and the sensor card MTS510 from Crossbow Inc. ( http://www.xbow.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/23/25/nihms614376.PMC4269839.pdf
http://grants2.nih.gov/grants/guide/pa-files/ PA-07-354.html 4.,Non-OADS,/arxiv_data1/oa_pdf/23/25/nihms614376.PMC4269839.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/3d/srep07538.PMC4269876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7538 | DOI: 10.1038/srep07538 6",Non-OADS,/arxiv_data1/oa_pdf/1b/3d/srep07538.PMC4269876.pdf
http://japan.kantei.go.jp/kan/topics/201106/iaea_houkokusho_e.html (2011) (Date of access:31/10/2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://www.iaea.org/ newscenter/focus/fukushima/japan-report2/japanreport120911.,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://radioactivity.nsr.go.jp/en/contents/ 4000/3180/view.html (2011) (Date of access:31/10/2014).,OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://www.meti.go.jp/english/earthquake/ nuclear/roadmap/pdf/20130807_01.pdf (2013) (Date of access:31/10/2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://www-pub.iaea.org/mtcd/publications/ pdf/te_1162_prn.pdf#search 5’IAEATECDOC1162’ (2000) (Date of access:31/ 10/2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://www.iaea.org/inis/collection/NCLCollectionStore/_ Public/11/531/11531386.pdf (1979) (Date of access:31/10/2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
"http://www.unscear.org/docs/reports/1977,%2032nd%20session%20(Suppl.%20No.40)/ ANNEX-B-1_unscear.pdf (1977) (Date of access:31/10/2014).",Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
59.13.http://digicoll.manoa.hawaii.edu/techreports/PDF/CEX-59.13.pdf (1960) (Date of access:31/10/2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
"Jensen, P. H. Atmospheric Dispersion and Environmental Consequences – Exposure from Radioactive Plume Pathways, Rep. Risø-M-2849(EN).http://orbit.dtu.dk/fedora/objects/orbit:91059/datastreams/file_7783642/content (1992) (Date of access:31/10/2014).",OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
http://www.osti.,Non-OADS,/arxiv_data1/oa_pdf/cf/f2/srep07541.PMC4269877.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/3a/srep07547.PMC4269879.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7547 | DOI: 10.1038/srep07547 9",Non-OADS,/arxiv_data1/oa_pdf/33/3a/srep07547.PMC4269879.pdf
wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/10/srep07528.PMC4269880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7528 | DOI: 10.1038/srep07528 9",Non-OADS,/arxiv_data1/oa_pdf/c1/10/srep07528.PMC4269880.pdf
Additional information Note The protein interactions from this publication have been submitted to the IMEx (http://www.imexconsortium.org) consortium through the IntAct database37and assigned the identifier IM-23549.,OADS,/arxiv_data1/oa_pdf/ea/92/srep07531.PMC4269881.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/92/srep07531.PMC4269881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7531 | DOI: 10.1038/srep07531 11",Non-OADS,/arxiv_data1/oa_pdf/ea/92/srep07531.PMC4269881.pdf
http://lanet-vi.soic.indiana.edu/lanetvi-22.pdf (2006) Date of access:26/09/2014.,Non-OADS,/arxiv_data1/oa_pdf/b5/53/srep07550.PMC4269882.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7550 | DOI: 10.1038/srep07550 7",Non-OADS,/arxiv_data1/oa_pdf/b5/53/srep07550.PMC4269882.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8b/6d/srep07540.PMC4269883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7540 | DOI: 10.1038/srep07540 8",Non-OADS,/arxiv_data1/oa_pdf/8b/6d/srep07540.PMC4269883.pdf
"Luciferase reporter assay .In order to figure out miR-223-3p downstream target gene, we searched the three microRNA targets gene prediction systems: PicTar (http://pictar.mdc-berlin.de/), microRNA (http://www.microrna.org/), MiRBase (http://www.mirbase.org/) and TargetSpy (http://www.targetspy.org/).",OADS,/arxiv_data1/oa_pdf/26/f2/srep07546.PMC4269886.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7546 | DOI: 10.1038/srep07546 8",Non-OADS,/arxiv_data1/oa_pdf/26/f2/srep07546.PMC4269886.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7542 | DOI: 10.1038/srep07542 5",Non-OADS,/arxiv_data1/oa_pdf/b8/1e/srep07542.PMC4269887.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/94/03/srep07536.PMC4269889.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7536 | DOI: 10.1038/srep07536 5",Non-OADS,/arxiv_data1/oa_pdf/94/03/srep07536.PMC4269889.pdf
ACS Nano http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6a/srep07543.PMC4269890.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7543 | DOI: 10.1038/srep07543 6",Non-OADS,/arxiv_data1/oa_pdf/1f/6a/srep07543.PMC4269890.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ab/5e/srep07529.PMC4269891.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7529 | DOI: 10.1038/srep07529 6",Non-OADS,/arxiv_data1/oa_pdf/ab/5e/srep07529.PMC4269891.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7551 | DOI: 10.1038/srep07551 8",Non-OADS,/arxiv_data1/oa_pdf/be/f8/srep07551.PMC4269895.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/e8/srep07549.PMC4269896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7549 | DOI: 10.1038/srep07549 10",Non-OADS,/arxiv_data1/oa_pdf/0d/e8/srep07549.PMC4269896.pdf
wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/srep07535.PMC4269897.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7535 | DOI: 10.1038/srep07535 12",Non-OADS,/arxiv_data1/oa_pdf/70/6e/srep07535.PMC4269897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/02/pgpm-7-367.PMC4270036.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2014:7 367–377Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  367Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/52761.S 0Patient profiling in diabetes and role   of canagliflozin Ambika Amblee1,2 1Division of endocrinology, John H  Stroger Jr Hospital of Cook County,   2Rush University Medical Center,   Chicago, iL, USA Correspondence: Ambika Amblee   Division of endocrinology, John H  Stroger Jr Hospital of Cook County,   1900 West Polk Street, Suite 805,  Chicago, iL 60612, USA   Tel +1 312 864 0543   Fax +1 312 864 9734   email aamblee@cookcountyhhs.or gBackground:  Physicians attempt to achieve glycemic goals in patients with type 2 diabetes  mellitus (T2DM) through various means, including glucose-lowering medications.",Non-OADS,/arxiv_data1/oa_pdf/4a/02/pgpm-7-367.PMC4270036.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international,  peer-reviewed, open access journal characterizing the influence of  genotype on pharmacology leading to the development of person - alized treatment programs and individualized drug selection for  improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/4a/02/pgpm-7-367.PMC4270036.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/02/pgpm-7-367.PMC4270036.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/24/pgpm-7-379.PMC4270037.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2014:7 379–385Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  379Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PGPM.S7276 0Mycophenolic acid aUc in Thai kidney transplant  recipients receiving low dose mycophenolate and  its association with UGT2B7  polymorphisms Manop Pithukpakorn1 Tiwat Tiwawanwong2 Yupaporn lalerd3 anunchai assawamakin3,4 nalinee Premasathian2 adis Tasanarong5 Wanna Thongnoppakhun3 attapong Vongwiwatana2 1Division of Medical genetics,   2Division of nephrology, Department  of Medicine,  3Division of Molecular  genetics, Department of research  and Development, Faculty of Medicine  siriraj hospital,  4Department of  Pharmacology, Faculty of Pharmacy,   Mahidol University,  5Department  of Medicine, Faculty of Medicine,   Thammasat University, Bangkok,   Thailand correspondence: attapong  Vongwiwatana   Division of nephrology, Department  of Medicine, Faculty of Medicine, siriraj  hospital, Mahidol University,  2 Prannok  road, Bangkok noi, Bangkok,   10700, Thailand   Tel +66 2 419 8383  email siavw@hotmail.co mBackground:  Despite use of a lower mycophenolate dose in Thai kidney transplant patients,  accep table  graft and patient outcomes can be achieved.",Non-OADS,/arxiv_data1/oa_pdf/cf/24/pgpm-7-379.PMC4270037.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/cf/24/pgpm-7-379.PMC4270037.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cf/24/pgpm-7-379.PMC4270037.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/06/pgpm-7-387.PMC4270038.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 387–398Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  387Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PGPM.S5262 9Finally sofosbuvir: an oral anti-HCv   drug with wide performance capability Zeid Kayali1 warren N Schmidt2,3 1Division of Gastroenterology and  Hepatology, University of Southern  California, Los Angeles, CA, USA;   2Department of internal Medicine  and Research Service, veterans Affairs  Medical Center, iowa City, iA, USA;   3Roy G and Lucille A Carver College  of Medicine, University of iowa, iowa  City, iA, USA Correspondence: warren N Schmidt   Department of internal Medicine,   University of iowa Hospitals   and Clinics,  200 Hawkins Drive,   4553 JCP iowa City, iA  52242, USA   Tel +1 (319)  353 7048  Fax +1 (319)  356 7918  email warren-schmidt@uiowa.ed uAbstract:  Chronic Hepatitis C virus  (HCV) infection is the leading cause of advanced liver  disease worldwide.",Non-OADS,/arxiv_data1/oa_pdf/43/06/pgpm-7-387.PMC4270038.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/43/06/pgpm-7-387.PMC4270038.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/43/06/pgpm-7-387.PMC4270038.pdf
"Available from: http://www.natap.org/2013/ HCV/20131025-A VDAC-B1-02-Gilead.pd f. Accessed August 25,  2014.",OADS,/arxiv_data1/oa_pdf/43/06/pgpm-7-387.PMC4270038.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/ppa-8-1629.PMC4270191.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1629–1634Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1629Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S3883 0Alitretinoin for the treatment of severe   chronic hand eczema Thomas King John McKenna Anton B Alexandroff Department of Dermatology,  University Hospitals of Leicester,  Leicester Royal infirmary, Leicester, UK Correspondence: Anton B Alexandroff   Department of Dermatology, Leicester  Royal Infirmary, Infirmary Square,  Leicester Le1 5ww, UK   email anton.alexandroff@uhl-tr.nhs.u kAbstract:  Chronic hand eczema is a common and often debilitating condition.",Non-OADS,/arxiv_data1/oa_pdf/9c/5a/ppa-8-1629.PMC4270191.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9c/5a/ppa-8-1629.PMC4270191.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/ppa-8-1629.PMC4270191.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/c4/ppa-8-1635.PMC4270192.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1635–1645Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1635OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6684 9Perceived need to take medication is associated  with medication non-adherence in patients  with rheumatoid arthritis hanneke e Zwikker1,2 sandra van Dulmen3–5 Alfons A den Broeder1,2 Bart J van den Bemt1,2,6 cornelia h van den ende1,2 1Department of rheumatology,   2Department of Pharmacy, sint  Maartenskliniek, nijmegen, the  netherlands; 3Department of Primary  and community care, radboud  University Medical centre, nijmegen,   the netherlands; 4niVel (n etherlands  institute for health services  research), Utrecht, the netherlands;   5Department of health science,   Buskerud and Vestfold University  college, Drammen, norway;   6Department of Pharmacy, radboud  University Medical centre, nijmegen,   the netherlandsBackground:  This is the first cross-sectional study that aims to examine associations between  beliefs about medication and non-adherence in patients with rheumatoid arthritis (RA) using  disease-modifying antirheumatic drugs, taking potential psychological confounders into  account.",Non-OADS,/arxiv_data1/oa_pdf/9b/c4/ppa-8-1635.PMC4270192.pdf
"Box 9011, 6500  gM nijmegen, the netherlands Tel +31 24 365 8213 Fax +31 24 365 9006 email b.vandenbemt@maartenskliniek.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Zwikker et al Running head recto: Association between perceived need to take medication and non-adherence DOI: http://dx.doi.org/10.2147/PPA.S66849",Non-OADS,/arxiv_data1/oa_pdf/9b/c4/ppa-8-1635.PMC4270192.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9b/c4/ppa-8-1635.PMC4270192.pdf
"In vitro adsorption, distribution, metabolism and excretion (ADME) studies were conducted at Cerep (Redmond, WA, USA) according to their institutional standard operating procedures (SOP) (http://www.cerep.fr/cerep/users/pages/catalog/profiles/catalog.asp).",OADS,/arxiv_data1/oa_pdf/77/20/bcpt0115-0456.PMC4270215.pdf
"World Health Organiza- tion, Geneva, 2002; 1, http://www.who.int/ipcs/publications/ new_issues/endocrine_disruptors/en/ (last accessed on 19 May2014).",Non-OADS,/arxiv_data1/oa_pdf/b4/c6/bcpt0115-0118.PMC4270256.pdf
http://chm.pops.int/ (last accessed on 1 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/b4/c6/bcpt0115-0118.PMC4270256.pdf
"Oslo, Norway, 2009.http://www.amap.no/ (last accessed on 1 June 2009).",Non-OADS,/arxiv_data1/oa_pdf/b4/c6/bcpt0115-0118.PMC4270256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 1003–1011Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1003REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4933 0Trabectedin for advanced soft tissue sarcomas:  optimizing use Alison Reid Juan Martin-Liberal Charlotte Benson Sarcoma Unit, The Royal Marsden  NHS Foundation Trust, London, UKAbstract:  Patients with locally advanced or metastatic soft tissue sarcoma have a poor outlook  with median survival in the order of 1 year.",Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
"This review examines Correspondence: Alison Reid The Royal Marsden NHS Foundation  Trust, Downs Road, Sutton,   Surrey SM2 5PT, UK Tel +44 208 661 3458 Email alison.reid@rmh.nhs.u k Journal name: Therapeutics and Clinical Risk Management Article Designation: REVIEW Y ear: 2014 Volume: 10 Running head verso: Reid et al Running head recto: Trabectedin for advanced soft tissue sarcomas DOI: http://dx.doi.org/10.2147/TCRM.S49330",Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
Available from: http://clinicaltrials.gov/show/ NCT01343277.,Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/23/tcrm-10-1003.PMC4270297.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/16/bctt-6-205.PMC4270298.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2014:6 205–209Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  205Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/ 10.2147/BCTT .S7367 4Immunohistochemical analysis of aldehyde  dehydrogenase isoforms and their association  with estrogen-receptor status and disease  progression in breast cancer Lynn M opdenaker1,2 Kimberly M Arnold1,3 ryan T pohlig3,4 Jayasree S padmanabhan1 Daniel C Flynn1,3 Jennifer Sims-Mourtada1–3 1Center for Translational Cancer  research, helen F Graham Cancer  Center, Christiana Care health  Services, Inc., Newark, Delaware, USA;   2Department of Biological Sciences,   3Department of Medical Laboratory  Sciences, 4Biostatistics Core Facility,   University of Delaware, Newark,   Delaware, USA Correspondence: Jennifer Sims-Mourtada   Center for Translational Cancer  research, helen F Graham Cancer  Center and research Institute   Christiana Care health Services, Inc.,  4701 ogletown Stanton rd Suite 4300,  Newark, Delaware 19713, USA   Tel +1 302 623 4648   Fax +1 302 623 4314   email jsimsmourtada@christianacare.or gAbstract:  In many types of tumors, especially breast tumors, aldehyde dehydrogenase (ALDH)  activity has been used to identify cancer stem-like cells within the tumor.",Non-OADS,/arxiv_data1/oa_pdf/4d/16/bctt-6-205.PMC4270298.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/4d/16/bctt-6-205.PMC4270298.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/60/ppa-8-1713.PMC4270299.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1713–1720Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1713OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6470 9Patient preference and ease of use for different  coagulation factor Viii reconstitution device  scenarios: a cross-sectional survey in five  european countries ernesto cimino1 silvia linari2 Mara Malerba3 susan halimeh4  Francesca Biondo5 Martina Westfeld5 1Dipartimento Medicina clinica  e sperimentale,  Universita’ degli  studi di napoli Federico ii, naples,   italy; 2Agenzia per l’ emofilia, AOU  careggi di Firenze, Florence, italy;   3Fondazione cà granda Ospedale  Maggiore Policlinico, centro emofilia  e Trombosi “A Bianchi Bonomi”,    Milan, italy; 4crc  coagulation  research centre gmbh, Duisburg,   germany; 5Pfizer italia, rome, italy correspondence: ernesto cimino Dipartimento Medicina clinica e  sperimentale, Universita’ degli studi di  napoli Federico ii, Via s Pansini,   5, 80131 napoli, italy Tel +39 081 746 2060 Fax +39 081 746 2060 email ernesto.cimino@unina.i tJournal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Cimino et al Running head recto: Patient preference for FVIII reconstitution devices DOI: http://dx.doi.org/10.2147/PPA.S64709 Introduction:  Hemophilia A treatment involves replacing the deficient coagulation factor VIII.",Non-OADS,/arxiv_data1/oa_pdf/90/60/ppa-8-1713.PMC4270299.pdf
Available from: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/90/60/ppa-8-1713.PMC4270299.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/90/60/ppa-8-1713.PMC4270299.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/amep-5-491.PMC4270300.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 491–498Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  491OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7322 1learning psychology as a challenging process  towards development as well as “studies   as usual”: a thematic analysis of medical   students’ reflective writing Olof semb1 niclas Kaiser2 sven-Olof Andersson1 Elisabet sundbom3 1Department of clinical sciences,   Division for Professional  Development, Umeå University, Umeå,   sweden; 2Department of Psychology,   Umeå University, Umeå, sweden;   3Department of clinical sciences,   Division for Psychiatry and Medical   Psychology, Umeå University,    Umeå, sweden correspondence: Olof semb   Department of clinical sciences,   Umeå University hospital,   sE-901 87 Umeå, sweden   Tel +46 90 7856493   Email olof.semb@psychiat.umu.s eAbstract:  Reflective writing in medical training has been shown to be most effective when   combined with some form of personal meeting or dialog.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/amep-5-491.PMC4270300.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/eb/dd/amep-5-491.PMC4270300.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/dd/amep-5-491.PMC4270300.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/8f/sar-5-129.PMC4270301.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2014:5 129–137Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  129Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S5683 5evolutionary and neuropsychological perspectives  on addictive behaviors and addictive substances:  relevance to the “food addiction” construct Caroline Davis School of Kinesiology and Health  Science, York University, Toronto,   ON, Canada Correspondence: Caroline Davis   School of Kinesiology and Health Science,  343 Bethune College, York University,  4700 Keele Street, Toronto,   ON M3J 1P3, Canada   Tel +1 416 736 2100 ext 77 327   email cdavis@yorku.c aAbstract:  It has been argued that food cannot be “addictive”, unlike conventional drugs  of abuse, because it is an essential part of life.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/sar-5-129.PMC4270301.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/46/8f/sar-5-129.PMC4270301.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/8f/sar-5-129.PMC4270301.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1705–1712Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1705Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3898 7Patient involvement in selection of  immunosuppressive regimen following  transplantation  Joyce Popoola1,3 Helen Greene2 Margaret Kyegombe2 iain A MacPhee1,3 1Department of Nephrology  and Transplantation, 2Department of  Pharmacy, St George’s Healthcare  NHS Trust, 3St George’s University  of London, London, UKAbstract:  Transplantation has made a considerable difference to the lives of many patients.",Non-OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
"Correspondence: Joyce Popoola Department of Nephrology  and Transplantation, St George’s  Healthcare NHS Trust, Blackshaw Road,  London, Sw17 0QT, UK Tel +208 725 2705 Fax +208 725 2068 email jpopoola@sgul.ac.u k Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Popoola et al Running head recto: Transplant patient involvement in immunosuppressant regime DOI: http://dx.doi.org/10.2147/PPA.S38987",Non-OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/213823/dh_117794.pdf.,OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
Available from:  https://www.govtrack.us/congress/bills/111/hr3590/text.,Non-OADS,/arxiv_data1/oa_pdf/89/8c/ppa-8-1705.PMC4270302.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/1e/cia-9-2165.PMC4270303.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2165–2176Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2165OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6836 3Validity of a screening tool for detecting subtle  cognitive impairment in the middle-aged  and elderly Kathryn M Bruce1  stephen r robinson2 Julian A smith1 gregory W Yelland2,3 1Department of surgery (MMC),   Monash University, Clayton, 2school  of health sciences, rMIT University,   Bundoora, 3Central Clinical school,   Monash University, Alfred health,   Melbourne, VIC, AustraliaAbstract:  The present study tested 121 middle-aged and elderly community-dwelling  individuals on the computer-based Subtle Cognitive Impairment Test (SCIT) and compared  their performance with that on several neuropsychological tests.",Non-OADS,/arxiv_data1/oa_pdf/3a/1e/cia-9-2165.PMC4270303.pdf
"Reasons range from detecting early stages of dementia to testing for the  adverse effects of medications and major surgery.1,2 A survey of geriatric specialists  found that cognitive assessments typically rely on screening tools that can be biased  by language, culture, and education.3 A review of cognitive screening in primary care  and geriatric services in the UK and Canada concluded that better screening tools are  urgently needed.4 An ideal screening tool is brief in application, requires simple responses from the  patient, is psychometrically robust, and is sensitive to changes across a wide range  of cognitive domains.2,5 The search for better screening tools has favored the devel - opment of computer-based tests,6 as they can provide uniformity of administration,  accurate recording of responses, and objective scoring.7–9 Several computerized test  batteries (eg, MicroCog, CogState, CANTAB) are now widely used to detect cognitive  impairment.10,11Correspondence: gregory W Yelland school of health sciences, rMIT  University, PO Box 71, Bundoora,  Victoria 3083, Australia Tel +61 4 1830 7018 Fax +61 3 9925 7503 email greg.yelland@rmit.edu.au Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Bruce et al Running head recto: Validity of a screening tool for subtle cognitive impairment DOI: http://dx.doi.org/10.2147/CIA.S68363",Non-OADS,/arxiv_data1/oa_pdf/3a/1e/cia-9-2165.PMC4270303.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3a/1e/cia-9-2165.PMC4270303.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3a/1e/cia-9-2165.PMC4270303.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 499–505Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  499OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7487 6improvements in canMEDs competencies   for medical students in an interdisciplinary   and voluntary setting Mads Dam Vildbrad Johanne Marie lyhne international Medical cooperation  committee, Aarhus University,    Aarhus, Denmark correspondence: Mads Dam Vildbrad   international Medical cooperation  committee, Medicinerhuset,   Building 1161, Ole Worms Allé 3,   DK-8000 Aarhus, Denmark   Tel +45 2045 0486   Email mads.dam.vildbrad@gmail.co mBackground:  To practice medicine, doctors must master leadership, communication, team  management, and collaboration, in addition to medical knowledge.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
"Available from:  http://www.royalcollege.ca/portal/page/portal/rc/common/documents/  canmeds/resources/publications/framework_full_e.pd f. Accessed  August 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
Available from: http://sundhedsstyrelsen.dk/publ/ Publ2013/05maj/ De7laegeroller2udg .pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/77/amep-5-499.PMC4270304.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/b1/vhrm-10-691.PMC4270305.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 691–698Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  691ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7368 8effects of exercise timing on sleep architecture  and nocturnal blood pressure in prehypertensives Kimberly Fairbrother1 Ben cartner1 Jessica R alley1 chelsea D curry1 David l Dickinson2 David M Morris1 scott R collier1 1Vascular Biology and autonomic  studies laboratory, Department  of Health and exercise science,   2Department of economics,   appalachian state University,    Boone, nc, Usa correspondence: scott R collier   Vascular Biology and autonomic   studies laboratory, appalachian state  University, 111 Rivers street – Hcc 046,  Boone, nc 28608, Usa   Tel +1 828 262 7145   Fax +1 828 262 3138   email c olliersr@appstate.ed uBackground:  During nocturnal sleep, blood pressure (BP) “dips” compared to diurnal BP ,  reducing stress on the cardiovascular system.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/vhrm-10-691.PMC4270305.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/vhrm-10-691.PMC4270305.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/b1/vhrm-10-691.PMC4270305.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/9d/cia-9-2151.PMC4270306.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 2151–2158Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  2151OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5344 1Aline de Freitas Brito1 Caio Victor Coutinho de  Oliveira2 Maria do socorro Brasileiro- santos1 Amilton da Cruz santos1 1Physical education Department,   2research laboratory for Physical  Training Applied to Performance and  health, Federal University of Paraíba,   João Pessoa, Brazil Correspondence: Caio Victor Coutinho  de Oliveira   Campus I, Castelo Branco I, Federal  University of Paraiba, João Pessoa,  Paraíba, Brasil 58.051-900   Tel +55 83 3216 7212   email caiovco@gmail.co mresistance exercise with different volumes: blood  pressure response and forearm blood flow in the  hypertensive elderlyJournal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Brito et al Running head recto: Resistance exercise, BP response, and forearm blood flow in the elderly DOI: http://dx.doi.org/10.2147/CIA.S53441 Background:  The purpose of this study was to evaluate the effect of two sessions of resistance  exercise with different volumes on post-exercise hypotension, forearm blood flow, and forearm  vascular resistance in hypertensive elderly subjects.",Non-OADS,/arxiv_data1/oa_pdf/5e/9d/cia-9-2151.PMC4270306.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5e/9d/cia-9-2151.PMC4270306.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5e/9d/cia-9-2151.PMC4270306.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2014:7 335–339Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  335RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S7441 1Use of radiofrequency in cosmetic dermatology:  focus on nonablative treatment of acne scars Brian J Simmons Robert D Griffith Leyre A Falto-Aizpurua Keyvan Nouri Department of Dermatology and  Cutaneous Surgery, University of  Miami Miller School of Medicine,   University of Miami, Miami, FL, USA Correspondence: Brian J Simmons   University of Miami Miller School of  Medicine, Department of Dermatology  and Cutaneous Surgery,  1475 Nw    12th Ave, Miami, FL  33136, USA   Tel +1 305 243 3996  Fax +1 305 243 4184  email bjsimmons@med.miami.ed uAbstract:  Acne is a common affliction among many teens and some adults that usually resolves  over time.",Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
Or use: http://dvpr.es/1zO8Bc H,Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
"Available from:  http://emedicine.medscape.com/article/1126583-overvie w. Accessed  September  8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/aa/15/ccid-7-335.PMC4270307.pdf
Available at http://www.alzheimers.org.,Non-OADS,/arxiv_data1/oa_pdf/30/93/tp2014122a.PMC4270308.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Effects of lifestyle interventions in the elderly T Shah et al 9 Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/30/93/tp2014122a.PMC4270308.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Role of functional LepRb in antidepressant ef ﬁcacy M Guo and X-Y Lu 9 Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/27/e7/tp2014126a.PMC4270309.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Inﬂammation and lithium modulate suicidal behavior E Beurel and RS Jope 7 Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/03/e8/tp2014129a.PMC4270310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)HTR1A and fear mechanisms B Straube et al 10 Translational Psychiatry (2014), 1 –10",Non-OADS,/arxiv_data1/oa_pdf/da/fc/tp2014130a.PMC4270311.pdf
overviewed this project.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8c/84/srep07422.PMC4270353.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/fd/lra-7-069.PMC4270354.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2014:7 69–74Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  69Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S6451 5Infiltration of liposome bupivacaine   into the transversus abdominis plane   for postsurgical analgesia in robotic   laparoscopic prostatectomy: a pilot study Andrew Sternlicht1 Max Shapiro1 Gary Robelen1 Usha vellayappan1 Ingolf A T uerk2 1Department of Anesthesiology  and Pain Medicine,  2Department  of Urology, S teward St Elizabeth’s  Medical Center, Tufts University  School of Medicine, Boston, MA, USA Correspondence: Andrew Sternlicht   CAP Anesthesia PC, St Elizabeth’s  Medical Center,  736 Cambridge St,  Department of Anesthesiology and Pain  Medicine, Brighton, MA  02135, USA   Tel +1 617 789 2782  Fax +1 617 254 6384  email a ndrew.",Non-OADS,/arxiv_data1/oa_pdf/34/fd/lra-7-069.PMC4270354.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/34/fd/lra-7-069.PMC4270354.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/fd/lra-7-069.PMC4270354.pdf
"Available from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/ E6_R1_Guideline.pd f. Accessed September 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/34/fd/lra-7-069.PMC4270354.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/60/opth-8-2533.PMC4270355.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2533–2539Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2533Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S7113 6Optic disc topography in Malay patients  with normal-tension glaucoma and primary  open-angle glaucoma abdul rahim adlina1,2  Koh alisa-Victoria1 ismail shatriah1 ahmad Tajudin liza- sharmini1  Mt saad ahmad2  1Department of Ophthalmology,   school of Medical sciences, health  Campus, Universiti sains Malaysia,   Kubang Kerian, Kelantan, Malaysia;  2Department of Ophthalmology,   hospital sultanah Bahiyah, alor setar,   Kedah, MalaysiaBackground:  There are limited data concerning the optic disc topography in normal-tension  glaucoma (NTG) and primary open-angle glaucoma (POAG) patients living in Southeast Asian  countries.",Non-OADS,/arxiv_data1/oa_pdf/c4/60/opth-8-2533.PMC4270355.pdf
"Previous descriptions of Correspondence: ismail shatriah Department of Ophthalmology,  school of Medical sciences, Universiti  sains Malaysia, 16150 Kubang Kerian,  Kelantan, Malaysia email shatriah@usm.m y Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Adlina et al Running head recto: Optic disc topography and glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S71136",Non-OADS,/arxiv_data1/oa_pdf/c4/60/opth-8-2533.PMC4270355.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/c4/60/opth-8-2533.PMC4270355.pdf
